Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2012 Report: 7th International Workshop on Autoantibodies ans Autoimmunity http/www/rheuma21st.com/archives///report_shoenfeld….html
2. 2012 Diagonal ear lobe crease and coronary risk factors J Amer Ger Soc 28:184-188, 190.
3. 2011 ASIA' – autoimmune / inflammatory syndrome induced by adjuvants J of Autoimmun 36: 4-8, 2011
4. 2011 Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: Two faces of the same coin Arthritis Care Res. 63: 178 – 183, 2011
5. 2011 Evidence of impaired sense of smell in hereditary angioedema Allergy 66: 149–154, 2011.
6. 2011 Neuropsychiatric syndromes in systemic lupus erythematosus: A meta- analysis Semin Arthritis Rheum 2011; 41: 1-11.
7. 2011 Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality Autoimmun Rev 10 :259–266, 2011
8. 2011 Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression Ann Rheum Dis 20: 145-150, 2011
9. 2011 The common immunogenic etiology of chronic fatigue syndrome: From infections to vaccines via adjuvants to the ASIA syndrome Infect Dis Clin North Am ; 25:851-63, 2011
10. 2011 Response to health in the occupied Palestinian territory. The Lancet Vol. 378, October 29, 2011
11. 2011 EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases Ann Rheum Dis 70:414-22, 2011
12. 2011 Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vccination in adult patients with autoimmune inflammatory rheumatic diseases Autoimmun Rev 10: 341-52, 2011
13. 2011 Thymoma and autoimmunity.   Cell Mol Immunol. Feb 14, 2011 ___ In Press Cellular & Molecular Immunology 8, 199-202 (May 2011).
14. 2011 Broken Heart Syndrome” (Takotsubo Cardiomyopathy) IMAJ 13: 643-644, 2011
15. 2011 Refractory disease in autoimmune diseases Autoimmun Rev 10: 653-654, 2011
16. 2011 Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4+ T cell response to β2GPI. Ann Rheum Dis 2011________Online First, published on September 12, 2011 as 10.1136/annrheumdis-2011-200063.
17. 2011 Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases Clin Rev Allergy Immunol 2011, Jul 6. [Epub ahead of print] _____In press.
18. 2011 Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev 10: 244-247 , 2011
19. 2011 Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmunity Reviews 10: 383–388, 2011
20. 2011 Autoimmunity: When the immune system becomes the self-ish giant Autoimmun Rev. 10: 575-576, 2011.
21. 2011 Cutting-edge issues in organ-specific autoimmunity Clin Rev Allerg Immunol. 41:123–125, 2011
22. 2011 Multi-center evaluation of autoantibodies to the major ribosomal P C22 epitope Rheumatol Int. ____ in press.
23. 2011 Assessment of IgG antibodies to oxidized LDL. in patients with acute coronary syndrome. Lupus 20: 730–735, 2011.
24. 2011 Abstract of: 'ASIA' – autoimmune (auto-inflammatory) syndrome induced by adjuvant- a new syndrome to be defined. In: Abstracts of selected invited lectures Lupus 20: 340-347, 2011
25. 2011 The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac diseases. Clin Rev Allergy Immunol 2011 Jan 5. [ Epub ahead of print].
26. 2011 The diagnostic and clinical significance of Anti-Muscarinic receptor autoantibodies. Clin Rev Allergy Immunol 2011 Jan 5. [Epub ahead of print].__________
27. 2011 Autoimmune (autoinflammatory) syndrome induced by adjuvants provides a diagnostic framework for enigmatic conditions The Rheumatologist 6 No. 6: 26-32, 2011.
28. 2011 Assessment of subclinical vascular disease associated with ankylosing spondylitis J . Rheumatol. 38: 723 – 729, 2011
29. 2011 Hydroxychloroquine: From Malaria to Autoimmunity. Clin Rev Allerg Immunol. Published online 8 January 2011; ___In Press
30. 2011 Explosion of autoimmune diseases and the mosaic of old and novel factors Cell Mol Immunol 8: 189–192, 2011 _____ In press
31. 2011 Ferritin and prolactin levels in multiple sclerosis IMAJ 13: 91-5, 2011
32. 2011 Autoimmune bullous diseases. The spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev 10 : 527–535., 2011.
33. 2011 b2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3b expression and reduces experimental-antiphospholipid-syndrome Journal of Autoimmunity 37: 8-17, 2011
34. 2011 Vitamin D insufficiency in a large MCTD population Autoimmun. Rev 2011; 10: 317-24.
35. 2011 Vaccination in patients with chronic or autoimmune rheumatic diseases: The ego, the id and the superego. Joint Bone Spine. 2011; _____ In Press.
36. 2011 A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 2011; _____In Press.
37. 2011 Prolactin and Autoimmunity : Hyperprolactinemia correlates with serositis and anemia in SLE patients Clin Rev Allergy Immunol Feb 11, 2011 ___ In Press.
38. 2011 Immunology, Autoimmunity, and Autoantibodies in Parkinson’s Disease. Clin Rev Allergy Immunol Jan 14, 2011 ___ In Press
39. 2011 Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults Clin Rev Allergy Immunol 2011 ___ In Press
40. 2011 The clinical significance of 25OH-Vitamin D status in Celiac disease Clin Rev Allergy Immunol Jan 7, 2011, ___In press.
41. 2011 Guillain-barre Syndrome – a classical autoimmune disease triggered by infection on vaccination Clin Rev Allergy Immunol ____In press
42. 2011 Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease Clin Rev Allergy Immunol 41:163–168, 2011.
43. 2011 IVIG attenuates TLR-9 Activation in B cells from SLE patients J Clin Immunol 31: 31-38, 2011.
44. 2011 Hyperferritinemia is associated with serologic antiphospholipid sndrome in SLE patients. Clin Rev Allergy munol ____________2011 , in press
45. 2011 Task force on catastrophic antiphopholipid syndrome (APS) and non-criteria APS manifestations (II): Thrombocytopenia and skin manifestations LUPUS 20: 174 – 181, 2011
46. 2011 Task force on catastrophic antiphopholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions LUPUS 20: 165 – 173, 2011
47. 2011 Vitamin D and autoimmune thyroid diseases Cellular & Molecular Immunology 2011; 8:243-7
48. 2011 Atherosclerosis and Macrovascular Involvement in Systemic Sclerosis: Myth or Reality Autoimmun Rev. 10: 259 – 266, 2011
49. 2011 The clinical significance of Anti-Beta-1 adrenergic receptor autoantibodies in cardiac disease Clin Rev Allerg Immunol __ in press, 2011.
50. 2011 Serum 25-OH Vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective Cohort Study and review of the literature. Autoimmun Rev 10: 490-494, 2011
51. 2011 Inflammatory and Autoimmune Mechanisms in the Induction of Atherosclerotic Damage in Systemic Rheumatic Diseases: Two Faces of the Same Coin Arth Care & Research 63: 178 - 183, 2011
52. 2010 Can lupus flares be associated with tuberculosis infection? 1486.    CRAI - Clin Rev Allerg Immunol 38: 163 – 168, 2010.
53. 2010 The pathogenesis of neural injury in animal models of the antiphospholipid syndrome    Clin Rev Allergy Immunol 38: 196 – 200, 2010.
54. 2010 Glucocorticoids and the cardiovascular system: State of the art. Current Pharmaceutical Design, 16: 3574-3585, 2010
55. 2010 Hormonal therapy in a patient with ovarian agenesis and possible SLE: a choice to be made Clin Rheumatol. 2010 Apr 2. [Epub ahead of print] ___In Press
56. 2010 Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus Ann NY Acac Sci; 1193: 70-77, 2010
57. 2010 Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69: 1155-1157 , 2010
58. 2010 Neurological manifestations of antiphospholipid syndrome. European Journal of Clinical Investigation 4:350-359, 2010
59. 2010 Atherosclerosis in systemic lupus erythematosus Autoimmunity 43: 98-102 , 2010
60. 2010 Geo-epidemiology and autoimmunity J Autoimmunity 34: J163 – J167, 2010
61. 2010 Effects of tobacco smoke on immunity, inflammation and autoimmunity J Autoimmunity 34: J258 - J265, 2010
62. 2010 An antibody profile of systemic lupus erythematosus detected by antigen micoarray. Immunology 130: 337-43, 2010
63. 2010 Antiphospholipid syndrome as a neurological disease Current Rheumatol Rev 6: 12 – 17, 2010.
64. 2010 Functional Impairment of Arterial Wall in Primary Sjögren’s Syndrome: Combined Action of Immunological and Inflammatory Factors. Arth Care Res 62: 712-8, 2010
65. 2010 The geoepidemiology of systemic lupus erythematosus Autoimmun Rev . 9: A277–A287, 2010 .
66. 2010 Defining and analyzing geoipedemiology and human autoimmunity. J Autoimmun : 34: J168 – J177, 2010
67. 2010 A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 34: 55-58, 2010.
68. 2010 Vaccination for atherosclerosis Clin Rev Allerg Immunol 38: 135 – 140, 2010
69. 2010 Challenges for the autoimmunologist Clin Rev Allerg Immunol 38: 75 - 76, 2010.
70. 2010 Antifibrosis: To reverse the irreversible Clin Rev Allergy Immunol 38: 276 – 286, 2010
71. 2010 Evidence for the use of intravenous immunoglobulins – a review of the literature Clin Rev Allergy Immunol; 38: 201 – 269, 2010.
72. 2010 Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol ; 38: 287 – 291, 2010.
73. 2010 Anti-phospholipid antibody-mediated reproductive failure in antiphospholipid syndrome Clin Rev Allergy Immunol 38: 141 – 147, 2010
74. 2010 Vitamin D insufficiency in a sunny environment: A demographic and seasonal analysis IMAJ 12: 751 – 756 , 2010
75. 2010 The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stress. Lupus 19: 1623-1631, 2010.
76. 2010 Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgari Clin Exp Immunol; 162: 543–549, 2010
77. 2010 Systemic lupus erythematosus and the SLE galaxy Autoimmun Rev. 10: 1-2, 2010
78. 2010 Effects of treatment strategy on endothelial function. Autoimmun Rev. 9: 840-844, 2010.
79. 2010 Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice Autoimmun Rev 9: 709–715, 2010
80. 2010 The proapoptotic activity of the interferon-inducible geneIFI16 provides new insights into its etiopathogenetic role in autoimmunity J Autoimmun 35: 114 – 123, 2010
81. 2010 Anti-tropopin autoantibodies and the cardiovascular system Heart 96: 1518-1524, 2010
82. 2010 Placebo use in clinical studies Harefuah 149/6: 365-369, 2010
83. 2010 Sialic acid–IVIg targeting CD22 . Blood 116: 1630 – 1632, 2010.
84. 2010 Polycystic ovary syndrome and autoimmunity European J of Internal Med 21: 369–371, 2010
85. 2010 The role of vitamin D in regulating immune responses IMAJ – Isr Med Assoc J 12: 174 – 5, 2010
86. 2010 The effect of blocking TNF-α in patients with cancer-related cachexia and anorexia Harefuah 149; 8: 512-514, 2010
87. 2010 The new H1N1 and HPV vaccines and old fears. Current Opinion in Rheumatology 22:431–436, 2010
88. 2010 Tolerogenic dendritic cells in autoimmune diseases: Crucial players in induction and prevention of autoimmunity Autoimmun Rev. 10: 8-17, 2010.
89. 2010 Gender influences SLE-immune cells, genetics, experimental models and lupus patients. Clin Exp Rheumatol 28: 297-299, 2010
90. 2010 Clinical and Molecular Evidence for Association of SLE with parvovirus B19 LUPUS 19: 783-92, 2010
91. 2010 What to wear – the physician's attire. Harefuah 149: 7: 433-434, 2010
92. 2010 Prolactin's role in the pathogenesis of the antiphospholipid syndrome Lupus. 19:1515-9, 2010
93. 2010 Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. Immunobiology. 215: 230-241,2010
94. 2010 IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus Ann Rheum Dis. 69: 1704-1710, 2010
95. 2010 IL-10/TGF-beta-Treated Dendritic Cells, Pulsed with Insulin, Specifically Reduce the Response to Insulin of CD4+ Effector/Memory T Cells from Type 1 Diabetic Individuals. J Clin Immunol. 2010; 30:659–668
96. 2010 Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE Autoimmuin Dis. Article ID 462841, 18 pages___ 2010
97. 2010 TLR2 is one of the endothelial receptors for β2-Glycoprotein I The Journal of Immunology 185: 1550 – 1557, 2010.
98. 2010 Geoepidemiology of autoimmune rheumatic diseases Nature Reviews Rheumatology 6: 468 – 476, 2010
99. 2010 Malignancies in autoimmune rheumatic diseases – a mini-review. Gerontology 57: 3-10, 2011
100. 2010 Mycobacterium tuberculosis, autoimmunity, and Vitamin D. CRAI- Clin Rev Allerg Immunol 38: 169 – 177, 2010
101. 2009 Screening tests for inflammatory activity: applications in rheumatology Modern Rheumatology 19:469–477, 2009
102. 2009 Vaccination, atherosclerosis and systemic lupus erythematosus Lupus 18: 1209 – 1212, 2009
103. 2009 Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases. Lupus 18: 1233 – 1238, 2009.
104. 2009 Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus 18: 1226 – 1232, 2009
105. 2009 Transverse myelitis and vaccines: a multi-analysis. Lupus 18: 1198 – 1204, 2009
106. 2009 Ten cases of systemic lupus erythematosus related to hepatitis B vaccine. Lupus 18: 1192 – 1197, 2009
107. 2009 Molecular mimicry in systemic lupus erythematosus Lupus 18: 1181 – 1185, 2009.
108. 2009 Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis. Lupus 18: 1154 – 1168, 2009
109. 2009 Common infectious agents prevalence in antiphospholipid syndrome. Lupus 18: 1149 – 1153, 2009.
110. 2009 Parasitic infection and autoimmunity Lupus 18: 1144 – 1148, 2009.
111. 2009 Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus Lupus 18: 1136 – 1143, 2009
112. 2009 Infectious antibodies in systemic lupus erythematosus patients Lupus 18: 1129 – 1135, 2009
113. 2009 Infections, vaccines and autoimmunity Editorial. Lupus 18: 1127 – 1128, 2009.
114. 2009 Vaccines and autoimmunity Nat Rev Rheumatol 5: 648-652, 2009.
115. 2009 Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin & Exp Immunol 158 (Suppl. 1): 43–50. 2009
116. 2009 Post-Influenza vaccination vasculitides a possible new entitiy J Clin Rheumatol 15: 269-270, 2009.
117. 2009 Olfacto: Smell: integrating neurodegeneration and autoimmunity – a personal view. Acta Reumatol Port 34: 190-196, 2009. (Portuguese).
118. 2009 The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. IMAJ 11: 558-563, 2009
119. 2009 Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides INFECTIOUS WEGENER'S - Ann NY Acad Sci 1173: 649-657, 2009
120. 2009 Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis Ann NY Acad Sci 1173: 814-821, 2009
121. 2009 Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea. Ann NY Acad Sci 1173: 675-682, 2009
122. 2009 Infections may have a protective role in the etiopathogenesis of Celiac disease Ann NY Acad Sci 1173: 670-674, 2009
123. 2009 Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease Ann NY Acad Sci 1173: 658-663, 2009
124. 2009 Infectious serologies and autoantibodies in inflammatory bowel diseases. Insinuations at a true pathogenic role. Ann NY Acad Sci 1173: 640-648, 2009
125. 2009 Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type-I diabetes mellitus and their close famity members. Ann NY Acad Sci 1173: 633-639, 2009
126. 2009 The role of infections in the immunopathogenesis of systemic sclerosis – evidence from serological studies Ann NY Acad Sci 1173: 627-632, 2009
127. 2009 Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Ann NY Acad Sci 1173: 600-609, 2009
128. 2009 Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen glass II alleles in chronic fatige syndrome. Ann NY Acad Sci 1173: 589-599, 2009
129. 2009 Gluten sensitivity in multiple sclerosis. Experimental myth of clinical truth? Ann NY Acad Sci 1173: 343-349, 2009
130. 2009 Autoimmune thyroid diseases and autoimmune rheumatic disorders. Tow-sided analysis Ann NY Acad Sci 1173: 211-216, 2009
131. 2009 Autoantibody screen in inflammatory myopathies high prevalence of antibodies to gliadin. Ann NY Acad Sci 1173: 174-179, 2009
132. 2009 Choroid plexus connexin 43 expression and gap junction flexibility are associated with clinical features of acute EAE Ann NY Acad Sci 1173: 75-82, 2009
133. 2009 Preface – The autoimmunologist and the congresses of autoimmunity Ann NY Acad Sci 1173: 1-3, 2009
134. 2009 Inflammatory bowel disease: Adverse effect of isotretinoin IMAJ 11: 505-506, 2009
135. 2009 Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. LUPUS 18: 884-888, 2009
136. 2009 European Forum on Antiphospholipid Antibodies: research in progress. LUPUS 18: 924-929, 2009
137. 2009 British medical journals play politics. IMAJ 11: 325 – 327, 2009
138. 2009 How is my patient doing? Evaluating hospitalized patients using continuous vital signs monitoring IMAJ 11: 382 – 384, 2009
139. 2009 Legionella-induced sudden hearing loss: a rare complication Infection 37: 377-378, 2009
140. 2009 Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIG). International Immunology 21:1057-1063 , 2009
141. 2009 Autoimmunity and environment: Infections and autoimmunity – friends or foes? Trends in Immunology , 30;(8): 409 - 414, 2009
142. 2009 Asherson – "In Memoriam".     Clinic Rev Allerg Immunol. 36: 71-73, 2009
143. 2009 Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? Lupus 18: 53-60, 2009.
144. 2009 Anti-elastin antibodies and elastin turnover in normal pregnancy and recurrent pregnancy loss. AJRI- Am J Reproduct Immunol 61: 167-174, 2009
145. 2009 Olfaction, psychiatric disorders and autoimmunity: Is there a common genetic association? Autoimmunity 42: 80-88, 2009
146. 2009 Different roles for anti-cyclic citrullinated peptide antibodies and; CD4+CD28 (null) cells in the acceleration of atherosclerosis in rheumatoid arthritis: Comment on the article by Farragher et al    Arthritis Rheum 60: 631-2, 2009.
147. 2009 Editorial: Neuropsychiatric manifestations of systemic lupus erythematosus – a primary disease manifestation. J of Neuroimmun 207: 1-2, 2009
148. 2009 The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease Nature Rheumatol 5: 99 – 105, 2009
149. 2009 A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases. Clin Rheumatol 28: 655 – 662, 2009
150. 2009 Infection and Primary Biliary Cirrhosis IMAJ 12: 112-115, 2009.
151. 2009 Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background Neurobiology of Aging __________, 2009
152. 2009 Infection and vasculitis Rheumatology 48: 475–482, 2009
153. 2009 Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the ‘‘CAPS Registry’’ J Autoimmun 32: 240-245, 2009
154. 2009 Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis Clin Rheumatol 28: 705-710, 2009
155. 2009 Influenza Vaccine and Autoimmunity IMAJ 11: 39-41, 2009
156. 2009 Olfactory defects point to nervous system involvement in lupus The Rheumatologist 3/4: 15-17, 2009
157. 2009 Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch Immunol Ther Exp, 57: 95-104, 2009
158. 2009 Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun 32: 261 – 266, 2009
159. 2009 Elevated cardiac troponins: the ultimate marker for myocardial necrosis, but not without a differential diagnosis IMAJ 11: 50-53, 2009
160. 2009 The sense of smell in systemic lupus erythematosus Arth Rheum 60; 5: 1484-1487, 2009
161. 2009 Autoimmune mechanisms in cardiovascular diseases Harefuah 148: 173-6, 2009
162. 2009 Olfaction - A window to the mind IMAJ 11: 238-243, 2009
163. 2009 Human antophospholipid antibodies induce TNFa in monocytes via Toll-like receptor 8. Immunobiology ___________(in press), 2009
164. 2009 The mosaic of autoimmunity: the role of environmental factors Frontiers in Bioscience E1, 501-509, 2009
165. 2009 The detection of pleural effusion using a parametric EIT technique Physiol Meas 30: 421- 428, 2009
166. 2009 The antiphospholipid syndrome as a neurological disease Semin Arth Rheum _______(in press), 2009.
167. 2009 Antiphospholipid syndrome and systemic lupus erythematosus: Are they separate entities or just clinical presentations on the same scale? Curr Opin Rheumatol 21: 495 - 500, 2009
168. 2009 The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: Compelling evidence. J Autoimmun 32: 1-6, 2009.
169. 2009 Atherosclerosis in autoimmune rheumatic disease – mechanisms and clinical findings. Clin Rev Allerg Immunol 37: 20-28, 2009
170. 2009 Intravenous immunoglobulin therapy for autoimmune diseases Autoimmunity; 42/6: 553-560, 2009
171. 2009 Chronic infections and atherosclerosis Clin Rev Allerg Immunol 37: 44-48, 2009
172. 2009 Current knowledge regarding Asherson’s syndrome Expert Rev Clin Immunol. 5: 587–591, 2009
173. 2009 Lack of antilipoprotein lipase antibodies in Takayasu's arteritis Clin and Dev Immunol _________(in press), 2009
174. 2009 Allergy and autoimmunity: parallels and dissimilarity. The Yin and Yang of; immunopathology Autoimmun Rev 8: 302-308, 2009
175. 2009 The autoimmunologist: a profession being created Harefuah 148: 706-7, 2009
176. 2009 Japanese-type apical hypertrophic cardiomyopathy. IMAJ 11: 705, 2009.
177. 2009 Hippocrates' oath is challenged IMAJ 11: 581 – 584, 2009
178. 2009 Is it worthwhile to be a reviewer for a medical-scientific journal? Harefuah 148: 824, 2009
179. 2009 Chronic stimulation of the immune system in sarcoidosis and monoclonal gammopathy of undetermined significance Harefuah 148: 909-810, 2009
180. 2009 Anti-ribosomal-P antibodies in lupus patients and healthy controls: Evaluation of three ELISA assays. IMAJ 11: 403 – 406, 2009
181. 2009 Parkinson's disease, autoimmunity, and olfaction Int J of Neuroscience 119: 2133-2143, 2009
182. 2009 Sequence uniqueness as a molecular signature of HIV-1-derived B-cell epitopes.    Int J of Immunopathol & Pharmacol 22: 639-646, 2009.
183. 2009 The Infectious etiology of vasculitis Autoimmunity 42: 432-8, 2009
184. 2009 Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis   J Autoimmun 33: 178 – 182, 2009.
185. 2009 EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies Ann Rheum Dis ______ 2009.
186. 2008 Chronic Fatigue Syndrome: Characteristics and Possible Causes for its Pathogenesis IMAJ 10: 79-82, 2008
187. 2008 Bacterial triggers and autoimmune rheumatic diseases Clin Exp Rheumatol Suppl. 48: S12 – S17, 2008.
188. 2008 Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: Risk factors for accelerated macrovascular damage? Clinic Rev Allerg Immunol. 36: 145-149, 2008
189. 2008 NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev 7: 348 – 390, 2008
190. 2008 Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination European J of Int Med 19: 383 – 385, 2008.
191. 2008 Multiple autoimmune diseases in a young woman: Tuberculosis and splenectomy as possible triggering factors? Another example of the "Mosaic" of autoimmunity. Letter to the Editor, The Journal of Rheumatology 35:6: 1224 - 1227, 2008
192. 2008 The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum, 39: 38 – 54, 2008.
193. 2008 Antibody clustering helps refine lupus prognosis Semin Arthritis Rheum 39: 66-70, 2008
194. 2008 What is the contents of the magic draft IVIG? Autoimmun Rev 7: 435 – 439, 2008.
195. 2008 Intravenou immunoglobulin – indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7: 445 - 452, 2008
196. 2008 Neuropsychiatric lupus and infectious triggers. Lupus 17: 380 – 384, 2008
197. 2008 Obituary: Asherson's syndrome of the catastrophic antiphospholipid antibodies. The Journal of Rheum 35: 10: 2066-2068, 2008
198. 2008 Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems Clinic Rev Allerg Immunol 34: 307 – 312, 2008.
199. 2008 Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: The olfactory and immune system interrelationship Clinical Immunol 130: 235 – 243, 2008
200. 2008 The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders.    Autoimmun Rev.7: 621–625, 2008.
201. 2008 Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients Ann Rheum Dis. 68: 1428 – 1432, 2008
202. 2008 Autoantibodies in gastrointestinal autoimmune diseases Handbook of Systemic Autoimmune Diseases. Josep Font, Manuel Ramos-Casals and Juan Rodes (Editors). Elsevier B.V. 2008. Volume 8 Chapter 17
203. 2008 Antioxidants and smoking in autoimmune disease — Opposing sides 2 of the seesaw?    Autoimmun Rev 8: 165-169, 2008.
204. 2008 Predictive, protective, orphan autoantibodies: The example of anti-phospholipid antibodies. Autoimmun Rev.7: 585–587, 2008
205. 2008 Hepatitis B: infedtion, vaccination and autoimmunity IMAJ 10: 61- 64, 2008
206. 2008 Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases IMAJ 10: 55-57, 2008
207. 2008 Photocopy machines and occupational antiphospholipid syndrome IMAJ 10:52-54 , 2008
208. 2008 Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm. IMAJ 10: 48 – 51, 2008
209. 2008 The story of the 16/6 idiotype and systemic lupus erythematosus IMAJ 10: 37-39,2008
210. 2008 A laatitudinal gradient study of common anti-infectious agent antibody prevalence in Italy and Colombia IMAJ 10: 65 - 68, 2008
211. 2008 Heat-shock proteins: Inflammatory versus regulatory attributes. CSC - Cell Stress and Chaperones 13: 119-25, 2008
212. 2008 Correlating low-similarity peptide sequences and HIV B-cell epitopes Autoimmune Rev 7: 291-296, 2007
213. 2008 Hyperferritinemia in autoimmunity IMAJ 10: 83 – 84, 2008
214. 2008 Harnessing vitiligo for melanoma treatment Harefuah 147: 33-37, 2008
215. 2008 Doctors as naïve (innocent) drug advertisers Harefuah 147: 98-99, 2008
216. 2008 Pemphigus and infectious agents Autoimmun Rev 8: 33-35, 2008
217. 2008 Amputation of digits or limbs in patients with antiphospholipid syndrome Semin Arthritis Rheum 38: 124 - 131, 2008
218. 2008 Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: A multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity J Rheumatol 35: 3; 398-406, 2008.
219. 2008 Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-β-2-glycoprotein-I autoantibodies. Rheumato Int 28: 661-665, 2008.
220. 2008 The curiously suspicious: Infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients J Autoimmun 30: 37-41, 2008
221. 2008 Autobntibody explosion in antiphospholipid syndrome. J Autoimmun 30: 74-83, 2008.
222. 2008 Editorial: (ABOUT YEHUDA SHOENFELD): Autoimmunity: From the mosaic to the kaleidoscope J Autoimmun 30: 1- 4, 2008.
223. 2008 Infections, rheumatism and autoimmunity: The conflicting relationship between human and their environment Autoimmun Rev. 8: 1-4, 2008
224. 2008 Animal model of vasculitides Clinic Rev Allerg Immunol 35: 11-18, 2008.
225. 2008 Pulmonary eosinophilia Clinic Rev Allerg Immunol 34: 367-371, 2008
226. 2008 Cutting edge issues in autoimmunity Clinic Rev Allerg Immunol 34: 275 - 278, 2008
227. 2008 Prediction and prevention of autoimmune skin disorders Arch Dermatol Res 301: 57-64, 2008
228. 2008 Autoantibodies as predictors of pregnancy complications. Rheumatology 47: iii6-iii8, 2008.
229. 2008 Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. Am J Cardiol 101: 1094 - 1097, 2008
230. 2008 Chronic fatigue syndrome with autoantibodies – the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev. 8: 52 – 55, 2008
231. 2008 Infections and autoimmune thyroid diseases: Parallel detection of antibodies against pathogens with proteomic technoloty Autoimmun Rev 8: 112-115, 2008
232. 2008 Gender bias in murine lupus Handbook of Systemic Autoimmune Diseases. Series Editor: Ronald A. Asherson..Endocrine Manifestations of systemic autoimmune diseases. Edited by: Sara E, Walker & Luis J. Jara. 2008. Volume 9; Chapter 3. pp: 21-27
233. 2008 The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun. 31: 325-330, 2008
234. 2008 Computerized grading for academic promotions at the faculty of medicine Harefuah 147 (8-9): 689, 2008
235. 2008 Autoantibodies and infertility in autoimmune diseases Handbook of Systemic Autoimmune Diseases. Series Editor: Ronald A. Asherson..Endocrine Manifestations of systemic autoimmune diseases. Edited by: Sara E, Walker & Luis J. Jara. 2008. Volume 9; Chapter 14. pp: 157-172
236. 2008 Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J Autoimmun 31:393-398 , 2008
237. 2008 Microangiopathic antiphospholipid antibody-associated syndromes: A tribute to Ronald Asherson     IMAJ 10: 894-895, 2008.
238. 2008 The immunoendocrine role of Vitamin D in autoimmunity Handbook of Systemic Autoimmune Diseases. Series Editor: Ronald A. Asherson..Endocrine Manifestations of systemic autoimmune diseases. Edited by: Sara E, Walker & Luis J. Jara. 2008. Volume 9; Chapter 26. pp: 293 – 299
239. 2008 Systemic polyarteritis nodosa following hepatitis B vaccination European J of Int Med 19: 575-578, 2008
240. 2008 Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis Ann Rheum Dis. 67: 724 – 725, 2008
241. 2008 Carotid artery intima-media thickness, heat shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis. Rheumatol Int 28:1099–1103, 2008
242. 2008 Infections and autoimmunity : a panorama Clinic Rev Allerg Immunol 34: 283 – 299, 2008
243. 2008 The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases – 2008 IMAJ 10: 13-19, 2008
244. 2008 The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune diseases – 2008 IMAJ 10: 8-12, 2008
245. 2008 The Mosaic of Autoimmunity: Genetic Factors Involved in Autoimmune Diseases – 2008 IMAJ 10: 3-7, 2008
246. 2008 The mosaic of schizophrenia: Has the time arrived to monitor the illness with biomarders? Clinical Biochemistry 41: 353–354, 2008
247. 2008 Hepatitis B virus (HBV) and autoimmune disease Clin Rev Allerg Immunol 34: 1-3, 2008
248. 2008 Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol Suppl. 48: S27 – S32, 2008
249. 2008 Whither autoimmunity: the lessons of anti-CCP and B cell depletion Clin Rev Allerg Immunot 34: 1-3, 2008
250. 2008 Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Ann Rheum Dis 67: 438-442; 2008
251. 2007 Chronic infections and atherosclerosis. Ann. N.Y. Acad. Sci. 1108: 594–602, 2007.
252. 2007 Autoantibody-triggered apoptosis of endothelial cells induces antiphospholipid antibody in infectious diseases Current Trends in Immunol 8: 11-18, 2007
253. 2007 C-reactive protein and its implications in systemic lupus erythematosus Acta Reum Port; 32:317-322, 2007
254. 2007 Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis Atherosclerosis 190: 73-83, 2007
255. 2007 Systemic vasculitis autoantibodies targeting endothelial cells Endothelial Biomedicine. William C Aird (Editor). Cambridge University Press. 2007. pp: 1411
256. 2007 Clinical and pathological significance of autoantibodies against protective molecules. From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publisher, Germany, pp. 131-140
257. 2007 Protective autoantibodies: Role in homeostasis, clinical importance and therapeutic potential. From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany, pp. 62-76.
258. 2007 Prediction of autoimmunity – more than just autoantibodies. From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany., pp. 2-5
259. 2007 Anti-phospholipid antibodies as predictors of autoimmune disease manifestations From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany, pp. 370-377
260. 2007 The human interferon-inducible protein IFI16: a mediator of inflammation and a target for autoimmunity From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany, pp. 210-215.
261. 2007 Endothelial dysfunction precedes atherosclerosis in systemic sclerosis—relevance for prevention of vascular complications Rheumatology 46: 759-762, 2007
262. 2007 Autoantibodies Involved in Neuropsychiatric SLE and Antiphospholipid Syndrome. Semin Arthritis Rheum 36:297-315, 2007
263. 2007 Clinical and Biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmunity Rev. 6; 119-125, 2007.
264. 2007 Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmunity 27: 211-217, 2006
265. 2007 Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients LUPUS 16: 39-45, 2007
266. 2007 Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmune Rev. 6: 257-259, 2007.
267. 2007 Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS LUPUS 16 : 110-120, 2007
268. 2007 Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arth & Rheum 56: 938-948, 2007
269. 2007 Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus? Clin Rev in Allergy & Immunol 32: 37-46, 2007
270. 2007 Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome. Clin Rev in Allergy & Immunol 32: 47-55, 2007
271. 2007 Molecular mimicry and autoimmunity Clin Rev in Allergy & Immunol 32: 111-118, 2007
272. 2007 BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer. J Clin Immunol 27: 257-265, 2007
273. 2007 Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus; 16, 176–180, 2007
274. 2007 Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss. J Autoimmunity 28 46-54, 2007
275. 2007 Myth and reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland Autoimmun Rev 6; 261–266, 2007
276. 2007 Internal medicine 2007 – where do we stand? To expand or to reduce? Harefuah 146 250-252, 2007
277. 2007 Physiological and pathological implications of laminins: From the gene to the protein. Autoimmunity 40: 83-94, 2007
278. 2007 Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies Lupus 16: 259-264, 2007
279. 2007 The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease. IMAJ 9: 271-276, 2007
280. 2007 Intravenous immunoglobulins (IVIG) improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study Ann Rheum Dis. 66: 977-979, 2007
281. 2007 Protective autoimmunity in cancer (review). Oncology reports 17: 245-251, 2007
282. 2007 To smell autoimmunity: Anti-P-Ribosomal autoantibodies, depression, and the olfactory system J Autoimmunity 28: 165-169, 2007
283. 2007 Cachexia, malignancy and Tumor Necrosis Factor alpha (TNFα). Harefuah 146: 349-351, 2007
284. 2007 B cell targeted therapy in autoimmunity J Autoimmunity 28: 62 – 68, 2007
285. 2007 Gender and autoimmunity Autoimmun Rev 6: 366 – 372, 2007
286. 2007 Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 6: 379 – 386, 2007
287. 2007 Are we at a stage to predict autoimmune rheumatic diseases? Arth & Rheum 56: 1736-1744, 2007
288. 2007 Vitamin D and autoimmunity: new etiological and therapeutical considerations. Published online 8 Jun 2007; Ann Rheum Dis. 66: 1137–1142, 2007.
289. 2007 The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model Int Immunol, 19: 857-865, 2007
290. 2007 The kaleidoscope of autoimmunity: multiple; autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol 3:  623-635, 2007
291. 2007 Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus Lupus 16: 324-328, 2007
292. 2007 Autoimmunity in the brain. The pathogenesis insight from celll biology. Ann NY Acad Sci 1107: 142-134, 2007
293. 2007 The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome. Clin Rheumatol 26: 2109-2114, 2007.
294. 2007 Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol 27: 246-256, 2007
295. 2007 The beneficial effects of statins in autoimmune disease therapy Drug News Perspect 20: 165-169, 2007
296. 2007 Colchicine-induced rhabdomyolysis Clin Rheumatol 2007, 26: 2197-2199.
297. 2007 Ferritin in autoimmune diseases. Autoimmune Rev 6: 457 – 463, 2007
298. 2007 Epstein–Barr virus and cytomegalovirus in autoimmune diseases are they truly notorious? a preliminary report Ann NY Acad Sci 1108: 567-577, 2007
299. 2007 Autoantibodies in nonautoimmune individuals during infections. Ann NY Acad Sci 1108: 584-593, 2007
300. 2007 Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis Ann NY Acad Sci 1108: 259-267, 2007
301. 2007 Catastrophic antiphospholipid syndrome. Lessons from the "CAPS Registry" – a tribute to the late Joseph Font Ann NY Acad Sci 1108: 448-456, 2007
302. 2007 Autoantibodies against protective molecules – C1q, C-reactive protein, serum amyloid P, Mannose-binding lectin, and apolipoprotein A1 Ann NY Acad Sci 1108: 227-239, 2007
303. 2007 Heat-shock protein 65 autoantibodies are differently associated with early atherosclerosis in rheumatoid arthritis and in healthy subjects Ann NY Acad Sci 1108: 408-413, 2007
304. 2007 Cross-reactive epitopes on β2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome. Ann NY Acad Sci 1108: 481-488, 2007
305. 2007 The diversity of autoantibodies to P-ribosomal: the infectious-autoimmunity plot J Mol Med 85:907–909, 2007
306. 2007 Intravenous immunoglobulin therapy in systemic lupus erythematosus. Hong-Kong Bulletin or Rheum Dis 7: 1-6, 2007
307. 2007 Accelerated atherosclerosis in rheumatoid arthritis Ann NY Acad Sci 1108: 349-358, 2007
308. 2007 Lupus erythematosus tumidus induced by sex reassignment surgery J Rheumatol 34: 9-11, 2007
309. 2007 EASI- the European Autoimmuniy Standardisation Initiative – A new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe Ann NY Acad Sci 1109: 138-144, 2007
310. 2007 Anti-Vitamin D, Vitamin D in SLE preliminary results. Ann NY Acad Sci 1109: 550-557, 2007
311. 2007 Diagnosing diseases by measurementy of electrical skin impedance. Ann NY Acad Sci 1109: 185- 192, 2007
312. 2007 Novel biomarkers in autoimmune diseases. Prolactin, Ferritin, Vitamin D and TPA levels in autoimmune diseases Ann NY Acad Sci 1109: 385 – 400, 2007
313. 2007 The steroid - sparing effect of intravenous immunoglobulin in patients with autoimmune diseases Expert Rev Clin Immunol 3: 774 - 780, 2007
314. 2007 Infection and vaccination in chronic fatigue syndrome: Myth or reality? Autoimmunity 40: 48 – 53, 2007
315. 2007 Fermented Wheat Germ Extract (Avemar) Inhibits Adjuvant Arthritis Ann NY Acad Sci 1110: 384 – 361, 2007
316. 2007 Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol 179: 5571 – 5575, 2007
317. 2007 Attenuation of colon carcinoma tumor spread by intravenous immunoglobulin Ann NY Acad Sci 1110: 567 – 577, 2007.
318. 2007 Hyperprolactinemia and autoimmune diseases Autoimmun Rev 6: 537 – 542, 2007
319. 2007 APS— More Systemic Disease than SLE Clinic Rev Allerg Immunol ; 32:129 – 130, 2007.
320. 2007 Clinical Thrombotic Manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up Clin Rev Allerg Immunol ; 32: 131–137, 2007
321. 2007 Livedo reticularis as a criterion for antiphospholipid syndrome Clin Rev Allerg Immunol 32: 138 – 144, 2007
322. 2007 Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome Clin Rev Allerg Immunol 32: 145 – 152, 2007
323. 2007 Anti-phospholipid antibodies and infertility Clin Rev Allerg Immunol 32: 159 – 161, 2007
324. 2007 Antiphospholipid syndrome and cancer Clin Rev Allerg Immunol 32: 184 – 187, 2007
325. 2007 Looking into the eyes of patients with antiphospholipid syndrome Clin Rev Allerg Immunol 32: 192 – 197, 2007
326. 2007 Outcome of patients having dermatomyositis admitted to the intensive care unit Clin Rheumatol 26: 1851 – 1855, 2007
327. 2007 Behavioral changes in systemic lupus erythematosus are of an autoimmune nature. Nat Clin Prac Rheum 3; 11: 592-593, 2007
328. 2007 Recurrent spontaneous abortions in antiphospholipid syndrome: natural killer cells—an additional mechanism in a multi factorial process Rheumatology 46:1517–1519, 2007
329. 2007 Precocious atherosclerosis in rheumatoid arthritis role of traditional and disease-related cardiovascular risk factors. Ann. N.Y. Acad. Sci. 1108: 372–381, 2007
330. 2007 Peripheral vascular occlusions leading to gangrene and amputatious in antiphospholipid antibody positive patiens Ann. N.Y. Acad. Sci. 1108: 515–529, 2007
331. 2007 Identification of histidine-rich glycoprotein, a potential autoantigen, in human and rat brain preparations Ann. N.Y. Acad. Sci. 1109: 473–483, 2007
332. 2007 Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma Ann. N.Y. Acad. Sci. 1110: 305-314, 2007
333. 2007 Harnessing autoimmunity (vitiligo) to treat melanoma – a myth or reality? Ann. N.Y. Acad. Sci. 1110: 410-425, 2007
334. 2007 Itravenous immunoglobulin and cytokines. Focus on tumor necrosis factor family members BAFF and APRIL Ann. N.Y. Acad. Sci. 1110: 426-432, 2007
335. 2007 Probiotic supplementation with lactobacillus casei (Actimel) induces a Th1 response in an animal model of antiphospholipid syndrome Ann. N.Y. Acad. Sci. 1110: 661-669 2007
336. 2007 Viral infection can induce the production of autoantibodies Current Opinion in Rheumatol 19: 636-643, 2007.
337. 2007 therapeutic potential of targeting anti-Ribosomal-P antibody in treating SLE patients with depression. Expert Opin Biol Ther 7: 1283-1285, 2007
338. 2007 Natural hidden autoantibodies IMAJ 9: 748-749, 2007
339. 2007 OxLDL/β2GPI–anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients utoimmun Rev 7: 52–58, 2007
340. 2007 Insights into atherosclerosis therapy in antiphospholipid syndrome Autoimmun Rev 7: 46–51, 2007
341. 2007 HBV vaccine and dermatomyositis: is there an association? Rheumatol Int 28: 6-9-612, 2007.
342. 2007 Tobacco smoking and autoimmune rheumatic disease Nat Clin Prac Rheumatol 3: 707- 715, 2007
343. 2007 Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages Lupus 16: 929-938, 2007
344. 2007 The need for a fifth faculty of medicine and where to locate it Harefuah 146: 821-822, 2007
345. 2007 Antiphospholipid syndrome (APS): Where does it come from? Best Practice & Research Clin Rheum 21: 1071-1078, 2007
346. 2007 The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis Thromb Haemost 98: 1157 – 1159, 2007.
347. 2007 Ventricular conduction block Harefuah 146: 940-944, 2007
348. 2006 IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J of Autoimmunity 27: 50-53, 2006
349. 2006 Editorial: Entering a great period in autoimmunity. J of Autoimmunity 27: 1-2, 2006.
350. 2006 Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases?. Natur Clin Practice Rheum 2: 481- 490, 2006.
351. 2006 Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases Clin Exp Rheum 24: 230-236, 2006.
352. 2006 Peer review – is there a better system? Harefuah 145: 581-583, 2006
353. 2006 Resident's restricted hours of duty – who will benefit from it: patients, society or the physicians? Harefuah 145: 499-502, 2006
354. 2006 The Reduction of Serum B-Lymphocyte Activating Factor levels following Quinacrine Add-On Therapy in Systemic Lupus Erythematosus. Scand J of Immunol 63: 299-303, 2006.
355. 2006 Darier's Disease IMAJ 8: 588 , 2006
356. 2006 Vaccines and autoimmunity The Autoimmune diseases 4th Ed. Noel R. Rose & Ian R. Mackay (Editors). Elsevier Publ. Amstersan – The Netherlands, 2006. pp: 309 – 316
357. 2006 Heart involvement in stystemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45: iv-8-iv13, 2006
358. 2006 Long term safety of IVIG therapy in multiple sclerosis: 10 years experience Autoimmunity 39: 513-517, 2006.
359. 2006 Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody Immunobiol 211: 695 – 699, 2006
360. 2006 European working party on systemic lupus erythematosus: a 15-year report. Autoimmun Rev 5: 549-553, 2006
361. 2006 Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited J Autoimmunity 27: 71 – 80, 2006
362. 2006 Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity J Autoimmunity 27: 134 – 139, 2006
363. 2006 Autoantibodies and prediction of reproductive failure Amer J of Reproduct Immunol 56: 337-344, 2006
364. 2006 The environment and antiphospholipid syndrome. Lupus 15: 784-790, 2006
365. 2006 Intensive lipid-lowering therapy: obivious benefits, possible risks IMAJ 8: 890-891, 2006
366. 2006 Graves’ Disease Presenting as Right Heart Failure IMAJ 8: 217-218, 2006
367. 2006 Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG) Autoimmunity 39: 711-717, 2006
368. 2006 Chronic fatigue syndrome Harefuah 145: 272-275, 2006
369. 2006 The Autoimmune characteristics of progressive or sudden sensorineural hearing loss. Autoimmunity 39: 153-158, 2006
370. 2006 Juvenile idiopathic arthritis. Autoimmunity Rev. 5: 279-298, 2006.
371. 2006 To smell the immune system: Olfaction, autoimmunity and brain involvement. Autoimmune Rev. 6: 54-60, 2006
372. 2006 A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis. The Interferon-inducible gene IFI16 Arthritis & Rheum 54: 3939-3944, 2006
373. 2006 MP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology. J of Neuroimmunology 181: 112-121, 2006
374. 2006 Traditional cardiovascular risk factors in primary Sjogren's syndrome – role of dyslipidamia Rheumatology 45: 1581-1582, 2006
375. 2006 Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmunity 27: 145-152, 2006
376. 2006 The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmune Rev 6: 94 – 97, 2006
377. 2006 New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. Clin Exp Rheumatol 24 (Suppl.40): S20-S25, 2006.
378. 2006 Mechanisms of disease: atherosclerosis in autoimmune diseases Nature clin Practice Rheumatol 2: 99-106, 2006
379. 2006 Editorial: The role of inflammatory cytokines in the pathogenesis of systemic lupus erythematosus – related atherosclerosis: a novel target for treatment? The J of Rheumatol 33: 3 : 445-447, 2006
380. 2006 BCG immunotherapy – from pathophysiology to clinical practice Expert Opinion Drug Saf. 5: 225-229, 2006
381. 2006 Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome Behavioural Brain Research 169: 289-293, 2006
382. 2006 International multicenter evaluation of autoantibodies to ribosomal P proteins Clinical and Vaccine Immunol; 13: 77–83., 2006
383. 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb and Haemostasis, 4: 295–306, 2006
384. 2006 Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus. Autoimmunity Reviews 5; 153–155, 2006
385. 2006 Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the "Euro-Lupus Project". Autoimmune Reviews 5: 180-186, 2006.
386. 2006 Hypophosphatemia as a prognostic measure of evaluation Harefuah 145; 11: 815-817, 2006
387. 2006 Lupus and cardikovascular disease: the facts Lupus 15: 3-10, 2006
388. 2006 Restricted specificity of anti-ribosomal P antibodies to SLE patients in Israel Clin Exp Rheumatol 24: 694-7, 2006
389. 2006 Can we predict autoimmune diseases of the gastrointestinal tract and the liver by autoantibodies Harefuah 146: 28-32, 2006
390. 2006 Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology; 45: 833-841, 2006
391. 2006 Anti-inflammatory and immunosuppressive drugs and reproduction Arthritis Res Ther. 8: 209, 2006.
392. 2006 Severe anemia diagnosed on computed tomography IMAJ. 8: 363, 2006.
393. 2006 Nonthrombotic manifestations of the antiphospholipid syndrome: Away from thrombosis? J Rheumatol 33:6- 1038 – 1044, 2006.
394. 2006 Matrix metalloproteinase-9 and autoimmune diseases J Clin Immunol . 26: 299-307, 2006
395. 2006 Editorial: Reshaping the mosaic of autoimmunity. Semin Arth & Rheum 35: 341-342, 2006.
396. 2006 Natural autoimmunity in physiology and pathology 1st Moscow International Conference, Moscow, Russia, September 15-17,2005 Autoimmun Rev 5: 357-363, 2006.
397. 2006 The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans. Lupus 5, 319–325, 2006
398. 2006 Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. The Am J Cardiol 98: 267-271, 2006.
399. 2006 Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides Cur Rheumatol Rep 2006; 8: 292 – 8.
400. 2006 Predicting and preventing autoimmunity, myth or reality? Ann. N.Y. Acad. Sci. 1069: 322–345, 2006.
401. 2006 2nd Conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005. Rev Autoimmunity Rev 5: 55-63, 2006
402. 2006 Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65: 2-6, 2006
403. 2006 Effect of Avemar@ - a fermented wheat germ extract – on rheumatoid arthritis. Preliminary data. Clin & Exp Rheumatol 24: 325-328, 2006
404. 2006 Association of α-actinin-binding anti-double stranded DNA antibodies with lupus nephritis Arth & Rheum 54: 2523-2532, 2006
405. 2006 Novel aspects of diagnostic test: multiple autoantigens, new algorithms and revolutionary techniques LUPUS 15: 389-390, 2006
406. 2006 European attempt to set guidelines for improving diagnostics of autoimmune rheumatic disorders. LUPUS 15: 391-396, 2006.
407. 2006 Application of a static fluorescence-based cytometer: the CellScan in clinical immunology LUPUS 15: 436-441, 2006
408. 2006 Stenosis in antiphospholipid syndrome: a new finding with clinical implications. LUPUS 15: 466-472, 2006
409. 2006 Autoimmune hemolytic; anaemia in the antiphospholipid syndrome. LUPUS 15: 473-477, 2006
410. 2005 Application of a static fluorescence-based cytometer (the Cellscan) in basic cytometric studies, clinical pharmacology, oncology and clinical immunology Clin Dev Immunol 12: 187-195, 2005
411. 2005 New therapeutic strategies for systemic sclerosis – a critical analysis of the literature. Clin Dev Immunol 12: 165-173, 2005
412. 2005 Anti-DNA idiotypes: from induction of disease to novel therapeutical approaches Immunol Letters 100: 73-77, 2005
413. 2005 Dermatolocial manifestations in the antiphospholipid syndrome Harefuah 144: 639-641, 2005
414. 2005 Renal failure and low molecular weight heparins. A dangrerous liaison ? The case of retroperitoneal hematoma IMAJ 7: 600-601, 2005
415. 2005 Measurement or electrical skin impedance of dermal-visceral zones as a diagnostic tool for inner organ pathologies: a blinded preliminary evaluation of a new technique. IMAJ 7: 631-634, 2005
416. 2005 Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy areality? Lupus 14: 665-669, 2005
417. 2005 From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link? Lupus 14: 697-701, 2005
418. 2005 Oxidized LDL / β2-Glycoprotein I complexes: new aspects in atherosclerosis. Lupus 14: 736-741, 2005
419. 2005 Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization. Int Arch Allergy Immunol 138: 334-336, 2005.
420. 2005 Thrombocytopenic conditions – autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS Am J Hematol 80: 232-242. 2005.
421. 2005 Review: intravenous immunoglobulin therapy and thromboembolic complications Lupus 14: 802-808, 2005
422. 2005 Multiple autoimmune disease in a patient with hyperprolactinemia. IMAJ 7: 740-741, 2005
423. 2005 Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris. Clin Exp Immunol 142: 426-432, 2005
424. 2005 Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon’s syndrome Autoimmunity 38: 417–424, 2005
425. 2005 The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome Immunobiology 210: 749-754, 2005
426. 2005 The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology 210: 743-747, 2005
427. 2005 Accelerated atherosclerosis in autoimmune rheumatic diseases Circulation 112: 3337-3347, 2005
428. 2005 Precocious Intima-Media Thickening in Patients with Primary Sjögren’s Syndrome Arthritis & Rheum 52: 3890-3897, 2005.
429. 2005 Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events. Arthritis & Rheum 52: 4011-4017, 2005
430. 2005 Infection and SLE. Autoimmunity 38: 473-485, 2005
431. 2005 Indications – intravenous immunoglobulins – IVIG Harefuah 144: 799-804, 2005
432. 2005 Low levels of heat shock proteins-60 and -65 autoantibodies in Sjogren's syndrome IMAJ 7: 778-780, 2005
433. 2005 Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65: 1730-1736, 2005
434. 2005 Protective molecules – C-reactive protein (CRP, serum amyloid P (SAP), pentraxin (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: revalence and clinical significance in autoimmunity J of clin Immunol 25: 582-591, 2005.
435. 2005 Intravenous immunoglobulin (IVIG) adverse effects and safe administration. Clin Rev in Allergy and Immunol; 29: 173-184, 2005
436. 2005 Intravenous immunoglobulin new indications and mechanisms of action. Clin Rev in Allergy and Immunol; 29: 165-166, 2005
437. 2005 Facing the enigma of immunomodulatory effects of intravenous immunoglobulin Clin Rev in Allergy and Immunol; 29: 185-199, 2005
438. 2005 Toward molecular targeting with specific intravenous immunoglobulin preparation. Clin Rev in Allergy and Immunol; 29: 213-217, 2005
439. 2005 Intravenous immunoglobulin and Guillain-Barré Syndrome. Clin Rev in Allergy & Immunol ; 281-287., 2005
440. 2005 Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev in Allergy and Immunol; 29: 219-228, 2005
441. 2005 Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy. Clin Rev in Allergy and Immunol; 29: 307-310, 2005
442. 2005 Intravenous immunoglobulin and atherosclerosis Clin Rev in Allergy and Immunol; 29: 311-319, 2005
443. 2005 Intravenous immunoglobulin and fibrosis Clin Rev in Allergy and Immunol; 29: 321-326, 2005
444. 2005 Intravenous immunoglobulin and recurrent pregnancy loss Clin Rev in Allergy and Immunol; 29: 327-332, 2005
445. 2005 Immune tolerance as a strategy for treatment of atherosclerosis. Drug Discovery Today . 2: 207-211, 2005.
446. 2005 Prediction and prevention of autoimmune diseases – additional aspects of the mosaic of autoimmunity. Lupus 15: 183-190, 2005
447. 2005 Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus 15: 191-197, 2005
448. 2005 Donato Alarcon-Segovia: a life dedicated to the study of autoimmunity. Autoimmunity Rev 4: 323-328, 2005.
449. 2005 Neuropsychiatric features of systemic lupus erythematosus. Autoimmunity Rev. 4: 329-344, 2005.
450. 2005 Anti-serum amyloid component P (SAP) antibodies in SLE patients correlate with disease activity. Ann Rheum Dis 64; 1698-1702, 2005
451. 2005 Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 64: 1205-1209, 2005
452. 2005 The homogeneous multiplexed system – a new method for autoantibody profile in systemic lupus erythematosus. Clin & Dev Immunol 12: 107-111, 2005
453. 2005 Novel approaches to therapy for systemic lupus erythematosus: unpdate 2005. Expert Rev Clin Immunol 1: 223 - 238, 2005
454. 2005 Evaluation of the BioPlexTM 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/ predictive autoantibodies Ann N.Y. Acad Sci 1050: 280-388, 2005.
455. 2005 Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38: 235-245, 2005.
456. 2005 Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity 38: 247-255, 2005
457. 2005 Pemphigus following hepatitis B vaccination – coincidence or causality? Autoimmunity 38: 117-119, 2005
458. 2005 IVIG therapy in autoimmunity and related disorders : our experience with a large cohort of patients. Autoimmunity 38: 123-137, 2005
459. 2005 Intravnous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL). Harefuah 144: 415 – 420, 2005
460. 2005 Medicine in the twentieth-one century: how it has changed in the last 30 years Harefuah 144: 332-334, 2005
461. 2005 Inflammation and accelerated atherosclerosis: basic mechanisms. Rheum Dis Clin North Am. 31: 355-62, 2005
462. 2005 . Does the flap of a buterfly's wings in Brazil set off a tornado in Texas? The JC Virus story in multiple sclerosis IMAJ 7: 283-5, 2005
463. 2005 Experimental Models of Systemic Lupus Erythematosus: anti- dsDNA in murine lupus. Rheumatology advance access,published May 24, 2005
464. 2005 Successful intravenous immunoglobulin therapy for resistant inflammatory pseudotumor of the orbit. Thyroid 15: 398-9, 2005
465. 2005 High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. Hum Immunol 66: 395-402, 2005
466. 2005 Autoimmune hepatitis: a part of the antiphospholipid syndrom ? IMAJ 7: 264-5, 2005
467. 2005 TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. Autoimmunity Rev 4: 153-161, 2005
468. 2005 From animal models to human genetics: research on the induction and pathogenicity of autoantibodies. Autoimmunity Rev 4: 178-187, 2005
469. 2005 Introduction autoantibodies – the smoke and the fire. Autoimmunity 38: 1-2, 2005
470. 2005 Anticardiolipin and anti-beta-glycoprotein-I antibodies Autoimmunity 38: 33-38, 2005
471. 2005 Multiplexed atheNA multi-lyte immunoassay for ANA screening in autoimmune diseases Autoimmunity 38: 105-9, 2005
472. 2005 Close association between valvular heart disease and central nervous system manifestations in the antiphospholipid syndrome. An Rheum Dis 18, 2005
473. 2005 Atherosclerosis subclinica in giovani pazienti con artrite reumatoide e bassa attività di malattia - Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity. Reumatismo 57: 16-21, 2005
474. 2005 Myocophenolate mofetil in animal model of autoimmune disease LUPUS 14: s12-s16, 2005
475. 2005 Vaccines in the 21st century: the genetic response and the innocent bystander Autoimmunity Rev 4: 79-81, 2005
476. 2005 A novel system to diagnose cataneous adverse drug reactions employing cellscan – comparison with histamine releasing test and Inf-gamma Relea Test. Clin Dev Immunol 12: 85-90, 2005
477. 2005 Atopy and asthma in migr`ants. Arch Allergy Immunol 136: 198-204, 2005
478. 2005 Patients' families abuse the medical and nursing staff Harefuah 144: 74-75, 2005
479. 2005 Characterization of a murine anti-laminin-1monoclonal antibody (AK8) produced by immunization with mouse-derived laminin-1. Clin & Develop Immunol 12: 67-73, 2005
480. 2005 Livedo Reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin & Exp Rheum 23: 499-504, 2005
481. 2005 The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogens and complexity Rheum Dis Clin North Am. 2005 31: 161-75, 2005
482. 2005 1st International conference on cutaneous lupus erythematosus Dusseldorf, Germany, September 1-5, 2004 Autoimmunity Rev 4: 66-78, 2005
483. 2005 Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Ann N.Y. Acad Sci. 1051: 779-786, 2005
484. 2005 Heterogeneity of anti-beta2-glycoprotein I antibodies.A factor variability in test results Thromb Haemost 93: 80-7, 2005
485. 2005 Revisiting old ghosts: prenatal viral exposure and schizophrenia IMAJ 7: 43-45, 2005
486. 2005 Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis Ann N.Y. Acad Sci. 1051: 299-303, 2005
487. 2005 Early atherosclerosis in rheumatoid arthritis. Effects of smoking of thickness of the carotid artery intima media. Ann N.Y. Acad Sci. 1051: 281-290, 2005
488. 2005 Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss Ann N.Y. Acad Sci. 1051: 743-778, 2005
489. 2005 Systemic thromboembolism in inflammatory bowel disease. Mechanisms and clinical applications. Ann N.Y. Acad Sci. 1051: 166-173, 2005
490. 2005 Pregnancy loss and endometriosis. Pathogenic role of anti-laminin-1 autoantibodies. Ann N.Y. Acad Sci. 1051: 174-184, 2005
491. 2005 Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases. Ann N.Y. Acad Sci. 1051: 529-542, 2005.
492. 2005 Anti-saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54: 1232-1236, 2005
493. 2005 The role of innate and adaptive immunity to Oxidized Low-density lipoprotein in the development of atherosclerosis Ann N.Y. Acad Sci. 1051: 442-454, 2005
494. 2005 B cell depletion in autoimmune rheumatic diseases Autoimmunity Rev 4: 436-441, 2005.
495. 2005 Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus 14: 571-575, 2005
496. 2005 Vaccines and autoimmunity The Autoimmune diseases 4th Ed. Noel R. Rose & Ian R. Mackay (Editors). Elsevier Publ. Amstersan – The Netherlands, pp: 309 – 316, 2005
497. 2005 BCG vaccination, autoimmunity and bladder cancer Progress in Bladder Cancer Research. A.M. Mallory (Editor). Horizons in Cancer Research Vol. 6 ISBN 1-59454-129-9 NOVA science Publishers, Inc., pp.: 147-153, 2005.
498. 2005 Toubi E. Protective autoantibodies Arthritis & Rheum 52: 2599-2606, 2005
499. 2005 Accelerated atherosclerosis in rheumatoid arthritis Harefuah 144: 561-563, 2005
500. 2005 The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factorm erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis Clin Dev Immunol 12: 197-202, 2005
501. 2005 Antiphospholipid antibodies bind ATP: A putative mechanism for the pathogenesis of neuronal dysfunction. Clin Dev Immunol 12: 175-180, 2005
502. 2004 Autoimmune pregnancy loss – experimental models "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 71-84, 2004
503. 2004 Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis Clin Exp Rheumatol 22 (Supl. 36): S35 – S40, 2004
504. 2004 Guillain-Barre syndrome following hepatitis B vaccination Clin & Exp Rheumatol 22: 767-770, 2004
505. 2004 The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity, 37: 457-464, 2004
506. 2004 Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum 34: 602-609, 2004
507. 2004 Intravenous immunoglobulin treatment for fibrosis, atherosclerosis and malignant conditions Adoptive Immunotherapy Methods and Protocols. Burkhard Ludewig & Matthias W. Hoffmann (Editors). Humana Press, Totowa, New Jersey, pp: 403-408, 2004
508. 2004 Intravenous immunoglobulin and the kidney - a two-edged sword Semin Arthritis Rheum 34: 593-601, 2004
509. 2004 Acupuncture therapy for rheumatoid arthritis APLAR J of Rheumatol 7: 207-214, 2004
510. 2004 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). Baseline predictors of vascular events Arthritis & Rheum 50: 3947-3957, 2004
511. 2004 The systemic nature of the antiphospholipid syndrome Scand J Rheumatol 33: 365-372, 2004
512. 2004 4th International Congress on Autoimmunity. http://www.Rheuma21st.com/archives/report_all_29Nov2004.html
513. 2004 Anti-laminin-1 autoantibodies, pregnancy loss and endometriosis. Clin Dev Immunol. 11:261-6,2004
514. 2004 Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients Sem Arth Rheum 34: 501-537, 2004
515. 2004 Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. Thrombosis Research 114: 589-592, 2004
516. 2004 Leptin. anti-HSP60, anti-HSP65 and anti-oxLDL in autoimmune rheumatic diseases. 12th International Congress of Immunology and 4 Annual Conference of FOCIS Immunology 315 - 324, 2004
517. 2004 Matsuura E. Are anti-Oxidized Low-Density Lipoprotein antibodies pathogenic or protective? Circulation 110:2552-2558, 2004.
518. 2004 Multiple sclerosis and anti-phospholipid syndrome - one or two diseases? Harefuah 143: 724-726, 2004
519. 2004 1st International Conference on Cutaneous Lupus Erythematosus: a meeting review. http://www.Rheuma21st.com/archives/report_cutaneous_lupus_shoenfeld_2004.html
520. 2004 Antiphosphatidylserine antibodies and reproductive failure Lupus 13: 661-665, 2004
521. 2004 Pericarditis following permanent pacemaker insertion IMAJ 6: 599-602
522. 2004 Autoantibodies associated with reproductive failure Lupus 13: 643-648, 2004
523. 2004 Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus Autoimmunity Rev. 3: 423-53, 2004
524. 2004 Intravenous immunoglobulin and antiphospholipid syndrome Arthritis & Rheum 50: 2711-2712, 2004
525. 2004 The infectious etiology of the antiphospholipid syndrome (APS). Autoimmunity Rev 3 Suppl. 1: 532-34, 2004
526. 2004 Toll-like receptors and their role in the development of autoimmune diseases. Autoimmunity, 37: 183-188, 2004
527. 2004 Vaccination may be associated with autoimmune diseases IMAJ 6: 430-432, 2004
528. 2004 Antiphospholipid antibodies in acute coronary syndrome. Lupus 13: 423-427, 2004
529. 2004 Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 112: 190-199, 2004
530. 2004 Features associated with epilepsy in the antiphospholipid syndrome J Rheumatol 31: 1344-8, 2004
531. 2004 The etiopathogenesis of autoimmunity Chapter in book "Stem cell therapy for autoimmune disease". Eds: Richard K. Brut & Alberto M. Marmont. Laandes Bioschience Georgetown, Texas, USA, pp: 106-112, 2004
532. 2004 Anti-phospholipid syndrome from a systemic disease toward the infectious etiology. La Revue de medicine interne 25: 10-11, 2004
533. 2004 Suppression of early atherosclerosis in LDL-recptor deficient mice by oral tolerance with β2-glycoprotein I Cardiovascular Research 62: 603-609, 2004
534. 2004 CD4+ CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109: 2744-2748, 2004
535. 2004 Vaccination and allergy Current Opinion in Otolaryngology & Head and Neck Surgery, 12: 223-231, 2004
536. 2004 Refractory leg infection as an inducer of the catastrophic antiphospholipid syndrome. Ann Rheum Dis . 63: 1004, 2004
537. 2004 Autoantigen cell activation for rapid diagnosis of different autoimmune disordersL comparison of proliferation assays with a static cytometer (CellsScan). Clin Application Immunol 3: 316-323, 2004
538. 2004 Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. Systemic LUPUS Erythematosus 4th edition. Robert G. Lahita (Editor), Elsevier Publication, Amsterdam, The Netherlands) pp. 3-27, 2004
539. 2004 Acupuncture therapy for rheumatoid arthritis. http://www.rheuma21st.com/archives/cutting_main_html. 27/04/2004
540. 2004 Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity. Clin Microbiol Infect 10: 421-424, 2004
541. 2004 IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus. LUPUS 13: 241-244, 2004
542. 2004 5th International symposium on IVIG: IVIG in the third millennium, 25-27 September 2003, Interlaken, Switzerland Autoimmunity Rev 3: 234-241, 2004
543. 2004 Monitoring the apoptotic process induced by oxidized low-density lipoprotein in Jurkat T-lymphoblast and U937 monocytic human cell lines Cell Biochemistry & Biophysics 40: 97-113, 2004
544. 2004 Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model Clin & Develop Immunol 11: 67-75., 2004
545. 2004 Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluagtion – a homogeneous multiplexed system. Clin & Develop Immunol, 11: 53-56, 2004
546. 2004 A meeting review: Heart, rheumatism and autoimmunity. Milan, Italy February 5-7, 2004 Autoimmunity Rev 3:337-354, 2004
547. 2004 Premature coronary disease in systemic lupus New Engl J Med 350:1571-5, 2004
548. 2004 A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo J Autoimmun 22: 217-225, 2004
549. 2004 IVIG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients. J Clin Immunol 24: 107-114, 2004
550. 2004 Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study Arthritis & Rheum 50: 1005-1007, 2004
551. 2004 B-Cell targeted therapy in autoimmunity. http://www.rheuma21st.com/archives/cutting_edge_b_cell_targeted_therapy_shoenfeld_html. 08/03/2004
552. 2004 Antiphospholipid syndrome infectious origin. J Clin Immunol 24: 12-23, 2004
553. 2004 Autoantibody panel screening in recurrent miscarriages Am J of Reproduct Immunol (AJRI) 51: 235-240, 2004
554. 2004 BLyS/BAFF: a potential target in the treatment of active systemic lupus erythematosus. IMAJ 6: 99-102, 2004
555. 2004 An unusually complicated case of primary sjogren's syndrome: development of transient "Lupus-type" autoantibodies following silicone implant rejection. J Rheumatol 31: 196-7, 2004
556. 2004 Therapy with biologic agents in SLE APLAR J Rheum 7:79-82, 2004
557. 2004 The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies Nature Med 10: 17-18, 2004
558. 2004 Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity Ann Rheum Dis 63: 31-35, 2004
559. 2004 I Latin American Congress of Immunology, Galapagos - September 15 – 18, 2003. Autoimmunity Rev 3: 76-87, 2004
560. 2004 Antiphospholipid Syndrome (Hebrew). Ramot - Tel-Aviv University Publ. pp. 1-64, 2004
561. 2004 Imunity system – dobry obranca, ale aj mozny diverzant. Vydanie prve. Vydal SAP – Slovak Academic Press Publ, Bratislave, Slovakia, pp: 1-273, 2004
562. 2004 Autoimmunity and autoimmune diseases such as systemic lupus erythematosus Systemic LUPUS Erythematosus 4th edition. Robert G. Lahita (Editor), Elsevier Publication, Amsterdam, The Netherlands) pp. 3-27, 2004
563. 2004 The etiopathogenesis of autoimmunity Stem cell therapy for autoimmune disease". Eds: Richard K. Brut & Alberto M. Marmont. Laandes Bioschience Georgetown, Texas, USA, pp: 106-112, 2004
564. 2004 Peptide mimetics of anti-dsDNA idiotypes as a tool for Lupus-specific IVIG preparation: specificity and efficacy in the treatment of experimental SLE "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, p: 106, 2004
565. 2004 Receptors of the innate immunity as targets for circulating autoantibodies: antiphospholipid syndrome as a paradigm "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 118-125, 2004
566. 2004 Anti-laminin-1 autoantibodies in reproductive failure: animal and human studies "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 243-252, 2004
567. 2004 Elevated anti-serum amyloid component P (SAP) antibodies in SLE patients correlate with disease activity From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 259-260, 2004
568. 2004 Atherogenic role of protein-modified oxidized low-density lipoproteins and their autoantibodies. "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 388-405, 2004
569. 2004 Autoantibodies and recurrent miscarriages "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack,Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 406-421, 2004
570. 2004 Introduction: Infection and Autoimmunity Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ.Amsterdam The Netherlands, pp:1-4,2004
571. 2004 Vaccination and autoimmunity Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 105-116, 2004
572. 2004 HIV and autoimmunity Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 171-179, 2004
573. 2004 Parvovirus B19 infection and its association to autoimmune disease Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 181-188, 2004.
574. 2004 Parasitic infection and autoimmunity Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 439-448, 2004
575. 2004 The infectious origin of the antiphospholipid syndrome Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 473-490, 2004
576. 2004 SLE and infections Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 491-503, 2004
577. 2004 HIV and autoimmunity HIV and autoimmunity
578. 2004 asculitides – miscellaneous vasculitides Neurologic involvement in systemic autoimmune diseases, volume 3. Doruk Erkan, Steven R. Levine (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 217-227, 2004
579. 2004 Intravenous immunoglobulin treatment for fibrosis, atheros and malignant conditions Adoptive Immunotherapy Methods and Protocols. Burkhard Ludewig & Matthias W. Hoffmann (Editors). Humana Press, Totowa, New Jersey, pp: 403-408, 2004
580. 2004 Eighth International Workshop on Autoantibodies and Autoimmunity Berlin, Germany, 10- 13, September 2003 Autoimmunity Rev 3; 77-84, 2004
581. 2003 Omental Cake in a Male IMAJ 5 73-74, 2003
582. 2003 Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheum 21: 111-113, 2003
583. 2003 BCG immunization and the 'Trojan Horse' phenomenon Clin Rheum 22: 6-7, 2003
584. 2003 Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol (AJRI) 49:51-56, 2003
585. 2003 An association of igG anti-laminin-1 autoantibodies with endometriosis in infertile patients Human Reprod 18: 544-549, 2003
586. 2003 Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations – possible immunomodulation of atherosclerosis. Autoimmunity 36: 91-97, 2003
587. 2003 Allergy and autoimmunity http://www.Rheum 21st.com
588. 2003 Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphopholipid syndrome Immunobiol 207: 47-50, 2003
589. 2003 Atherogenic autoantigen: oxidized LDL complexes with β2-glycoprotein I Immunobiol 207: 17-22, 2003
590. 2003 Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Immunobiol 207: 13-16, 2003
591. 2003 10th International Congress on antiphospholipid antibodies – summary Autoimmunity Rev 2: 79-85, 2003
592. 2003 Antiphospholipid syndrome: pathogenic mechanisms Autoimmunity Rev 2: 86-93, 2003.
593. 2003 Why viral (SARS, Ebola and AIDS) epidemics now? Harefuah, 142: 324-325, 2003
594. 2003 SLE and infections. Clin Rev Allergy & Immunol 25: 29-40, 2003
595. 2003 Systemic lupus erythematosus and parvovirus B-19. Casual coincidence or causative culprit? Clin Rev Allergy & Immunol 25: 41-48, 2003
596. 2003 Pyomyositis or "injectiositis" – staphylococcus aureus multiple abscesses following intramuscular injections IMAJ 5: 295-296, 2003
597. 2003 From proteomics to molecular epidemiology: relevance of autoantibodies. Autoimmunity Rev. 2: 165-169, 2003
598. 2003 The prevalence of celiac disease antibodies in patients with the antiphospholipid syndrome. Lupus 12: 394-399, 2003
599. 2003 Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model Lupus 12: 364-369, 2003
600. 2003 The pathogenic fole of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice Human Reproduct 18: 1094-1099, 2003
601. 2003 23rd European Workshop for Rheumatology Research Marseille France 27/2-2/3, 23-3-2003 http/www/rheuma21st.com/archives/report 11.4.3004 pp: 1-6
602. 2003 Multiple autoantibodies associated with autoimmune reproductive failure J Assisted Rep & Genetics 20: 53-57, 2003
603. 2003 Summary of an expert conference on the use of IVIG. 14-15 February 2003, Berne http/www/rheuma21st.com/archives/report_expert_ivig_shoenfeld_sherer.html. 27 March, 2003
604. 2003 The glucocorticoid induced osteoporosis (GIO) international congress, March 2003, Turin, Italy http/www/rheuma21st.com/archives/report_gio_int_cong_shoenfeld_cutolo.html. April 3, 2003
605. 2003 Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis Harefuah,142: 182-165, 2003
606. 2003 Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies LUPUS 12, 514-517, 2003
607. 2003 Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report LUPUS 12, 518-5523, 2003
608. 2003 Treatment of pregnant patients with antiphospholipid syndrome LUPUS 12, 524-529, 2003
609. 2003 Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines LUPUS 12, 530-534, 2003
610. 2003 TNFa DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome LUPUS 12, 546-549, 2003
611. 2003 Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. LUPUS 12, 550-554, 2003
612. 2003 The effects of antiphospholipid antibodies obtaind from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. LUPUS 12, 573-578, 2003
613. 2003 Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment J Thromb Haemost 1: 523-531, 2003
614. 2003 A medical nutriment has supportive value in the treatment of colorectal cancer. British J of Cancer 89: 465-469, 2003
615. 2003 Silicone gel breast implants and connective tissue disease – a comprehensive review. Autoimmunity 36: 193-197, 2003.
616. 2003 Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiplw low-doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18 – binding protein: Fc construct. Eur J Immunol 33: 2278 – 2286, 2003
617. 2003 The importance of the Cochrane Collaboration Harefuah, 142: 674-676, 2003
618. 2003 Autoimmune aspects of cytokine and anticytokine therapies Am J of Med 115: 390 – 397, 2003
619. 2003 Stroke and the antippholpholipid syndrome: consensus meeting Taormina 2002 LUPUS 12, 508-513, 2003
620. 2003 Prophylaxis of the antiphospholipid syndrome: a consensus report LUPUS 12, 499-503, 2003.
621. 2003 Systemic antiphospholipid syndrome LUPUS 12, 497-498, 2003
622. 2003 Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis LUPUS 12, 504-507, 2003
623. 2003 Novel approaches to therapy for SLE Clin Rev Allergy & Immunol 25: 105-111, 2003
624. 2003 Atherosclerosis and antiphospholipid syndrome Clin Rev Allergy & Immunol 25: 79-88, 2003
625. 2003 Innate Immunity, inflammation, and atherogenesis The Heart in Systemic Autoimmune Diseases, volume 1. Andrea Doria, Paolo Pauletto (Editors). Roland A. Asherson (Series Editor). Elsevier Publ. Amsterdam, The Netherlands: pp. 77-88, 2003.
626. 2003 Atherosclerosis and autoimmunity The Heart in Systemic Autoimmune Diseases, volume 1. Andrea Doria, Paolo Pauletto (Editors). Roland A. Asherson (Series Editor). Elsevier Publ. Amsterdam, The Netherlands: pp. 89-95, 2003
627. 2003 Intravenous immunoglobulin for fibrosis, atherosclerosis and malignant conditions Intravenous Immunoglobulins in the Third Millennium. Marinos C Dalakas, Peter J Spath (Editors). The Parthenon Publishing Group. pp. 361, 2003
628. 2003 Intravenous immunoglobulin as an immunomodulatory agent in systemic lupus erythematosus and lupus nephritis Intravenous Immunoglobulins in the Third Millennium. Marinos C Dalakas, Peter J Spath (Editors). The Parthenon Publishing Group. pp. 357, 2003
629. 2003 Intravenous immunoglobulin as therapy for RA. Targeted Therapies in Rheumatology. Josef S Smolen, Peter E Lipsky (Editors). Martin Dunitz; Taylor & Francis Group, London and New York, 2003
630. 2003 Osteonecrosis in patients with SLE Clin Rev Allergy & Immunol 25: 13-24, 2003
631. 2003 Immuniation of naïve mice with mouse laminin-1 affected pregnancy outcome in a mouse model Am J Reprod Immunol (AJRI) 50: 159-165, 2003
632. 2003 Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer LUPUS 12, 436-442, 2003
633. 2003 Prevalence and clinical correlations of antibodies against six b2-Glycoprotein-I-related peptides in the antiphospholipid syndrome J Clin Immunol 23: 377-383, 2003
634. 2003 The Catastrophic Antiphospholipid Syndrome – Asherson's Syndrome Ann Med Interne, 154: 195-196, 2003
635. 2003 Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus Ann Rheum Dis 62: 1071-1077, 2003
636. 2003 Apoptosis in systemic lupus erythematosuss Harefuah; 142: 844-847, 2003
637. 2003 Intelligent nutrision: health-promoting mechanisms of probiotics IMAJ 5: 812-813, 2003
638. 2003 Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis Ann Rheum Dis 62: 1221-1223, 2003
639. 2003 Asthma as a paradigm for autoimmune disease Int Arch Allergy Immunol 32: 210-214, 2003
640. 2003 Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome Hum Antibodies 12:57-62, 2003
641. 2003 Lack of association between anti-phospholipid antibodies (APLA) and attention deficit/hyperactivity disorder (ADHD) in children Clin & Developmental Immunol; 10: 105-109, 2003
642. 2003 CNS dysfunction in the antiphospholipid syndrome Lupus 12, 903-907, 2003
643. 2003 Antiphosphatidylserine antibodies affect rat yolk sacs in culture: a mechanism for fetal loss in antiphopholipid syndrome Am J Reproduct Immunol (AJRI) 51: 144-151, 2004
644. 2003 Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unreaveled Trends in Immunology 24: 2-4, 2003
645. 2003 Titers of antibody to common pathogens: relation to food-based interventions in rural Kenyan schoolchildren Am J Clin Nutr. 77: 242-9, 2003
646. 2003 Fibrosis regression induced by intravenous gammaglobulin treatment Ann Rheum Dis 62: 175-177, 2003
647. 2003 Vaccines, viruses and voodoo J Invest Allergol Clin Immunol 12:155-68, 2002
648. 2003 The influence of different cultivating conditions on polymorphonuclear leukocyte apoptotic precesses in vitro, I: the morphological characteristics of PMN spontaneous apoptosis. Ultrastruct Pathol 27: 23-32, 2003
649. 2003 Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome J Rheum 30: 214-219, 2003
650. 2002 Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome. Ann Hematol 81: 161-163, 2002.2002
651. 2002 Bacterial I induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 109: 797-804, 2002
652. 2002 Anti-inflammatory effects of intravenous immunoglobulin (IVIG) in symposium in Immunology VII Eibl, M. and Huber H. ed. Springer - Verlag. Herlag. Heidelberg. pp. 171-184
653. 2002 Autoantibodies to cardiolipin and Beta -2 -Glycoprotein-I in coronary artery disease patients with and without hypertension Cardiology 97: 2-5, 2002
654. 2002 Prevention of tumor spread by matrix metalloproteinase-9 inhibon: old drugs, new concept Eur J Intern Med 13: 101-103, 2002
655. 2002 A possible role for IVIG in the treatment of soft tissue sarcoma: a clinical case and an experimental model Int J Oncol 20: 839-43, 2002
656. 2002 Immunomodulation for treatment and prevention of atherosclerosis Autoimmunity Rev 1: 21-27, 2002
657. 2002 Lupus-like syndrome due to minocycline. Harefuah 141: 151-152, 2002
658. 2002 Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumor T and B cell lines. Int J Oncol 20: 563-570, 2002
659. 2002 The family of metalloproteinases and their immunomodulatory significance Harefuah, 141, 118-110, 2002
660. 2002 Systemic involvement in the antiphospholipid syndrome: lessons from animal models. The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 101-106, 2002
661. 2002 Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of of microvascular endothelial cells Int Immunol 14: 121-122, 2002
662. 2002 Acupuncture therapy fo r rheumatoid arthritis. http/www/rheuma21st.com/archives/cutting_shoenfeld_acupuncture.html , 2002
663. 2002 Atherosclerosis: Is Atherosclerosis a cellular or humoral mediated outoimmune disease? Ann Rheum Dis. ; 61: 97-99, 2002
664. 2002 Milestones in the antiphospholipid syndrome The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 3-9, 2002
665. 2002 Antiphospholipid antibodies and infections-drugs The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 343-358, 2002
666. 2002 Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water Biological Trace Element Research 90: 251-260, 2002
667. 2002 Antiphospholipid antibodies in human and murine atherosclerosis The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 137-141, 2002.
668. 2002 Novel perspectives in the treatment of the antiphospholipid syndrome - from anticoagulation to immunomodulation The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: p. 421, 2002
669. 2002 Cardiac valvulopathy in the antiphospholipid syndrome Clin Rev Allergy Immunol, 23: 341-348, 2002
670. 2002 The Antiphospholipid Syndrome II , Autoimmune Thrombosis. Elsevier Publ. Amsterdam- The Netherlands, pp 1-457, 2002
671. 2002 From Proteomics to Molecular Epidemiology: Relevance of Autoantibodies PABST Science Pub. , Germany, pp. 1-700, 2002
672. 2002 Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus Int Immunol 14: 1303-1311, 2002
673. 2002 Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages Cancer 95: 2032 - 2037, 2002.
674. 2002 Autoantibodies associated with reproductive failure From Proteomics to Molecular Epidemiology: Relevance of Autoantibodies (Report of the 6th Dresden Synposium on Autoantibodies Sept. 4-7, 2002). K Conrad, M. Fritzler, M. Meurer, U. Sack, Y Shoenfeld (Editors). PABST Science Pub. , Germany, 2002, pp: 300-313.
675. 2002 Infectious origin of antiphospholipid syndrome. From Proteomics to Molecular Epidemiology: Relevance of Autoantibodies (Report of the 6th Dresden Synposium on Autoantibodies Sept. 4-7, 2002). K Conrad, M. Fritzler, M. Meurer, U. Sack, Y Shoenfeld (Editors). PABST Science Pub. , Germany, 2002, pp: 149-160
676. 2002 Summary of the 10th International Congress on Antiphospholipid Antibodies http/www/rheuma21st.com/archives/report , 26.11.2002
677. 2002 Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease IMAJ 4, 892-893, 2002
678. 2002 HIV and autoimmunity Autoimmunity Rev 1/6: 329-337, 2002
679. 2002 Autoantibody-mediated atherosclerosis Autoimmunity Rev 1/6: 348- 353, 2002
680. 2002 Pathogenesis and natural history of osteonecrosis Sem Arth Rheum 32: 94-124, 2002
681. 2002 Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins Eur J Immunol 32: 3414-3424, 2002
682. 2002 Fibrotic diseases Harefuah, 141: 973-978, 2002
683. 2002 Autoimmune aspects of cytokines and anti-cytokine therapies. http/www/rheuma21st.com/archives/report , 25.11.2002
684. 2002 Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11: 736-743, 2002
685. 2002 Air flights and venous thromboembolism - a preventable condition IMAJ 4 1080 - 1081, 2002
686. 2002 Allergic disease and autoimmune effectors pathways Developmental Immunology 9: 161-167, 2002
687. 2002 Antiinflammatory and immunomodulatory properties of statins. Immunologic Research 25: 271-286, 2002
688. 2002 The 10th International Vasculitis and ANCA Workshop, 25-28 April 2002, Cleveland, Ohio, USA. - Report http/www/rheuma21st.com/archives/report_10th _intern_vasculitis_part2.html , 2002
689. 2002 The expanding world of autoimmunity Trends Immunol. 23: 278-279, 2002
690. 2002 Immunization of Naive BALB/c mice with human b2Glycoprotein-I breaks tolerance to the murine molecule Arth Rheum 46: 1399-1404, 2002
691. 2002 Studies of sick building syndrome. IV Mycotoxicosis J Asthma 39: 191-201, 2002
692. 2002 Concise communication: The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice Arth Rheumat 46: 1689-1690, 2002
693. 2002 Fading into extinction Harefuah, 141: 442-443, 2002
694. 2002 Medicine and intercessory prayer Harefuah, 141: 527-529, 2002
695. 2002 Transverse myelitis in patients with antiphospholipid antibodies - the importance of early diagnosis and treatment. Clin Rheumatol 21: 207-210, 2002
696. 2002 The pathogenic role of anti-endothelial cell antibodies. http/www/rheuma21st.com/archives/cutting_edge_grunebaum_antiendo.html , 2002
697. 2002 International Meeting on Autoimmunity and Pregnancy Loss. 8 June, 2002, Park hotel Villa Fiorita, Italy http/www/rheuma21st.com/archives/report_schoenfeld_pregnancy.html , 2002
698. 2002 Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome. ANNALS of the New York Academy of Sciences. 966: 415-424, 2002.
699. 2002 Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications Clev Clin J Med ,69 SII: 65-68, 2002
700. 2002 Anti-b2-Glycoprotein I autoantibodies and atherosclerosis. Intern Rev Immunol 21: 51-66, 2002
701. 2002 IVIG in autoimmunity and cancer-efficacy versus safety Expert Opin Drug Saf. I(2): 153-158, 2002.
702. 2002 Induction of anti-RA33 hnRNP autoantibodies and transient spreadto U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice. Clin Exp Rheumatol. 20: 517-24, 2002
703. 2002 Brief report: immune factors in autism: a critical review J Autism Dev Disord. 32: 337-45, 2002
704. 2002 IVIG to prevent tumor metastases (review) Int J Oncol 21: 875-80, 2002
705. 2002 6th Dresden Symposium on Autoantibodies 4-7 September 2002. http/www/rheuma21st.com/archives/report_6th_dresden_symposium_shoenfeld.html , 2002
706. 2002 The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro ant in vivo studies Clin Exp Immunol 130: 233-240, 2002
707. 2002 Association between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis Eur. J Int Med 13: 434-438, 2002
708. 2002 Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis - induced and high-fat-diet-driven atherosclerotic lesions. J Am Col Cardiol 7: 1333-8, 2002
709. 2002 The effects of IgG purified from women with SLE and associated pregnancy loss on rat embryos in culture Am J Reproduct Immunol 48: 296-304, 2002
710. 2002 Neurological and Neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome. Neuroendocrine immune basis of the rheumatic diseases II. Cutolo M, Bijlsma J W.J, Lahita R G, Masi A T, Straub R H, Bradlow L (Editors) Annals of the New York Academy of Sciences, Volume 966, 2002.
711. 2002 Lessons from monoclonal antiphospholipid antibodies The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 113-118, 2002
712. 2002 Cytokines, Th1/Th2 and adhesion molecules in the antipholpholipid syndrome The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 107-112, 2002
713. 2002 Infection and atherosclerosis - impact on autoimmune rheumatic disease, Washington D.C., USA 29-30 April 2002 - Report http/www/rheuma21st.com/archives/report_infection_atherosclerosis.html , 2002
714. 2002 In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations - a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med 12: 133-139, 2002
715. 2002 Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes Clin immunol 103: 69-78, 2002
716. 2002 Serological markers in inflammatory bowel disease: the pros and cons Eur J Gastroenterol Hepatol 14: 103-105, 2002
717. 2002 Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment IMAJ 4: 288-289, 2002
718. 2002 Antiphospholipid syndrome. Clinical and immunologica manifestations and patterns of disease expression in a cohort of 1,000 patients Arth Rheum 46: 1019-1027, 2002.
719. 2002 Novel aspects in autoimmunity and autoimmune diseases: Summary of 3rd International Congress on Autoimmunity Geneva Switzerland, Feb. 20-24, 2002.   http/www/rheuma21st.com/archives/shoenfeld_3int_cong_autoimmun.html , 2002
720. 2001 Antiphospholipid syndrome induced by HIV Lupus 10: 370-374, 2001
721. 2001 The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol Microbiol 45: 72-77, 2001
722. 2001 Mexico-Israel Symposium: beta2-glycoprotein I in human and murine atherosclerosis. IMAJ 3: 85-87, 2001
723. 2001 Association between periodontitis, gingivitis and atherosclerosis     Harefuah. 140: 126-128, 2001.
724. 2001 Autoantibodies to oxidized low-density lipoprotein in coronary artery disease Am J Hypertension 14: 149-154, 2001
725. 2001 Malignancies and autoimmune rheumatic diseases      J Clin Rheumatol. 7: 47-49, 2001.
726. 2001 Eppur si muove (Galileo Galilei 1564-1642): the idiotypic dysregulation of autoantibodies as part of the etiology of SLE. Harefuah, 140: 227-229, 2001.
727. 2001 Mass casualty events during night shifts in the internal medicine departments Harefuah, 140: 230-231, 2001
728. 2001 Highlights of the XXIX meeting of the Mexican Society of Rheumatology, February 9-13, 2001 http/www.rheuma21st.com/archives/highlights29mexmeet.html
729. 2001 Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis    Curr Atheroscler Rep. 3: 328-33, 2001.
730. 2001 Intravenous immunoglobulin (IVIg) as an inhibitor of tumor growth: from autoimmunity to cancer (Chap. 13 ) Old Herborn University Seminar Monograph. Editors: Peter J. Heidt Volker D. Rusch; Dirk Van Der Waaij, 2001, Herborn Litterae, pp:93-107
731. 2001 Intravenous immunoglobulin (IVIg) in autoimmune diseases - expanding indications and increasing specificity (Chap. 13 ) Old Herborn University Seminar Monograph. Editors: Peter J. Heidt Volker D. Rusch; Dirk Van Der Waaij, 2001, Herborn Litterae, pp:85-91
732. 2001 Azathioprie therapy for patients with systemic lupus erythematosus 929.       Lupus 10: 152-153, 2001.
733. 2001 High-dose intravenous immunoglobulins for lupus nephritis - a salvage immunomodulation Lupus 10: 209-213, 2001
734. 2001 Vaccination and systemic lupus erythematosus: the bidirectional dilemmas Lupus 10: 237-240, 2001
735. 2001 Diet and lupus Lupus 10: 246-248, 2001
736. 2001 Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases Pharmacology 62: 133-137, 2001
737. 2001 The catastrophic antiphospholipid syndrome - a review of 115 patients and possible clues to pathogenesis and treatment http/www.rheuma21st.com/archives/cutting_asherson_caps.html , 2001, 1-16
738. 2001 Report on the European Atherosclerosis Society workship on the immune system in atherosclerosis http/www.rheuma21st.com/archives/shoenfeld_immune_sys_atherosclerosis%10.html , 2001, 1-4
739. 2001 Intravenus immunoglobulins treatment of patients with Graves' opthalmopathy Harefuah; 140: 392-394, 2001
740. 2001 Atherosclerosis and autoimmunity.     Lupus 10: 249-252, 2001
741. 2001 6th International Lupus Conference Barcelona 26-28, March 2001 http/www.rheuma21st.com/archives/shoenfeld ….html , 2001, 1-11
742. 2001 BCG and autoimmunity: another two-edged sword JAI 16: 235-240, 2001
743. 2001 Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies Ann Rheum Dis 60: 433-440, 2001
744. 2001 Atherosclerosis and Autoimmunity Elsevier Publ. Amsterdam- Lausanne- New Yorrk- Shannon- Singapore-Tokyo; The Netherlands, pp. 1 - 370, 2001
745. 2001 Intravenous immunoglobulin (IVIg) as an inhibitor of tumor growth: from autoimmunity to cancer. Old Herborn University Seminar Monogrph. (Editors: Peter J. Heidt, Volker D. Rusch, Dirk Van Der Waaij), 2001, Herborn Litterae, pp:93-107
746. 2001 Intravenous immunoglobulin (IVIg) in autoimmune diseases - expanding indications and increasing specificity. Old Herborn University Seminar Monogrph. Editors: Peter J. Heidt, Volker D. Rusch; Dirk Van Der Waaij, 2001, Herborn Litterae, pp:85-91.
747. 2001 Introduction: autoimmunity an additional 'risk factor' for atherosclrosis Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 1-2, 2001
748. 2001 Ceramide pathway and apoptosis in autoimmunity and atherosclerosis. Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 55-72, 2001
749. 2001 Lipid and immunity Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 87-111, 2001
750. 2001 Atherosclerosis: evidence for the role of autoimmunity Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 139-142, 2001.
751. 2001 Oxidized autoantigens in atherosclerosis Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 143-150, 2001
752. 2001 Anti-prothrombin antibodies in thrombosis and atherosclerosis Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 185-190, 2001
753. 2001 Detection of cellular activity in atherosclerosis by the novel cellscan system Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D. and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 191-200, 2001.
754. 2001 Functional heterogeneity of pathogenic anti-endothelial cell antibodies. Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D. and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 211-220, 2001
755. 2001 Brain vasculitis and antiphospholipid syndrome Brain disease therapeutic strategies and repair. Publication: Martin Dunitz; pp: 193-200, 2001
756. 2001 HAREFUAH peer review Harefuah; 140: 403-405, 2001
757. 2001 The mosaic of autoimmunity. A classical case of inhalation of a polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases IMAJ 3: 381-382, 2001
758. 2001 Atherosclerosis as an infectious, inflammatory and autoimmune disease. TRENDS in Immunol 22: 293-295, 2001
759. 2001 Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, Beta-2-glycoprotein-I, and oxidized LDL antibodies Cardiology 95: 20-24, 2001
760. 2001 Following up of 90 patients with anti-phospholipid syndrome: manifestations of the disease, follow-up of antibodies titers and correlations with clinical manifestations in the Israeli population - patients in the Sheba medical center, Tel-Hashomer Harefuah, 140: 495-500, 2001
761. 2001 New approaches in the diagnosis of sepsis IMAJ 3: 439-442, 2001
762. 2001 The dual association between lymphoma and autoimmunity http/www.rheuma21st.com/archives…report_shoenfeld_duallyphoma.html , 2001, 1-7
763. 2001 Are autoantibodies present in patients with subacute and chronic urticaria. J Investing Allergol Clin Immunol, 11: 16-20, 2001
764. 2001 Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells Arthritis & Rheum 44: 1484-1494, 2001
765. 2001 HIV and Autoimmunity http/www.rheuma21st.com/archives file:////Shoenfeld/public/REPRINT…report_zandmann_shoenfeld_hiv.html , 2001, 1-11
766. 2001 Anti-endothelial cell antibodies (AECA) in systemic sclerosis - increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 33: 171-179, 2001
767. 2001 Induction and treatment of the antiphospholipid syndrome - lessons from models Eur J Clin Invest 31: 736-40, 2001
768. 2001 Editorial: Alternative therapies in rheumatic diseases – pros and cons     Lupus 10: 453-456, 2001.
769. 2001 Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus 10: 496-499, 2001
770. 2001 Atherosclerosis as an autoimmune condition Harefuah 140: 720-722, 2001
771. 2001 The Sixth International Lupus Conference, Barcelona 24-28 March 2001 Lupus 10: 580-587, 2001
772. 2001 Antiphospholipid antibody levels in intravenous immunoglobulin (IVIG) preparations. Lupus 10: 568-570, 2001
773. 2001 Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-deficient mice     J Am Coll Cardiol 38: 900-905, 2001.
774. 2001 The dual association between lymphoma and autoimmunity. Blood Cells Molec Dis 27: 750-756, 2001
775. 2001 Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment IMAJ 3: 698-699, 2001
776. 2001 Accelerated atheroma antiphospholipid antibodies, and the antiphospholipid syndrome. Rheum Dis Clin North Am. 27: 603-610, 2001
777. 2001 The department of internal medicine – returned to its formal glory Harefuah; 140: 835-6, 2001
778. 2001 AVEMAR (a new benzoquinone-containing natural product) administration interferes with the The response in experimental SLE and promotes amelioration of the disease Lupus 10: 622-627, 2001
779. 2001 Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases Sem Arth Rheum 31: 127-132, 2001
780. 2001 IVIG therapy in sepsis Harefuah, 140: 955-958, 2001
781. 2001 Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis Am J Reprod Immunol 46: 268-73, 2001
782. 2001 ytokyne levels in various intravenous immunoglobulin (IVIG) preparations Hum Antibodies 10: 51-53, 2001
783. 2001 Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model. Magnes Res 14: 173-179, 2001
784. 2001 Catastrophic antiphospholipid syndrome: Clue to the pathogenesis from series of of 80 patients Medicine (Baltimore) 80: 355-377, 2001
785. 2001 The mosaic of autoimmunity Scand J Clin Lab Invest 61: 3-15, 2001
786. 2001 Brain vasculitis and antiphospholipid syndrome. A chapter in book: Brain disease therapeutic strategies and repair Publication: Martin Dunitz; pp: 193-200, 2001
787. 2001 The mosaic of pemphigus Harefuah 140: 1049-111053, 2001
788. 2001 anti- inflammatory and immunomodulatory properties of statins http/www/rheuma21st.com/archives///report_shoenfeld_antiinfl_statins.html
789. 2001 Treatment of MRL/1pr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin Exp Immunol, 126: 570-577, 2001
790. 2001 Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome: what is its role? J Clin Rheumatol 7:291-294, 2001
791. 2001 Morbidity and mortality in systemic lupus erythematosus Harefuah, 140: 1177-1180, 2001
792. 2001 A new reality - epidemiology of terror Harefuah, 140: 994-996, 2001
793. 2001 Detection of cellular activity in atherosclerosis by the novel cellscan system Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D. and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 191-200, 2001
794. 2001 Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins. Springer Semin Immunopathol 23: 447-57, 2001
795. 2000 Heat shock protein 60/50, beta2-glycoprotein I and Oxidized LDL as players in murine atherosclerosis.     J Autoimmunity 15: 199-202, 2000.
796. 2000 The revolution in medicine toward the third millenium: from a lecture to medical students on their first exposure to clinical medicine     Harefuah, 139: 109-110, 2000.
797. 2000 Anti-endothelial cell antibodies in patients with coronary atherosclerosis.       Immunol Letters 73: 23-27, 2000.
798. 2000 Molecular Mimicry: lessons from experimental models of systemic lupus erythematosus and antiphospholipid syndrome. (Chap. 16) in: Molecular Mimicry, Microbes, and Autoimmunity. Editors: M.W.Cunningham, R.S. Fujinami, 2000, ASM Press, Washington, D.C. pp. 223-233, 2000.
799. 2000 The relationship of anti-phospholipid antibodies to infections - do they bind to infecting agents or may they even be induced by them?     Clin Exp Rheum 18: 431-2, 2000.
800. 2000 Anti-cardiolipin antibody from a patient with antiphospholipid syndrome recognizes only an epitope expressed by cardiolipin/ ß2-glycoprotein-I (ß2GPI) complex and induces APS.     Clin Exp Rheum 18:479-84, 2000.
801. 2000 Detection of antibodies to gangliosides and glycolipids in various Intravenous Immunoglobulin (IVIg) preparations     Immunol Invest 29: 337-347, 2000.
802. 2000 Anti-beta2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue pactor in endothelial cells    IMAJ - Isr Med Ass J 2: 27-31, 2000.
803. 2000 Atherosclerosis and the immune system: is atherosclerosis an autoimmune disease?     Sem Clin Immunol 1 : 5-6, 2000.
804. 2000 Use of intravenous immunoglobulin in livedo vasculitis.       Clin Exp Rheumatol, 18: 404-406, 2000.
805. 2000 Suppression of atherogenesis in female-low-density lipoprotein receptor knokout mice following magnesium fortification of drinknig water: the importance of diet.     Pathobiology 68: 93-98, 2000.
806. 2000 Novel approaches to therapy for systemic lupus erythematosus.     Eur J Int Med 11 130-134, 2000.
807. 2000 Anti-P53 autoantibodies as diagnostic or prognostic markers of cancer.      Sem Clin Immunol 1, 339-44, 2000.
808. 2000 Autoantibodies associated with atherosclerosis.         Ann Med 32: 37-40, 2000.
809. 2000 Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or mycobacterium tuberculosis.        Circ Res 86: 1203-1210, 2000.
810. 2000 Immunological and clinical aspects of anti-RA33 antibodies in various autoimmune diseases. Harefuah 138: 1043-1045, 2000.
811. 2000 Smoking, sex hormones and rheumatoid arthritis. Harefuah, 138; 949-951, 2000.
812. 2000 VI International Congress of Immunorehabilitation, Eilat, Israel, May 3-6, 2000    http/www.rheuma21st.com/archives/immunorehab_shoenfeld..html , 26.6.2000 1-7.
813. 2000 Peptide immunotherapy in autoimmune diseases       Drug News & Perspectives 13: 78-84 , 2000
814. 2000 Hepatitis C virus, autoimmunity and cancer.       Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 285-298, 2000.
815. 2000 The contribution of experimental models to our understanding of etiology, pathogenesis and novel therapies in the antiphospholipid syndrome    In book: "Hughes Syndrome Antiphospholipid syndrome" (Ed: M.A. Khamashta) Springer Publ : 379-385, 2000
816. 2000 Idiotypic network dysregulation: a common etiopathogenesis of diverse autoimmune diseases   Appl Biochem Biotechnol 83: 155-62; discussion 297-313, 2000.
817. 2000 Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - a preliminary report    Clin Rheumatol 19: 207-211,2000.
818. 2000 The smoking - cancer - autoimmunity connection Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 309-316, 2000.
819. 2000 High dose intravenous immuoglobulins: a new step in the treatment of systemic lupus erythematosus      IMAJ 2: 388-392, 2000.
820. 2000 The induction of experimental vascular diseases by immunization with pathogenic autoantibodies.    Clin Exp Rheumatol : 18: 257-261, 2000.
821. 2000 Vaccination as an additional player in the mosaic of autoimmunity.     Clin Exp Rheumatol 18: 181-184, 2000.
822. 2000 GM, 9th International vasculitis/ANCA workshop     Archived Reports http://www.rheuma21st.com/archives/VASCULITIS ANCA_WORKSHOP.html (27.4.2000) 1-5.
823. 2000 Anti-cardiolipin antibodies in feltal blood and amniotic fluit derived from patients with the anti-phospholipid syndrome       Eur. Soc Hum Reprod Embryol.15:1170-1172,2000.
824. 2000 Intravenous Immunoglobulin Treatment of Lupus Nephritis        Sem Arthritis Rheumatism 29: 321-327, 2000.
825. 2000 Treatment of hematologic disorders other than immune thrombocytopenic purpura with intravenous immunoglobulin (IVIG) - report of seven cases and review of the literature. Eur J Int Med 11: 85-88, 2000.
826. 2000 Intravenous immunoglobulin therapy in antiphospholipid syndrome.      Rheumatology (Oxford), 39: 421-426, 2000.
827. 2000 Is cancer an autoimmune process dependent on anti-apoptotic autoantibodies?       Med Hypotheses, 55: 103-108, 2000.
828. 2000 Systemic lupus erythematosus and cancer: associated or not? Lupus 11: 137-44, 2000
829. 2000 Immunomodulation of experimental autoimmune diseases via oral tolerance.       Crit Rev Immunol; 20: 1-16, 2000.
830. 2000 Autoimmunity in atherosclerosis: lessons from experimental models. Lupus 9: 223-227, 2000
831. 2000 Is the physician like the pilot? Lessons learned from two professions demanding great responsibility        Eur J Int Med 11: 127-129, 2000.
832. 2000 Anti-idiotypic in autoimmunity      Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 365-378, 2000.
833. 2000 Prostacyclin-a new hope: its function and indications for therapeutic use.     Harefuah, 138: 54-58, 2000.
834. 2000 Vaccination and autoimmunity - 'Vaccinosis': a dangerous liaison?     J Autoimmunity , 14: 1-10, 2000.
835. 2000 A pure simuove - an autoimmune disease: auto-antibodies to tissue transglutaminase in celiac disease.    Harefuah. 138: 122-126, 2000.
836. 2000 Peptide immunotherapy: lessons from experimental models of systemic lupus erythematosus and antiphospholipid syndrome. http/www.rheuma21st.com/archives…ng_edge_Peptideimmunotherapy.html , 1.2.2000 1-5.
837. 2000 The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome - molecular mimicry? J Rheumatol, 27: 1: 12-14, 2000
838. 2000 Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus - like syndrome in MRL-lpr / lpr mice. Eur J Immunol, 30: 438-447, 2000
839. 2000 Effect of azathioprine on the anticoagulant activity of warfarin.     Ann Pharmacother 34: 120-2, 2000.
840. 2000 Recurrent peicarditis as a manifestation of familial mediteranean fever.      Circulation 101: E71-72, 2000.
841. 2000 Autoimmunity in atherosclerosis: The role of autoantigens.      Clin Rev Allergy & Immunol. 18: 73-86, 2000. 6178
842. 2000 Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis.      J Autoimmun, 14: 115-121, 2000.
843. 2000 The internal medicine subspeciality in the third millenium - where do we go? I accuse! Harefuah, 138: 407-409, 2000.
844. 2000 Serum autoantibodies in patients with primary sclerosing cholangitis       J Hepatol 32: 182-7, 2000.
845. 2000 Dermatomyositis and polymyositis associated with the antiphospholipid syndrome - a novel overlap syndrome.        Lupus 9: 42-46, 2000.
846. 2000 The good, the bad and the ugly of vaccination.       IMAJ 2: 225-227, 2000.
847. 2000 . SLE and Cancer Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 31-40, 2000
848. 2000 PSS (Scleroderma) and Cancer Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 45-48, 2000
849. 2000 Paraneoplastic Syndromes Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 121-132, 2000
850. 2000 Autoantibodies, autoimmunity and cancer Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 141-150, 2000
851. 2000 Thymoma and autoimmune diseases Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 249-252, 2000
852. 2000 Apoptosis: The relation between anti-fas antibodies, and immunosurveillance against cancer and autoimmunity Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 1-19, 2000.
853. 2000 Hepatitis C virus, autoimmunity and cancer Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 285-298, 2000.
854. 2000 The smoking - cancer - autoimmunity connection Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 309-316, 2000
855. 2000 Anti-idiotypic in autoimmunity. Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 365-378, 2000
856. 2000 The contribution of experimental models to our understanding of etiology, pathogenesis and novel therapies in the antiphospholipid syndrome. "Hughes Syndrome Antiphospholipid syndrome (Ed: M.A. Khamashta) Springer Publ : 379-385, 2000.
857. 2000 Molecular mimicry: lessons from experimental models of systemic lupus erythematosus and antiphospholipid syndrome Molecular Mimicry, Microbes, and Autoimmunity. (Editors: M.W. Cunningham, R.S. Fujinami), 2000, ASM Press, Washington, D.C. pp. 223-233.
858. 2000 Introduction: The immune system, the autoimmune state and autoimmune disease.     Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 1-18, 2000.
859. 2000 Rheumatoid arthritis and cancer        Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 19-30, 2000.
860. 2000 SLE and Cancer   Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 31-40, 2000.
861. 2000 PSS (Scleroderma) and Cancer Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 45-48, 2000.
862. 2000 Paraneoplastic Syndromes      Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 121-132, 2000.
863. 2000 Autoantibodies, autoimmunity and cancer         Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 141-150, 2000.
864. 2000 Hidden autoantibodies   Clin Rev Allergy & Immunol. 18: 3-10, 2000.
865. 2000 The story of the murine antiendothelial monoclonal antibody BGM: from patients' bedside to laboratory bench and from animal models to patients Clin Rev Allergy & Immunol. 18: 3-10, 2000.
866. 2000 Thymoma and autoimmune diseases            Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 249-252, 2000.
867. 2000 The prediction of coronary atherosclerosis employing artificial neural networks.     Clin Cardiol 23: 453-456, 2000.
868. 2000 Mycoplasma-pneumoniae- induced thrombotic thrombocytopenic purpura      Acta Haematologica. 103: 112-115, 2000.
869. 2000 Rheumatoid arthritis and cancer Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 19-30, 2000
870. 2000 Introduction: The immune system, the autoimmune state and autoimmune disease Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 1-18, 2000
871. 2000 Autoantigens and Autoantibodies: Diagnostic Tools and Clues to Understanding Autoimmunity Report on the 5th Dresden Symposium on Autoantibodies held in Dresden on October 18-21. 2000. pp: 1-766, PABST science Pub. Berlin, Germany.
872. 2000 Cancer and Autoimmunity Elsevier Publ. Amsterdam- Lausanne- New Yorrk- Shannon- Singapore-Tokyo; The Netherlands, pp. 1 - 446, 2000
873. 2000 The Antiphospholipid Syndrome CRC Press, Inc, 2000 Corporate Blvd., N.W., Boca Raton, Florida 33431, U.S.A.
874. 2000 Natural Autoantibodies: Their Physiological Role and Regulatory Significance CRC Press. 2000 Boca Raton Florida, USA, 33431.
875. 2000 Recurrent peicarditis as a manifestation of familial mediteranean fever Circulation 101: E71-72, 2000.
876. 2000 Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells. Int Immunol 13: 203-210, 2000
877. 2000 Iloprost treatment of finger gangrene in a patient with Raynaud's Syndrome Harefuah, 140: 40-43, 2000
878. 2000 32nd Rheumatologic Scientivic Conference of the Institute of Rheumatology and the Medical Faculty of Charles Zuniversity, Prague, Czech Republic, 3rd November 2000.   File:////Shoenfeld/public/reprints…Shoenfeld - Prague - Rheumat21.htm , 2000, 1-4.
879. 2000 Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain      Am J Cardiol 86: 1206-1311, 2000.
880. 2000 Are the research physicians an endangered species? Harefuah 139: 441-442, 2000.
881. 2000 Ciprofloxacin afects pregnancy loss in CBA/JxDBA/2J mice possibly via elevation of interleukin-3 and granulocyte macrophage-colony stimulating factor production AJRI 44: 293-298, 2000
882. 2000 Isotretinoin-induced adult onset Still's disease Clin Exp Rheumatol; 18: 616-8, 2000
883. 2000 Autoantigens and autoantibodies: diagnostic tools and clues to understanding autoimmunity http/www.rheuma21st.com/archives/shoenfeld_dresden.html , 9.11.2000 pp: 1-11
884. 2000 Editorial: Changing of the Guard - tribute to Ya'acov Rotem Harefuah; 138: 359, 2000
885. 2000 Pulmonary adenocarcinoma in myasthenia gravis - autoimmunity and late development of malignancy. Harefuah; 139, 354-355, 2000
886. 2000 Vaccination and arthritis revisited. http/www.rheuma21st.com/archives/apls_shoenfeld..vaccination_revisited_html , 11.9.2000 pp: 1-6.
887. 2000 Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus: 9: 573-83, 2000
888. 2000 9th Internationl Symposium on Antiphospholipid Antibodies, September 12-16, 2000, Tours, Loire Valley, France. http/www.rheuma21st.com/archives/apls_shoenfeld..html , 11.10.2000 pp: 1-10.
889. 2000 Linseed Oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome.      J Autoimmun 15: 381-385, 2000.
890. 2000 Adoptive transfer of b2-glycoprotein I - reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice.      Circulation 102: 1822 - 1827, 2000.
891. 2000 the idiotypic dysregulation of autoantibodies as part of the etiology of SLE. Lupus 9: 481 - 483, 2000.
892. 2000 The idiotypic network in antinuclear-antibody-associated diseases.       Int Arch Allergy Immunol, 123: 10-15, 2000.
893. 2000 Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis.      Wien Klin Wochenschr. 112/ 15-16: 660-664, 2000.
894. 2000 Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment     Nat Immun (1998) 16: 207-214, 2000.
895. 2000 Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis.       Rheumatol Int 19:199-201, 2000.
896. 2000 Antiphospholipid syndrome: insights from animal models    Curr Opin Hematol. 7: 321-4, 2000.
897. 1999 Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin.      Clin Rheumatol 18: 170-173, 1999.
898. 1999 Autoimmunerkrankungen: Mosaiksteine der pathogenese, autoimmune faktoren bei der entstehung der atherosklerose Aspekte, 8-15,12/99.
899. 1999 Magnesium fortification of drinking water suppresses atherogenesis in male LDL-receptor - deficient mice     Pathobiology, 67: 207-213, 1999.
900. 1999 Association between mitral annulus calcification and anti b2-glycoprotein I antibody levels J Noninvasive Cardiol III: 111-115, 1999.
901. 1999 Archived reports: VII international symposium of Sjogren's Syndrome. Venice, Italy, December 1-4, 1999    http/www.rheuma21st.com/archives/Sjogren99.html. , 25.12.1999 : 1-13.
902. 1999 Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus Clin Rheumatol 18: 238-240, 1999.
903. 1999 Characteristics and pathogenic role of anti-b2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.   Int Immunol 12: 1917-1926, 1999.
904. 1999 A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response. Lupus 8: 705-712, 1999.
905. 1999 Antibodies to the cytoplasm, cell membrane and nuclear membrane of malignant neoplasms in pooled normal human polyspecific immunoglobulin G. 783.       Int J Oncol 15: 1091-1096, 1999.
906. 1999 Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatology ; 26: 2383-2385, 1999.
907. 1999 Use of intravenous immunoglobulin in idiopathic membranous nephropathy. Int Med 38; 11: 917, 1999
908. 1999 Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. Clin Exp Rheumatol; 17: 521-6, 1999
909. 1999 Accelerated atherosclerosis in the antiphospholipid syndrome secondary to SLE: is there a role for anti-beta2GPI antibodies?      Rheumat 21st com/archives/cutting_ edge_ atherosclerosis.html , 4.10.1999.
910. 1999 Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, Aptil 20-25, 1998.     Sem Ar & Rheum Vol 29, No. 2: 112 - 130, Oct19 99.
911. 1999 New treatment avenues: oral tolerance - mechanisms and applicability to human diseases. IMAJ 1: 45-49, 1999.
912. 1999 Inflammatory and immune aspects of atherosclerosis IMAJ 1: 112-116, 1999.
913. 1999 Physiological functions of leukocyte adhesion molecules and their implication in pathology.     Semin Clin Immunol 2: 7-15, 1999.
914. 1999 Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome    Lupus 8: 502-507, 1999.
915. 1999 Intravenous immunoglobulin (IVIG) therapy in autoimmune diseases - SLE, antiphospholipid syndrome, vasculitis. What is new?     http://www.rheuma21st.com/archives/cutting_edge_immunoglobulin.html (16.09.99) 1-5, 1999.
916. 1999 Immunomodulation of various autoimmune diseases by intravenous immunoglobulin Drugs of Today, 35: 513-518, 1999.
917. 1999 DNA levels in circulating immune complexes decrease at severe SLE flares - correlation with complement component C1q J Autoimmunity 13: 111-119, 1999.
918. 1999 Anti-cytokine therapy in inflammatory joint diseases.     Harefuah, 137 : 120-123, 1999.
919. 1999 Multicenter evaluation study on a n4ew HEp2 ANA screening enzyme immune assay.      J Autoimmunity 13: 89-93, 1999.
920. 1999 Predicion and prevention of primary billary cirrhosis.        Harefuah, 137: 39-41, 1999.
921. 1999 The involvement of Beta 2-Glycoprotein I (ß2GPI) in human and murine atherosclerosis.      J Autoimmunity 13: 57-60, 1999.
922. 1999 Inhibition of diabetes in NOD mice by idiotypic induction of SLE       J Autoimmunity 13: 49-55, 1999.
923. 1999 Clinical and laboratory features of SLE: involvement of the central nervous system.      Archived Reports http://www.rheuma21st.com/archives/featuresle.html (31.07.99) 1-9, 1999.
924. 1999 Gamma-globulin inhibits tumor spread in mice       Int Immunol 11: 1247-1251, 1999.
925. 1999 In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration       J Autoimmunity 13: 129-135, 1999.
926. 1999 Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty.      Immunol Lett 68: 263-266, 1999.
927. 1999 Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin Int Arch Allergy and Immunol 119: 231-238, 1999
928. 1999 Reactivity of peripheral blood lymphocytes to oxidized low-density lipoprotein: a novel system to estimate atherosclerosis employing the cellscan.     Clin Cardiol 22: 526-532, 1999.
929. 1999 Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin.     Lupus 8: 324-327, 1999.
930. 1999 Anti-cardiolipin, anti--endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: Relationship with vascular access thrombosis and thromboembolic events. Hum Antibodies 9: 125-31, 1999
931. 1999 Monoclonal anti-endothelial cell antibodies from Takayasu arthritis activate endothelial cells from large vessels     Arthritis & Rheum, 42: 1421-32, 1999.
932. 1999 Anti-idiotype immunomodulation of experimental anti- phospholipid syndrome via effect on Th1/Th2 expression.   Clin Exp Immunol, 117: 190-197,1999.
933. 1999 Relapse of sarcoidosis after alternative medical treatment. Harefuah, 136: 849-850, 1999
934. 1999 Cancer and antibodies to p53.   Harefuah, 136: 868-869, 1999.
935. 1999 Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus.    Clin Rheumatol 18: 238-240, 1999.
936. 1999 European forum on antiphospholipid antibodies   http:// www.rheuma21st com/archives/euro_antiphos.html : 1-8, 1999.
937. 1999 Immunolocalization of beta2-Glycoprotein I (Apolipoprotein H) to human atherosclerosis plaques: potential implications for lesion progression Circulation 99: 2227-2230, 1999.
938. 1999 Molecular mimicry between host and pathogen: examples from parasites and implication.    Immunology Letters 67: 147-152, 1999.
939. 1999 Environment factors may modulate antiphospholipid antibody production in familial members of patients with systemic lupus erythematosus     Arthritis & Rhematism 42: 1062-1063, 1999.
940. 1999 Atherosclerosis - related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis      Lupus 8: 220-226, 1999.
941. 1999 Microchimeras - the secret path that leads to immunity? Harefuah, 136: 618-619
942. 1999 Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation.      Clin Immunol 91: 106-16, 1999.
943. 1999 Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.     Proc Nat Acad Sci (USA) 96: 5164-5168, 1999.
944. 1999 Marked improvement of Churg-Strauss Vasculitis with intravenous gammaglobulins   South Med J 92: 412-4, 1999.
945. 1999 Blood and marrow transplantation in autoimmune diseases reported at 25th annual meeting of European Group for Blood and Marrow Transplantation     http//www.rheuma 21st.com/archives, 21/4/99.
946. 1999 malignancy work-up in patients with cancer-associated (paraneoplastic) autoimmune diseases: pemphigus and myasthenic syndromes as cases in point (Review)     Oncol Rep, 6: 665-668, 1999.
947. 1999 Survival without surgical repair of acute rupture of the right ventricular free wall Clin Cardiol 22: 319-320 , 1999.
948. 1999 Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis.    Clin Cardiol 21: 813-816, 1998 - reply. Clin Cardiol 22: 158-158, 1999.
949. 1999 Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8: 127-133, 1999.
950. 1999 Beta(2) glycoprotein I containing immune-complexes in Lupus patients: association with thrombocytopenia and lipoprotein (a) levels.       Lupus 8: 116-120, 1999.
951. 1999 Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease [In Process Citation]        Clin Exp Rheumatol, 17: 99-102, 1999.
952. 1999 Anti-endothelial cell antibodies in systemic sclerosis Clin Dian Lab Immunol, 6: 150-60, 1999.
953. 1999 Enhanced Fatty Streak Formation in C57BL/6J Mice by Immunization With Heat Shock Protein-65   Arterioscler Thromb Vasc Biol, 19: 505-510, 1999.
954. 1999 The Antiphospholipid (Hughes') Syndrome: An Entity to Be Expanded     AJRI Am J of Reproductive Immunol, 41:113-116, 1999.
955. 1999 Low cholesterol, depression and unexplained deaths - the link and the mystery Harefuah, 136: 82-85, 1999
956. 1999 Autoantibody spread may explain multiple antibodies 773         The Immunologist 7/6 ; 189-193., 1999.
957. 1999 Depression and the immune system 773         Harefuah, 136: 288-190, 1999.
958. 1999 The X-ANCA-immunological aspects and clinical significance 773         Harefuah, 136: 280-282, 1999.
959. 1999 Atheroma: links with antiphospholipid, antibodies Hughes syndrome and lupus 744.        Q J Med 92: 57-59, 1999.
960. 1999 Hepatitis C virus and Autoimmunity The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 355-364, 1999
961. 1999 Prolactin and Autoimmunity The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 339-346, 1999.
962. 1999 Cytokines in Autoimmunity. The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 313-322, 1999.
963. 1999 Detection of Cellular Activity in Autoimmune Disorders by the Cellscan System The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 295-304, 1999
964. 1999 A Focus on Anti-Tyrosinase Antibodies in Melanoma and Vitiligo.      The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 261-268, 1999.
965. 1999 Innovations in Autoimmunity in the Last Decade   The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 7-18, 1999.
966. 1999 Immunomodulation of Experimental Antiphospholipid Syndrome: Lessons from Murine Models The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 81-84, 1999.
967. 1999 Hyperhomocysteinemia - a risk factor for vascular disease?      Harefuah 136: 129, 1999.
968. 1999 A mouse model for heparin - induced thrombocytopemnia.        Semin Hematol 36: 12-16, 1999.
969. 1999 Rheumatologic features of hematologic disorders     Curr Opin Rheumatol . 11: 62-7, 1999.
970. 1999 A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants J Rheumatol 26: 73-7, 1999.
971. 1999 Low cholesterol, depression and unexplained deaths - the link and the mystery.     Harefuah 136: 82, 1999.
972. 1999 Ocular manifestations in the antiphospholipid syndrome.      Harefuah 136: 50, 1999.
973. 1999 . Enhancement of atherosclerosis in beta-2 glycoprotein I - immunized apolipoprotein E - deficient mice      Pathobiology 67: 19-25,1999
974. 1999 Hepartitis C virus and Autoimmunity The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 355-364, 1999
975. 1999 Prolactin and Autoimmunity The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 339-346, 1999
976. 1999 Cytokines in Autoimmunity The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 313-322, 1999
977. 1999 Detection of Cellular Activity in Autoimmune Disorders by the Cellscan System The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 295-304, 1999.
978. 1999 A Focus on Anti-Tyrosinase Antibodies in Melanoma and Vitiligo The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 261-268, 1999
979. 1999 Innovations in Autoimmunity in the Last Decade The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 7-18, 1999.
980. 1999 Immunomodulation of Experimental Antiphospholipid Syndrome: Lessons from Murine Models The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 81-84, 1999
981. 1999 The Decade of Autoimmunity Elsevier Publ Amsterdam, The Netherlands. pp. 1-500, 1999.
982. 1999 Use of intravenous immunoglobulin in idiopathic membranous nephropathy Int Med 38; 11: 917, 1999
983. 1998 Viagra – utility and risk Harefuah 135; 20-23, 1998.
984. 1998 Antiphospholipid syndrome and vasculitis – just a coincidence?    Harefuah 134: 273-276, 1998.
985. 1998 Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression.    Arthritis & Rheumatism 41: 224-232, 1998.
986. 1998 Prevalence of hypophosphatemia in sepsis and infection: The role of cytokines.    Amer J Med 104: 40-47, 1998.
987. 1998 Infectious agents and atherosclerosis.    Harefuah 134: 204-207, 1998.
988. 1998 Chapter 1.3.8 Haematology and Oncology in Rheumatology: Oxford Textbook of Rheumatology (Maddison et al – Eds).    Oxford University Press, 1998, Oxford U.K. pp. 288-298.
989. 1998 Anti-DNA and antiphoshpholipid antibodies in IVIG preparations: In Vivo study in naive mice. .    J. Clin Immunol, 18, 52-60, 1998.
990. 1998 Fibrosarcoma after silicone breast augmentation: associated?    Harefuah, 134: 339-441, 1998.
991. 1998 Breast silicone implant and autoimmunity: coincidence or cause and effect relationship? Harefuah, 134: 361-364, 1998.
992. 1998 Differential effects of anti-b-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 97: 900-906, 1998.
993. 1998 Massive proteinuria as a main manifestation of primary antiphospholipid syndrome.     Phatobiology 1998; 66: 49-52.
994. 1998 Stem cells transplatation – a cure for autoimmune diseases.    Lupus 7, 137-140, 1998.
995. 1998 Cow milk feeding in infancy: is it a predisposing factor to insulin-dependent diabetes mellitus?    Harefuah 134; 489-492, 1998.
996. 1998 Autoantibodies, autoimmunity and cancer. Oncol Rep. 5:753-761, 1998.
997. 1998 Dietary polyunsaturated fatty acids decrease anti-dsDNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus. Lupus 7, 192-197, 1998.
998. 1998 The pathogenic 16/6 idiotype in pateints with silica associated systemic lupus erythematosus (SLE) and in uranium miners with increased risk for development of SLE.    J Rheumatol 25:4, 660-666, 1998.
999. 1998 Animal Models of Anti-Phospholipid Syndrome Reumatologia V Teorii a Praxi V. Eds: Josef Rovenski. 1998: pp. 217-227. Vydavatelstvo Osveta. Banska Bystriia. Slovakia
1000. 1998 The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis.   J Clin Invest, 15; 101 : 2029-2035: 1998.
1001. 1998 Atherosclerosis and the antiphospholipid syndrome: A link unravelled?    Lupus 7: 140-143, 1998.
1002. 1998 Hantavirus seropositivity in Israeli patients with renal failure.    Viral Immunol. 11: 103-8, 1998.
1003. 1998 Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus.    Clin Rev Allergy & Immunol. 16: 321-334, 1998.
1004. 1998 Functional properties of antiendothelial cell antibodies    Clin Rev Allergy & Immunol. 16: 297-311, 1998.
1005. 1998 Central nervous System (CNS) involvement in SLE: The diagnostic role of antibodies to neuronal antigens.    Clin Rev Allergy & Immunol. 16: 275-284, 1998.
1006. 1998 Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.   Clin Rev Allergy & Immunol. 16: 265-273, 1998.
1007. 1998 The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions.   Clin Rev Allergy & Immunol 16: 227-236, 1998.
1008. 1998 Autoantibodies in angioneurotic edema.    Clin Rev Allergy & Immunol. 16: 207-210, 1998.
1009. 1998 Introduction: Autoantibodies as a clinical diagnostic tool.   Clin Rev Allergy & Immunol 16: 205-206, 1998.
1010. 1998 Anti-endothelial cell antibodies in the sera of hyperprolactinemic women.   Lupus 7: 377-382. 1998.
1011. 1998 Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with b2-glycoprotein I.   Circulation. 98: 1108-1115, 1998.
1012. 1998 Immunomodulation of experimental antiphospholipid syndrome   Scand J Rheumatol. 27 (suppl) 107: 48-52, 1998.
1013. 1998 Anti-phospholipid autoantibodies – do they have a pathogenic role in infertility?   Scand J Rheumatol. 27 (suppl) 107: 40-43, 1998.
1014. 1998 Antiphospholipid syndrome in pregnancy – animal models and clinical implications.   Scand J Rheumatol. 27 (suppl) 107: 33-36, 1998.
1015. 1998 Interleukin-3 and pregnancy loss in antiphospholipid syndrome Scand J Rheumatol. 27 (suppl) 107: 19-22, 1998.
1016. 1998 BCG In: Encyclopedia of Immunology. Editor: I Roitt, P. Delves. Academic Press. USA. p. 335-336, 1998.
1017. 1998 Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation: An autoimmune phenomenon Immunol Res 18: 55-60, 1998.
1018. 1998 Lessons from experimental APS models Lupus 7: 158-161, 1998.
1019. 1998 Viagra, the first oral treatment for impotence.   Harefuah 135; 1-2, 1998.
1020. 1998 Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA.   Int Immunol 10: 861-868, 1998.
1021. 1998 Cytomegalovirus and atherosclerosis. Harefuah 134: 869-871, 1998.
1022. 1998 Colchicine treatment for recurrent pericarditis. A decade of experience.   Circulation, 97: 2183-2185: 1998.
1023. 1998 Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis Atherosclerosis 138; 147-152: 1998.
1024. 1998 Bone marrow transplantation for severe autoimmune diseases: treatment of choice or a treatment of no choice?    Harefuah, 134: 785-787: 1998.
1025. 1998 Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders Lancet , 351: 1620-1624: 1998.
1026. 1998 Clinical characteristics of ruptured chordae tendinae in hospitalized patients: primary tear versus infective endocarditis Clin Cardiol ; 21: 813-816, 1998
1027. 1998 Thromboembolic phenomena in patients with hereditary factor XI deficiency.     Ann Med Interne 149: 492-494, 1998.
1028. 1998 Autoimmunity and Autoimmune Diseases such as SLE Chapter in book: Systemic Lupus Erythematosus. Ed: R.G.Lahita, Academic Press San-Diego, USA pp. 1-16, 1998.
1029. 1998 Cytokines, antibodies to cytokines and autoimmunity       Drug of Today 34: 825-835, 1998.
1030. 1998 Renal biopsy in the elderly - to do or not to do?     Harefuah 135: 645, 1998.
1031. 1998 Pathogenic and Diagnostic Relevance of Autoantibodies. Report on the 4th Dresden Symposium on Autoantibodies held in Dresden on October 21-24, 1998. 450 pp. PABST science Pub. Berlin, Germany, 1998.
1032. 1998 Report on the catalytic and super antibodies satellite meeting held in conjunction with the 10th International Congress of Immunology     WWW.rheuma21st.com, 15.11.98.
1033. 1998 Pulmonary hypertension and multivalvular damage caused by anorectic drugs.   Harefuah 135: 491, 1998.
1034. 1998 ß2GP-I in the anti phospholipid (Hughes') syndrome - from a cofactor to an autoantigen - from induction to prevention of antiphospholipid syndrome      Lupus 7: 503-506, 1998.
1035. 1998 Models animaux de syndrome antiphospholipides     Rev Rhumatisme. [Ed.Fr]: 65: 676-681, 1998. [Engl. Ed.]: 65:614-618, 1998.
1036. 1998 Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLE.      Clin Exp Rheumatol 16: 717-20, 1998.
1037. 1998 Anti-phospholipid syndrome:from patient's bedside to experimental animal models and back to the patient's bedside.   Hematol Cell Ther 40: 175-82, 1998.
1038. 1998 Primary biliary cirrhosis: Is (and how much of) the patology preventible?   Immunologic Research 18: 117-121, 1998.
1039. 1998 Chapter 1.3.8 Oncology and Haematology Oxford Textbook of Rheumatology (Maddison et al – Eds). Oxford University Press, 1998, Oxford U.K. pp. 288-298
1040. 1998 Animal models of Anti-Phospholipid Syndrome Reumatologia V Teorii a Praxi V. Eds: Josef Rovenski. 1998: pp. 217-227. Vydavatelstvo Osveta. Banska Bystriia. Slovakia.
1041. 1998 BCG Encyclopedia of Immunology. Editor I Roitt, P. Delves. Academic Press. USA. p. 335-336, 1998
1042. 1998 The idiotypic network in autoimmune diseases – Induction and Treatment. 43.           Pathogenic and Diagnostic Relevance of Autoantibodies. Eds: Conrad K, Humbel RL, Member M, Shoenfeld Y, Tan & N.
1043. 1998 Autoimmunity and autoimmune Diseases such as SLE Systemic Lupus Erythematosus, Ed: R.G.Lahita, Academic Press San-Diego, USA pp. 1-16, 1998
1044. 1998 The Dual Relationship Between Thymectomy and Autoimmunity The Kaleidoscope of Autoimmune Disease. Sudhir paul, University of Texas/Huston Medical Scholl, Houston, TX. pp. 1-448, 1998
1045. 1998 Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol ; 21: 813-816, 1998.
1046. 1998 Autoimmune diseases and autoimmunity post-bone marrow transplantation.     Bone Marrow Transplant, 22: 873-81, 1998.
1047. 1998 Oral tolerance to low dose ß2-glycoprotein-I: immunomodulation of experimental antiphospholipid syndrome.     J Immunol, 161: 5303-12, 1998.
1048. 1998 High-Dose Intravenous γ g-globulins for herparin induced thrombocytopenia: A prompt response.      J Clin Immunol, 18: 330-334; 1998.
1049. 1998 Comparative clinical study of cefonicid, chloramphenicol, and penicillin in community-acquired pneumonia Int J Mol Med 2:343-348, 1998 .
1050. 1998 The Dual Relationship Between Thymectomy and Autoimmunity. The Kaleidoscope of Autoimmune Disease   Autoimmune Reactions, Ch.23, pp.371-382 ,Edited by: Sudhir Paul, Human Press Inc., Totowa, New Jersey, U.S.A., 1998.
1051. 1998 ANCA testing. New developments and clinical implications    Clin Rev. Allergy Immunol 16:303-11,1998.
1052. 1998 Autoantibodies-antigen driven or idiotypically induced    Bratisl Lek Listy, 99:410-2, 1998.
1053. 1998 Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.   Blood 1998, 92:3250-9.
1054. 1998 Health effects of cigarette smoking    Clin Dermatol 1998,16:545-56.
1055. 1998 Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. J Autoimmun 1998, 11:489-493.
1056. 1998 Immunomodulation of murine experimental SLE-like disease by interferon-Y.    Lupus 7: 445-454, 1998.
1057. 1998 Environmental factors and scleroderma Harefuah, Vol.135 No.9: 370-373, 11/1998.
1058. 1998 Idiotypes of autoantibodies    APLAR J Reumatol 2: 54-64; 1998.
1059. 1998 Kleidoscopic Autoimmunity   Harefuah, 135, 262-263, 1998.
1060. 1998 The role of ultraviolet light, and sun and fluoresent light, in the pathogenesis of systemic lupus erythematosus.    Harefuah, 135:295-298, 1998.
1061. 1998 Autoimmunity and autoimmune diseases such as systemic lupus erythematosus.   System Lupus Erythematosus, AP-Academic press, 3rd Ed. 1-16,1998. (Editor R. Sahita).
1062. 1998 Malignant thymoma associated with autoimmune diseases: A retrospective study and review of the literature.    Sem Arthritis Rheumat, 28: 73-80,1998.
1063. 1998 Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum, 41:1738-47, 1998.
1064. 1998 Idiotypic induction of autoimmunity. J Biolo Reg d Homeost Agents, 12, 49-52, 1998.
1065. 1998 Target recognition of b2-Glycoprotein (b2GPI)-dependent anticardiolipin antibodies: Evidence for involvement of the fourth domain of b2GPI in antibody binding.    J Immunol, 160: 3917-3923, 1998.
1066. 1997 Vasaculitis: classification, mechanisms, animal models and treatment. Harefuah 132: 567-572, 1997.
1067. 1997 Thymoma, thymic hyperplasia,thymectomy in autoimmune diseases. Int J Oncol 10:939-943, 1997
1068. 1997 Autoimmunity and cancer-beneficial relationship: a new concept for the production of human monoclonal antibodies    Int J Oncol 10:901-904, 1997.
1069. 1997 New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation Ann Rheum Dis 56: 5-11, 1997.
1070. 1997 T cell help and antiphospholipid antibody immunogenesis (letter). Arthritis Rheumat 40: 196-197, 1997.
1071. 1997 Finding a valid model for antineutrophil cytoplasmic antibody-related vasculitis Arthritis Rheum 5: 986-987;1997
1072. 1997 Manipulation of autoantibody idiotypes in autoimmune diseases Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 203-215, 1997
1073. 1997 Cancer therapy with anti-idiotypic antibodies Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 407-417, 1997.
1074. 1997 Novel aspects of IVIG treatment in autoimmune diseases. Proceedings of the XIX ILAR Congress of Rheumatology. 456-458, Singapore, 8-13 June,1997
1075. 1997 Autoantibodies - antigen driven or idiotypically induced. Proceeding of the XIX ILAR Congress of Rheumatology. 230-233, Singapore, 8-13 June, 1997
1076. 1997 Immunointerventions in experimental model for antiphospholipid syndrome. Ann Med Interne 147: 50-53 (suppl), 1997.
1077. 1997 Animal models for antiphospholipid syndrome Proceeings of the XIX Ilar Congress of Rheumatology , 420-423,Singapore,8-13 June, 1997
1078. 1997 Do some antiphospholipid antibodies target endothelial cells? Ann Med Interne 147: 22-23 (suppl): 1997.
1079. 1997 Early detection of recurrent mono-metastases of breast cancer to endocrine tissues by following CEA levels    Oncol Reports, 4: 623-624: 1997.
1080. 1997 The emerging concept of pathogenic natural antibodies. Human Antibodies Hybridoma 8: 70-75, 1997.
1081. 1997 Systemic Lupus Erythematosus (Hebrew) Prolog Pub., Tel-Aviv, Israel, pp. 1-86, 1997
1082. 1997 Treatment of Hypertension (Hebrew) Prolog Pub., Tel-Aviv, Israel. pp. 1-70, 1997.
1083. 1997 Idiotypes in Medicine: Autoimmunity, Infectious Diseases and Cancer Elsevier Publ. Amsterdam, The Netherlands pp. 1-500, 1997.
1084. 1997 Is familial mediterranean fever an autoimmune disease or an immune mediated condition? Familial Mediterranean Fever. Sohar E, Gafni J, Pras M (Eds.) Freund Publishing House Ltd., London, 267-278, 1997
1085. 1997 Introduction – Idiotypes and Anti-idiotypes Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.53-63
1086. 1997 Idiotypes of Anti-DNA Antibodies. Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier, Amsterdam, The Netherlands, 1997. Pp.75-88
1087. 1997 Idiotypes of Anti-Ro and Anti-La. Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.95-97.
1088. 1997 Idiotypes of Anti-Phospholipid Antibodies Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.119-128
1089. 1997 Idiotypes of Platelet Associated Antibodies Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. pp.189-192
1090. 1997 Idiotypes of Natural Autoantobodies and Monoclanal Gammopathies. Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.193-203
1091. 1997 Manipulation of Autoantibody Idiotypes In Autoimmune Diseases Idiotypes in Medicine Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.227-238.
1092. 1997 Advances in immunotherapy and treatment of Bechet’s disease. Harefuah 132: 350-353, 1997.
1093. 1997 IgG subclasses of human autoantibodies. Ann Med Interne 148: 29-38, 1997
1094. 1997 Selective inhibitors of cyclooxygenase-2: an upgrade in nonsteroidal anti-inflammatory drugs. Harefuah 132: 411-416, 1997.
1095. 1997 Short term effect of high dose insulin on thymic morphology of ICR female mice. Diabetes Research 32: 27-35, 1997.
1096. 1997 Calcium blockers and cancer - is there any link between them? Harefuah 132: 876-878, 1997.
1097. 1997 Induction of autoimmunity: A role for the idiotypic network in B lymphocytes and autoimmunity.   (Ed:Chiorazzi N, Labrita RG, Ravelka K, Ferrarimi M) Ann N Y Acad Sci 815: 342-349, 1997.
1098. 1997 Pathogenesis of hemolytic uremic syndrome and thrombotic throbocytopenic purpura.   Harefuah 32: 665-669; 1997.
1099. 1997 Ischemic hepatitis in congestive heart failure after an episode of hypotension   Harefuah 132: 459-460, 1997.
1100. 1997 Nucleosomes as an autoantigen in SLE. Harefuah 132:475-478, 1997 .
1101. 1997 Idiotypes and anti-idiotypes Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 53-65, 1997
1102. 1997 Idiotypes and anti-DNA antibodies Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 75-89, 1997
1103. 1997 Idiotypes of anti-Ro and anti-La Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 95-99, 1997
1104. 1997 Idiotypes of anti-phospholipid antibodies Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 119-129, 1997
1105. 1997 Idiotypes of platelet associated antibodies (autoimmune thrombocytopenia) Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 165-169, 1997
1106. 1997 Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity Lupus 6: 425-435, 1997
1107. 1997 Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human b2-glycoprotein I.   Int Immunol 9: 6; 913-921, 1997.
1108. 1997 Neurological dysfunction and hyperactive behavior associated with antiphospholipid syndrome: a mouse model. J Clin Invest 100:613-619, 1997.
1109. 1997 Novel aspects of IVIG treatment in autoimmune diseases.    Proceedings of the XIX ILAR Congress of Rheumatology,pp 456-458 Singapore,8-13 June,1997.
1110. 1997 Animal models for antiphospohlipid syndrome (APS). Proceedings of the XIX ILAR Congress of Rheumatology. pp 420-423, Singapore, 8-13 June, 1997.
1111. 1997 Animal models for Systemic Lupus Erythemathosus Proceedings of the XIX ILAR Congress of Rheumatology, pp 186-187, Singapore 8-13 June, 1997.
1112. 1997 Autoantibodies - antigen derived or idiotypically induced.   Proceedings of the XIX ILAR Congress of Rheumatology.pp 230-233, Singapore 8-13 June, 1997.
1113. 1997 Infections and Wegener’s granulomatosis - a cause and effect relationship? Q J Med 90: 367-373,1997.
1114. 1997 Anti-neutrophil cytoplasmic antibody-enriched IgG induces adhesion of human T lymphocytes to extracellular matrix proteins. Clinical Immunol Immunophathol 83: 3; 245-253, 1997.
1115. 1997 The idiotypic network. Animal models and clinical implications.    Japanese J Rheumatol 7 (invited article) : 75-82, 1997.
1116. 1997 Successful treatment of early secondary myelofibrosis in SLE with IVIG.   Lupus 6: 408-411,1997.
1117. 1997 Finding a valid model for antineutrophil cytoplasmic antibody-related vasculitis. Arthritis Rheum 5: 986-987,1997.
1118. 1997 Libman-Sacks endocarditis-a jubilee year Harefuah 132:718-719,1997.
1119. 1997 Pathogenicity of human anti-platelet factor 4(PF4)heparin in vivo: generation of mouse anti-PF4/ heparin and induction of thrombocytopenia by heparin. Clin Exp Immunol 108:333-339,1997.
1120. 1997 Oxidized low-density lipoprotein (Ox LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS). Clin Exp Immunol: 108;227-233,1997
1121. 1997 Systemic lupus erythematoses in Israel. Harefuah 132:636-638,1997.
1122. 1997 Anti-DNA Antibodies: Is DNA the self antigen or a shelf antigen, or are all autoimmune diseases immunogen driven? Immunoregulation in Health and Disease, Academic Press, New York, Lukic ML, Colic M, Stoikovic MM,Cuperlovic K (Eds.) pp.139-148, 1997.
1123. 1997 Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: additional evidence for the kaleidoscope of autoimmunity   Lupus 6: 474-476, 1997.
1124. 1997 Autoantibodies to tyrosinase-the bridge between melanoma and vitiligo.   Cancer 79: 1461-1464, 1997.
1125. 1996 The Immune System (Hebrew) pp. 1-95, 1996. Prolog Pub., Tel-Aviv, Israel.
1126. 1996 Actin autoantibodies Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 10-12, 1996
1127. 1996 Autoantibody subclasses Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 103 - 108, 1996
1128. 1996 Hidden Autoantibodies Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 357 - 363, 1996
1129. 1996 Idiotypes and anti-idiotypic antibodies Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 408 - 416, 1996
1130. 1996 Natural autoantibodies Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 534 - 539, 1996
1131. 1996 Pathogenic mechanisms Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 607- 617, 1996
1132. 1996 Tyrosinase autoantibodies Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 842 - 845, 1996
1133. 1996 “The dead sea: A source of life” therapeutic and economic potential Special issue of the Isr J Med Sci: 1996 Vol 32(Suppl).
1134. 1996 Hematologic Manifestations The Clinical Management of Systemic Lupus Erythematosus (SLE). (2nd Ed.). Editor: Peter H. Schur. Lippincott-Raven, N.Y., U.S.A., pp. 95-108, 1996.
1135. 1996 Pregnancy and antiphospholipid syndrome. A report and relevant abstracts from the 4th Int. Conference on SLE. Jerusalem March 1995. Early Pregnancy Biology and Medicine 2: 53 - 69, 1996.
1136. 1996 Anti-endothelial cell IgG antibodies from patients with Wegener’s granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 39: 758 - 766, 1996.
1137. 1996 Clinical practice today. Harefuah 130: 606 - 607, 1996.
1138. 1996 No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus (SLE) J Rheumatol 23 : 629 - 632, 1996.
1139. 1996 Immune network and autoimmunity Internal Medicine 35: 3 - 9, 1996.
1140. 1996 Intravenous immunoglobulin in women with five or more abortions. Amer J Reproductive Immunol 35: 360 - 362, 1996.
1141. 1996 Rheumatology in Israel. Brit J Rheumatol 35: 778-780, 1996.
1142. 1996 Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci 32: 288 - 291, 1996
1143. 1996 Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93: 1574 - 1587, 1996
1144. 1996 Fungal infections and autoimmune diseases. Harefuah 130: 388 - 390, 1996.
1145. 1996 Guillain-Barre as an autoimmune disease Int Arch Allergy & Immunol 109: 318 - 326, 1996.
1146. 1996 Superantigens and experimental SLE induced by idiotypic dysregulation. Clin Exp Rheumatol 14: 359 - 366, 1996.
1147. 1996 The pathogenic role of anti-phosphatidylserine antibodies: Active immunization with the antibodies leads to the induction of antiphospholipid syndrome Clin Immunol Immunopathol 78: 14 - 20, 1996.
1148. 1996 Induction of thyroid autoantibodies in naive mice by idiotypic manipulation Clin Immunol Immunopathol 78: 180 - 187, 1996.
1149. 1996 Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome. Amer J Reproduct Immunol 35: 80 - 84, 1996.
1150. 1996 New therapeutic avenues in autoimmunity Res Immunol (Inst. Pasteur) 147: 361-376, 1996.
1151. 1996 Mixed connective tissue disease: thirty three years of uncertainty. Harefuah, 130: 99-103, 1996.
1152. 1996 Satisfaction among patients of homeopathic clinic Harefuah, 130:86-89, 1996.
1153. 1996 Autoantibodies in leprosy sera Clin Rheumatol 15:26-28, 1996.
1154. 1996 Comparison of clinical and laboratory parameters for systemic lupus erythematosus activity in Israelis versus Europeans Isr J Med Sci 32:100-104, 1996.
1155. 1996 Iatrogenic damage Harefuah 130:53-55, 1996.
1156. 1996 Celiac disease and autoimmunity Isr J Med Sci 32:33-36, 1996.
1157. 1996 Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture’s syndrome Isr J Med Sci 32:29-31, 1996
1158. 1996 Prolactin, bromocriptine and autoimmune diseases Isr J Med Sci 32:23-27, 1996.
1159. 1996 Aspirin, interleukin-3 and the antiphospholipid syndrome Isr J Med Sci 32:13-17, 1996.
1160. 1996 Th1/Th2 cells and autoimmunity. Harefuah 131: 189-193, 1996.
1161. 1996 Immunomodulation of experimental APS: lessons from murine models. Lupus 5: 458-462, 1996.
1162. 1996 Clinico-Pathological Conferences: Severe fatal shock after syncope in an old man. Harefuah 131: 360-363, 1996.
1163. 1996 Cellular immune responses in rheumatic fever Harefuah 131: 321-323, 1996.
1164. 1996 Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. Clin Exp Rheumatol 14: 479-483, 1996.
1165. 1996 Nucleosomes, DNA and SLE : Where is the starting point ? Clin Exp Rheumatol 14: 475-478, 1996.
1166. 1996 Hematologic manifestations. In: The Clinical Management of Systemic Lupus Erythematosus (SLE). (2nd Ed.). Editor: Peter H. Schur. Lippincott-Raven, N.Y., U.S.A., pp. 95-108, 1996.
1167. 1996 Pancreatitis induced by clarithromycin Ann Int Med 125: 701. 1996.
1168. 1996 Treatment of systemic lupus erythematosus and antiphospholipid syndrome: From experimental models to patients’ bedside Int Arch Allergy Immunol 111: 355-361, 1996.
1169. 1996 Interleukin 12 - polyfunctional cytokine. Harefuah 131: 501-505, 1996.
1170. 1996 Playing with fire. Harefuah 131: 474-476, 1996.
1171. 1996 “BCG itis” - sepsis following BCG treatment. Harefuah 131: 541-543, 1996.
1172. 1996 Everything you wanted to know about magnesium and didn’t dare to ask. Harefuah 131: 556-558, 1996.
1173. 1996 No Russian immigrants, no women, no Hebrew Harefuah 131: 604-605, 1996.
1174. 1996 . Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis. Immunol Res 15: 315 - 322, 1996.
1175. 1996 Partial lipodystrophy and complement dysfunction. Turk J Immunol 2: 43-45, 1996
1176. 1996 Immunosuppression and immunomodulation of experimental models of systemic lupus erythematosus and antiphospholipid syndrome. Transplantation Proceed 28: 3096-3098, 1996.
1177. 1996 Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. Semin Arthritis Rheum 26: 558-563, 1996.
1178. 1996 Leucocytoclastic vasculitis after coronary bypass artery grafting. Brit J Dermatol 135: 1015 - 1016, 1996.
1179. 1996 The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus. 614.       Immunol Lett 53: 77-82, 1996.
1180. 1996 Modulation of experimental systemic lupus erythematosus with linomide. Lupus 5: 328-333, 1996.
1181. 1996 Catalytic antibodies: generation, nature and possible role as chemical warfare scavengers. Military Medicine 161: 1/1996, p. 7.
1182. 1996 Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spouses. 614.       J Autoimmunity 9: 767-775, 1996
1183. 1996 Dopamine and kidneys - the protective efect on the kidneys - legend or reality. Harefuah, 130: 480-483, 1996.
1184. 1996 Tuberculose et auto-immunite: ou en sommes - nous ? 616.       Annales de L’ Institut Pasteur 7: 133-136, 1996.
1185. 1996 Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Hum Antibody Hybridomas 7: 91-96, 1996.
1186. 1996 Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma). Isr J Med Sci 32: 537-541, 1996.
1187. 1996 The medical and scientific aspects of spa therapy. Isr J Med Sci 32: (suppl 3) 8-10, 1996.
1188. 1996 The dead sea is alive. Isr J Med Sci 32 (Suppl 3): 1-3, 1996.
1189. 1996 Levels of lupus autoantibodies in pregnant SLE patients: correlations with disease activity and pregnancy outcome Clin Exp Rheumatol 14: 275-280, 1996.
1190. 1996 The diverse pathogenic potential of anti-DNA antibodies from various sources to induce experimental systemic lupus erythematosus Pathobiology 64: 32-39, 1996.
1191. 1996 Infections and autoimmunity - emerging clinical trials. Turk J Immunol 1: 11-13, 1996.
1192. 1996 Analysis of different glycosylation states in IgG subclasses. Clinica Chimica Acta 252: 147 - 158, 1996.
1193. 1996 Vaccine-induced Autoimmunity. J Autoimmunity 9: 699-703, 1996.
1194. 1996 Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo). Hum Antibody Hybridoma 7:151-156,1996.
1195. 1996 Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves Lupus 5: 196 - 205, 1996.
1196. 1996 Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105: 84 - 88, 1996.
1197. 1996 Pathogenic role of anti-endothelial cell antibodies in vasculitis J Immunol 156: 4946 - 4951, 1996.
1198. 1996 Common infections, idiotypic dysregulation, autoantibody spread and induction of autoimmune diseases. J Autoimmunity 9: 235 - 239, 1996.
1199. 1996 Tyrosinase autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld Elsevier, Amsterdam, The Netherlands, pp. 842 - 845, 1996.
1200. 1996 Pathogenic mechanisms. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 607- 617, 1996.
1201. 1996 Natural autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 534 - 539, 1996.
1202. 1996 Idiotypes and anti-idiotypic antibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 408 - 416, 1996.
1203. 1996 Hidden Autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 357 - 363, 1996.
1204. 1996 Autoantibody subclasses. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 103 - 108, 1996.
1205. 1996 Actin autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 10-12, 1996.
1206. 1996 Severe blastocystis hominis in an elderly man. J Infection 33: 57 - 59, 1996.
1207. 1996 Melanoma-associated hypopigmentation: Where are the antibodies? Am J Clin Oncol (CCT):19; 613-618,1996.
1208. 1996 Finding a valid model for human Wegener’s granulomatosis: comment on the article by Tomer et al. Arthritis Rheum 39: 1262 - 1263, 1996.
1209. 1996 Pancreatitis induced by clarithromycin Ann Int Med 125: 701. 1996.
1210. 1996 Low dose aspirin and secondary myocardial infaction Isr J Med Sci 32: 789 - 790, 1996
1211. 1996 Autoantibodies Elsevier, Amsterdam, The Netherlands, pp. 1 - 880, 1996.
1212. 1996 The Complete Guide for Signs Symptoms and Diseases (Hebrew) pp. 1-377, 1996. Prolog Pub., Tel-Aviv, Israel.
1213. 1995 Autoantibody profile of primary sclerosing cholangitis Pathobiology 63:76-82, 1995.
1214. 1995 Multireactive pattern of serum autoantibodies in asymptomatic individuals with immunoglobulin A(IgA) deficiency. Clin Diag Lab Immunol 2: 469 - 472, 1995.
1215. 1995 Induction of Goodpasture antibodies to noncollagenous domain (NC1) of type IV collagen in mice by idiotypic manipulation. Hum Ab Hybridomas, 6: 122 - 128, 1995
1216. 1995 Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA Immunology Lett 48: 129-132, 1995.
1217. 1995 Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies Clin Chem 41: 858-861, 1995.
1218. 1995 Natural autoantibodies in sera of patients with Gaucher’s disease J Clin Immunol 15:363-372, 1995.
1219. 1995 Apoptosis and its association with autoimmunity Clin Rheumatol 14:505-509, 1995.
1220. 1995 Absence of anti-idiotypic antibodies in IVIG preparations to autoantibodies of rare autoimmune diseases Clin Immunol Immunopathol 77:229-235, 1995.
1221. 1995 The mosaic of SLE-II: highlights of the fourth international conference on systemic lupus erythematosus - 1995 Lupus 4:438-449, 1995.
1222. 1995 Images in allergy and immunology Int Arch Allergy & Immunology 108:339, 1995.
1223. 1995 Fecundity in autoimmune diseases Early Pregnancy Biology and Medicine 1:93-105, 1995.
1224. 1995 Pseudotumour cerebri in SLE Clin Rheumatol 14:708-710, 1995.
1225. 1995 Apoptosis (programmed cell death) in autoimmunity - autoimmunological aspects. Harefuah 129:339-341, 1995
1226. 1995 The Hanta viruses - clinical syndromes. Harefuah 129:421-423, 1995.
1227. 1995 The viral autoimmunity relationship Viral Immunology 8:1-9, 1995.
1228. 1995 Characterization of biological active antineutrophil cytoplasmic antibodies induced in mice. Arthritis Rheum 38:1375-1381, 1995.
1229. 1995 Cerebral infarction in Crohn’s disease Harefuah 129:173-175, 1995
1230. 1995 Antiphospholipid syndrome: from the laboratory bench to the patients’ bedside. Lupus 4 (suppl 1):S33-S36, 1995.
1231. 1995 Atherosclerosis as an autoimmune disease Harefuah 129:257-259, 1995.
1232. 1995 Myelin-and microbe-specific antibodies in Guillain-Barre syndrome. J Clin Lab Analysis 9:308-319, 1995.
1233. 1995 The occurrence of thromboembolic events following airplane flights - “The economy class syndrome” Isr J Med Sci 31:621-623, 1995.
1234. 1995 Viral myocarditis: are we dealing with an autoimmune phenomenon? Ann Med Intern 146:322-324, 1995.
1235. 1995 Primary Sjogren’s syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile Clin Exp Rheumatol 13:497-500, 1995.
1236. 1995 D-penicillamine-induced autoantibodies in a mouse model Clin Exp Rheumatol 13:483-488, 1995.
1237. 1995 Autoimmune aspects of primary pulmonary hypertension Pathobiology 63:71-75, 1995.
1238. 1995 Pseudotumor cerebri in systemic lupus erythematosus Sem Arthritis Rheum 25:103-108, 1995.
1239. 1995 Infections, idiotypes and SLE. Lupus 4:333-335, 1995.
1240. 1995 Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen. Melanoma Res 5:337-343, 1995.
1241. 1995 Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 102:120-129, 1995.
1242. 1995 The presence of antiphospholipid antibodies in acute myocardial infarction Lupus 4:309-313, 1995.
1243. 1995 Use and mechanism of action of IVIG in autoimmune diseases Harefuah 129:123-126, 1995.
1244. 1995 Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation Scand J Immunol 42:226-234, 1995
1245. 1995 Systemic lupus erythematosus and thymoma - A double-edged swords Int Arch Allergy Immunol 108:99-102, 1995.
1246. 1995 Catalytic antibodies: Structure and possible applications. Antibody Engineering Protocols. Ed. S. Paul Humana Press Totowa, New-Jersey 1995 pp. 203-210.
1247. 1995 Autoantibody profile in the sera of women with hyperprolactinemia. J Autoimmunity 8:415-424, 1995.
1248. 1995 Aspirin modulates interleukin-3 production: Additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome J Rheumatol 22:1086-1090, 1995.
1249. 1995 Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin J Rheumatol 22:1068-1074, 1995.
1250. 1995 Early onset of autoimmunity in MRL/++ mice following immunization with b2 glycoprotein I Clin Exp Immunol 101:78-81, 1995.
1251. 1995 A need for standardization of the anti-endothelial-cell antibody test Immunol Today 16:363-364, 1995.
1252. 1995 Idiotypic network, pathogenic autoantibodies and autoimmunity Clin Exp Immunol 101 (suppl):26-28, 1995.
1253. 1995 Role of b2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells Lupus 4:179-186, 1995.
1254. 1995 Impaired binding capacity of asialyl and agalactosyl IgG to Fc gamma receptors. Clin Exp Rheumatol 13:315-319, 1995.
1255. 1995 Antiphospholipid syndrome and the idiotypic network Lupus 4:204-208, 1995.
1256. 1995 Fecundity in autoimmune diseases. Early Pregnancy Biology and Medicine. 1:93-105, 1995.
1257. 1995 Anti-DNA antibodies: is DNA a self antigen or shelf antigen or are autoimmune rheumatic diseases immunogen driven? Rheumatol Europe 24:17-20 (supp 2), 1995.
1258. 1995 The pathogenic human monoclonal anti-DNA antibody that induces experimental SLE in mice is encoded by a VH4 gene segment Int Immunol 7:689-696, 1995.
1259. 1995 Identification and characterization of antimitochondrial autoantibodies in sera of patients with monoclonal gammopathies. Immunol Lett 45:163-166, 1995.
1260. 1995 Multiple autoantibodies in patients with silicone breast implants J Autoimmunity 8:267-277, 1995.
1261. 1995 Early pregnancy loss and the antiphospholipid syndrome. In: Implantation and Early Pregnancy in Humans. Edited: Barnea ER, Check JH, Grudzinskas JG, Marno T. The Parthenon Pub Group, New-Yourk, USA, pp. 333-354, 1994.
1262. 1995 Bromocriptine immunomodulation of experimental SLE and primary anti-phospholipid syndrome via induction of nonspecific T suppressor cells Cellular Immunol 162:114-122, 1995
1263. 1995 Anti-neuronal antibodies in antiphospholipid syndrome with central nervous system involvement: the difference from systemic lupus erythematosus. Lupus 4:145-147, 1995.
1264. 1995 Mosaic of anti-endothelial antibodies: Review of the first international workshop on AECA. Clinical and pathological significance. Lupus 4:95-99, 1995.
1265. 1995 Disorders of the immune system leading to autoimmunity Multi-Systemic Autoimmune Disease: An Integrated Approach. Eds: L. Kater Hb de la Faille. Elsevier, The Netherlands pp. 1-17, 1995.
1266. 1995 Idiotypic induction of autoimmunity: do we need an autoantigen? Clin Exp Rheumatol 12 (suppl 11):S37-S40, 1994.
1267. 1995 Antiphospholipid syndrome: from the laboratory bench to the patients’ bedside. Lupus 4 (suppl) 1:S33-S36, 1995.
1268. 1995 Catalytic antibody-structure and possible applications Harefuah 128:295-299, 1995.
1269. 1995 Laboratory diagnosis of antiphospholipid syndrome Clin Lab Med 15:85-109, 1995
1270. 1995 Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation, the importance of the T cell. Arth Rheum 1: 115-122, 1995.
1271. 1995 The treatment of a widespread cancer of the colon and rectum: quality of life vs pronlongation of life ? Harefuah 128: 231-233, 1995.
1272. 1995 Goodpasture’s syndrome as an autoimmune disease - identification of the autoantigen. Harefuah 128:100-103, 1995.
1273. 1995 Anti-thymocyte globulin therapy in autoimmune diseases. Harefuah 128:104, 1995.
1274. 1995 Natural (anti-phospholipid-PDH-DNA) autoantibodies and their physiologic serum inhibitors. Isr J Med Sci 31:31-35, 1995.
1275. 1995 Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Int Arch Allergy Immunol 106:8-12, 1995.
1276. 1995 A new experimental model for Wegener’s granulomatosis Isr J Med Sci 31:13-16, 1995.
1277. 1995 Hypertension (Hebrew) pp. 1-64, 1995. Prolog Pub., Tel-Aviv, Israel
1278. 1995 Diseases of the Joints (Hebrew) pp. 1-64, 1995. Prolog Pub., Tel-Aviv, Israel.
1279. 1994 Anti-nuclear antibodies associated with schistosomiasis and anti-schistosomal antibodies associated with SLE Autoimmunity 17:127-141, 1994
1280. 1994 Anti-mitochondrial (pyruvate dehydrogenase) antibodies in leprosy. J Clin Immunol 14:14019, 1994.
1281. 1994 The significance of antibodies to DNA in the primary antiphospholipid syndrome. Clin Exp Rheumatol 12:1-3, 1994.
1282. 1994 Early detection of autoimmune diabetes mellitus Harefuah 126:211-214, 1994.
1283. 1994 Autoimmune thrombocytopenia purpura Clin Immunotherapeutics 1:348-357, 1994.
1284. 1994 Idiotypic induction of autoimmune diseases: a new aspect of infection and autoimmunity. In: The Impact of Biotechnology on Autoimmunity Edited Dalgleish AG, Albertini A, Paoleti R. Kluwer Acad Pub 1994 Boston, USA.
1285. 1994 Usefulness of colchicine in preventing recurrences of pericarditis Amer J Cardiol 73:916-917, 1994.
1286. 1994 Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome. Transplant Proc 26:3211-3213, 1994.
1287. 1994 Early dental loss in Sjogren's syndrome. Histologic correlates Oral Surg Oral Med Pathol. 78: 181-6, 1994.
1288. 1994 Anticardiolipin antibodies in infections are heterogeneous in their dependency on b2-glycoprotein I: Analysis of anticardiolipin antibodies in leprosy Lupus 3:515-521, 1994
1289. 1994 Anti-phospholipid antibodies: A critique of their heterogeneity and hegemony. Sem Thrombosis & Homostasis 20:89-100, 1994.
1290. 1994 Idiotypic induction of autoimmunity: a new aspect of the idiotypic network FASEB J 8:1296-1301, 1994.
1291. 1994 Clinico-pathological conferences: When assumptions are insufficient: Sarcoidosis. Harefuah 127:564-568, 1994.
1292. 1994 Autoimmune multiorgan involvement in elderly men, is it SLE? Clin Rheumatol 13:631-635, 1994.
1293. 1994 Effect of long acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome Lupus 3:397-400, 1994
1294. 1994 Suppression of experimental SLE with specific anti-idiotypic antibody-saporin conjugate Clin Exp Immunol 98:434-441, 1994.
1295. 1994 Suppression of experimental antiphospholipid syndrome and SLE in mice by anti-CD4 monoclonal antibodies Arthritis Rheum 8:1236-1244, 1994.
1296. 1994 Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy. Clin Exp Immunol 97:181-186, 1994
1297. 1994 Superantigens and autoimmunity Harefuah 126:715-719, 1994.
1298. 1994 Vitiligo-and melanoma - associated hypopigmentation: a similar appearance but a different mechanism. Cancer Immunol Immunopathol 38:411-416, 1994.
1299. 1994 Anti-endothelial cell antibodies: a need for standardization. Lupus 3:77-84, 1994.
1300. 1994 Acute varicella infection heralding Wilsonian crisis. J Clin gastroenterol 18:265-266, 1994.
1301. 1994 Penicillamine - A friend or an enemy Harefuah 126:328-334, 1994.
1302. 1994 Sjogren’s syndrome in Israel: Primary versus secondary disease Clin Rheumatol 13:438-441, 1994.
1303. 1994 Role of Il-3 in the antiphospholipid syndrome. Lupus 3:259-261, 1994
1304. 1994 Immunization with anticardiolipin cofactor (b2GP-I) induces experimental antiphospholipid syndrome in naive mice J Autoimmunity 7:441-455, 1994.
1305. 1994 Anti-DNA antibodies: Their idiotypes and SLE Clin Rev Allergy 12:237-253, 1994.
1306. 1994 Anti-Ro (SSA) antibodies in patients with rheumatoid arthritis - a possible marker for gold induced side effects J Rheumatol 21:1040-1042, 1994.
1307. 1994 What really happens to fecundity in autoimmune diseases? Immunol Allergy Clinics North Amer 14:701-724, 1994.
1308. 1994 Anti-idiotypes and their application under autoimmune, neoplastic and infections conditions Int Arch Allergy Immunol 105:211-224, 1994
1309. 1994 The coexistence of SLE with other autoimmune diseases: The kaleidoscope of autoimmunity. Sem Arthritis Rheum 24:105-113, 1994.
1310. 1994 Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members J Clin Immunol 14:723-326, 1994.
1311. 1994 Thromboembolic events in heparin induced thrombocytopenia Harefuah 127:448-450, 1994.
1312. 1994 IgA in Sjogren’s syndrome Clin Exp Rheumatol 12:543-551, 1994.
1313. 1994 Antigens and antibodies in malignant melanoma Tumor Biol 15:188-202, 1994.
1314. 1994 Experimental systemic lupus erythematosus: Role of the idiotypic network. In: Autoimmune Disease Models: A Guidebook. Ed: Cohen IR, Miller A Academic Press Inc. USA. Pp. 245-253, 1994.
1315. 1994 Consensus: Diagnostic criteria for Sjogren’s syndrome. Harefuah 127:342-344, 1994.
1316. 1994 Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 21:100-104, 1994.
1317. 1994 Early detection of autoimmune diabetes mellitus 444.       Harefuah 126:211-214, 1994.
1318. 1994 Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels. Breast Cancer Research and Treatment 30: 197-200, 1994.
1319. 1994 Kluwer Academic Publishers. 1994 pp. 73-80
1320. 1994 Experimental systemic lupus erythematosus: Role of the idiotypic network. Autoimmune Disease Models: A Guidebook. Editors: Cohen IR, Miller A. Academic Press Inc. USA. pp. 245-253, 1994.
1321. 1994 Idiotypic induction of autoimmune diseases The Impact of Biotechnology on Autoimmunity. Eds: Dalgleish AG, Albertini A, Paoletti R. Kluwer Academic Pub. 1994. pp. 73-80.
1322. 1994 Induction of tissue factor like activity in monocytes by anti-cardiolipin antibodies. J Immunology 153:1328-1332, 1994.
1323. 1994 Early detection of micrometastases Harefuah 126:268-271, 1994.
1324. 1994 CA-125 in the diagnosis and prognosis of epithelial ovarian cancer Harefuah 126:283-285, 1994.
1325. 1993 Pathogenic natural autoantibodies Clin Immunol News Lett 13:13-36, 1993.
1326. 1993 Relationship of interleukin-4 to isotypic distribution of anti-dsDNA antibodies in SLE. Int Arch Allergy Immunol 101:408-415, 1993
1327. 1993 Antimitochondrial antibodies and primary biliary cirrhosis Harefuah 125:148-153, 1993
1328. 1993 Inhibitions of natural anti-cardiolipin autoantibodies Clin Exp Immunol 93:265-268, 1993.
1329. 1993 Prevention of fetal loss in experimental antiphospholipid syndrome by low molecular weight heparin. Amer J Obstet Gynecol 169:423-426, 1993.
1330. 1993 The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. Am J Repro Immunol 29:155-161, 1993.
1331. 1993 The kaleidoscope of autoimmunity Autoimmunity 15:245-251, 1993.
1332. 1993 In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy Amer J Reproduc Immunol 29:206-210, 1993.
1333. 1993 Autoantibodies in systemic sclerosis Harefuah 124:370-374, 1993.
1334. 1993 The perinuclear factor - a specific diagnostic marker for rheumatoid arthritis. Harefuah 124:415-419, 1993.
1335. 1993 Predominance of IgG subclass of anti-Ro/SS-A, but not anti-La/S-B antibodies in primary Sjogren’s syndrome J Autoimmunity 6:379-387, 1993.
1336. 1993 Car accident - a personal angle Isr J Med Sci 29:484-488, 1993.
1337. 1993 Vitiligo autoantibodies are effective against melanoma Cancer 72:2365-2367, 1993.
1338. 1993 Silicone implants for breast augmentation and autoimmune diseases. Harefuah 125:360-364, 1993.
1339. 1993 The complement system and systemic sclerosis. Immunol Res 12:312-315, 1993.
1340. 1993 The effect of intravenous gammaglobulin on the induction of experimental antiphospholipid syndrome Clin Immunol Immunopathol 69:97-102, 1993.
1341. 1993 Lessons from experimental anti-phospholipid syndrome Semin Clin Immunol 6:39-46, 1993.
1342. 1993 Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE Lupus 2:233-238, 1993.
1343. 1993 Pathogenic serum IgG anti-cardiolipin antibodies and the idiotypic network Ann Rheumat Dis 52:742-748, 1993.
1344. 1993 Autoimmunity and schizophrenia: an epiphenomenon or an etiology Isr J Med Sci 29:593-597, 1993.
1345. 1993 Anti-DNA Idiotypes: Their Pathogenic Role in Autoimmunity. Concept in Immunopathol Clin and Molec Aspects of Autoimmune Dis. 8:85-114, 1993.
1346. 1993 Manipulation of Anti-DNA Idiotypes: A Possible Treatment Approach to Autoimmune Disease. Concept in Immunopathol Clin and Molec Aspects of Autoimmune Dis. 8:114-128, 1993.
1347. 1993 Ca 15-3 a tumor marker in breast cancer. Harefuah 125:484-488, 1993.
1348. 1993 Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic Autoimmunity 16:23-27, 1993.
1349. 1993 Idiotypic induction of autoimmunity: A new classification of autoimmune diseases Isr J Med Sci 2:11-14, 1994.
1350. 1993 Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data Int Arch Allergy Immunol 100:215-218, 1993.
1351. 1993 Preliminary criteria for the classification of Sjogren’s syndrome Arthritis Rheumat 36:340-347, 1993.
1352. 1993 The antiphospholipid syndrome (APLS): obstetric and reproductive impacts. Isr J Obstet Gynecol 4:19-21, 1993.
1353. 1993 The detection of antithyroglobulin activity in human serum monoclonal immunoglobulins (monoclonal gammopathies). Immunol Res 12:330-337, 1993
1354. 1993 The significance of experimental models of systemic lupus erythematosus and anti-phospholipid syndrome induced by idiotypic manipulation Isr J Med Sci 30:10-18, 1993.
1355. 1993 The complement system in primary biliary cirrhosis. J Clin Lab Immunol 38:51-61, 1993.
1356. 1993 Animal models of SLE in : G.S. Panayi (Ed): Immunoloty of the Connective tissue Diseases. Kluwer Academic Pub. Boston, USA 22:157-192, 1993.
1357. 1993 Early pregnancy loss and the anti-phospholipid syndrome Implantation and Early Pregnancy in Humans. Editors: Barnea F, Check JH, Grudzinskas JG, Maruo T. The Parthenon Pub. Group. New-Yrok, USA. 1993, pp. 333-355.
1358. 1993 Manipulation of anti-DNA idiotypes: A possible treatment approach to autoimmune disease Concept Immunopathol Clin and Molec Aspects of Autoimmune Dis. 8:114-128, 1993.
1359. 1993 Anti-DNA idiotypes: Their pathogenic role in autoimmunity Concept in Immunopathology Clinical and Molecular Aspects of Autoimmune Diseases 8:85-114, 1993.
1360. 1993 Hematology and Oncology in Rheumatology Oxford Textbook of Rheumatology. Editors: Maddison PJ, Isenberg DA, Woo P, Glass DN. Oxford University Press, Oxford U.K. 1993. pp. 154-163.
1361. 1993 Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic? Autoimmunity 16:23-27, 1993.
1362. 1993 Experimental models of SLE The Kidney in Collagen Vascular Diseases. Editors: Grishman E, Churg J, Needle MA, Venkatasehan VS. Raven Press 1993. pp. 5-22.
1363. 1993 Anti-phospholipid syndrome in young persons with acute myocardial infarction. Harefuah 124:146-149, 1993.
1364. 1993 Treatment of Raynaud’s phenomenon Harefuah 124:288-291, 1993.
1365. 1993 Polymyositis and anti-Jo-1 antibodies Harefuah 124:206-210, 1993
1366. 1993 Pathogenic significance and diagnostic value of lupus autoantibodies Int Arch Allergy Immunology 100:293-306, 1993.
1367. 1993 Antinuclear antibody profile in UCD line 200 chickens: A model for progressive systemic sclerosis. Int Arch Allergy Immunol 100:307-313, 1993.
1368. 1993 Prevention of fetal-loss in experimental anti-phospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 91:1834-1837, 1993.
1369. 1993 Manipulation of autoimmune diseases with T-suppressor cells: lesson from experimental SLE and EAE. Immunol Lett 36:109-116, 1993.
1370. 1993 The pneumonia-urinary tract infection syndrome: Loss of diagnostic ability in medicine Harefuah 124:590-592, 1993.
1371. 1993 Prolactin and bromocriptine in rheumatic and autoimmune diseases Harefuah 124:775-779, 1993.
1372. 1992 Complement profile in primary biliary cirrhosis. Immunol Res 11:98-103, 1992.
1373. 1992 Primary biliary cirrhosis: Increasing problem Isr J Med Sci 28:726-728, 1992.
1374. 1992 A multidimentional autoantibody analysis specifying SLE patients with neuropsychiatric symptomatology Isr J Med Sci 28:422-427, 1992.
1375. 1992 The mosaic of SLE: Highlights of the third international conference on SLE Lupus 1:269-283, 1992.
1376. 1992 Interleukin-3 like activity levels in pregnant wome: possible modulation by progesterone J Reprod Immunol 22:211-216, 1992.
1377. 1992 Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype J Autoimmunity 5:495-509, 1992.
1378. 1992 Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 10:391-393, 1992.
1379. 1992 Diversity and pattern of inheritance of autoantibodies in families with multiple cases of SLE. Ann Rheum Dis 51:611-818, 1992.
1380. 1992 Distribution of two common idiotypes of anti-cardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, SLE and monoclonal gammopathies Lupus 1:91-96, 1992.
1381. 1992 Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anti-cardiolipin antibody (H-3). J Clin Invest 89:1558-1663, 1992.
1382. 1992 Autoantibodies to brain pulynucleotides in patients with schizophrenia. Immunol Res 11:66-73, 1992.
1383. 1992 Leukomoid reaction in a patient with pulmonary edema Isr J Med Sci 28:307, 1992.
1384. 1992 Autoantibodies in the sera of patients with lymphoma Leukemia and Lymphoma 7:117-122, 1992.
1385. 1992 Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J Clin Immunol 12:201-209, 1992.
1386. 1992 The relationship between the lupus anticoagulant, anti-cardiolipin antibodies and anti-phospholipid antibodies Isr J Med Sci 28:38-41, 1992.
1387. 1992 Viral and autoimmune mechanisms in the etiology of dilated idiopathic cardiomyopathy Harefuah 122:245-249, 1992.
1388. 1992 Homeopathy: permit or forbid Harefuah 122:195-196, 1992.
1389. 1992 Coma with triphasic wave pattern in EEG as a complication of temporal arteritis. Neurology 42:439-440, 1992.
1390. 1992 The beta-2 glycoprotein-I (b2-GP-I) and anti-phospholipid antibodies Clin Exp Rheumatol 10:205-208, 1992.
1391. 1992 Will physicians-researchers vanish? Harefuah 122: 122-123, 1992.
1392. 1992 Primary biliary cirrhosis and autoimmune rheumatic diseases: Prediction and prevention Isr J Med Sci 28:113-116, 1992.
1393. 1992 .Manipulation of anti-DNA idiotypes. A possible treatment approach to autoimmune diseases Clin Molecular Aspects of Autoimmune Diseases (Karger) 8:114-129, 1992.
1394. 1992 Anti-DNA idiotypes. Their pathogenic role in autoimmunity Clin Molecular Aspects of Autoimmune Diseases (Karger) 8:85-113, 1992.
1395. 1992 A new player in the antiphospholipid syndrome: The b2 glycoprotein I cofactor. Autoimmunity 14:105-110, 1992.
1396. 1992 Chapter 15. Chronic infection and autoimmunity Molecular Immunobiology of Self - Reactivity. Editors: Bona CA, Kaushik AK. Marcel-Dekker. Inc. New-York 1992, pp. 284-313
1397. 1992 BCG Encyclopedia of Immunology. Editor: Roitt I. Academic Press. N.Y. USA 1992. pp. 221-222.
1398. 1992 Benign familial neutropenia Genetic Diversity Among Jews: Diseases and Markers at the DNA Level. Editors: Bone-Tamir B, Adan A. Oxford University Press N.Y. 1992. pp. 267-274.
1399. 1992 Autoimmunity and autoimmune diseases like SLE Systemic Lupus Erythematosus (2nd Ed) Editor: R.G. Lahita. Churchil Livingston. N.Y. USA, 1992. pp. 1-14.
1400. 1992 Idiotypes, antinuclear antibodies anti-idiotypes and autoimmunity Enfermedades Autoimmunes del Tejido Conectivo. Editors: Kamashta MA, Font J, Hughes GRV. Ediciones Doyma, Madrid, Spain. 1992. pp. 29-41
1401. 1992 Induction of experimental models in autoimmunity Harefuah 123:528-534, 1992.
1402. 1992 What is going to happen as for the prediction of autoimmune disorders is concerned Ann Med Intern 143:525-526, 1992.
1403. 1992 The effect of cyclosporin A on early and late stages of experimental lupus Arthritis Rheumat 35:1350-1355, 1992.
1404. 1992 Induction of experimental primary and secondary anti-phospholipid syndrome in anive mice. Amer J Reproduct Immunol 28:219-222, 1992.
1405. 1992 Cytokines, interleukin-3 and autoimmunity Isr J Med Sci 29:159-164, 1992.
1406. 1992 Pathogenic natural autoantibodies Isr J Med Sci 29:142-145, 1992.
1407. 1992 Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis. Int Arch Allergy Immunol 99:34-36, 1992.
1408. 1992 The detection of anti-Ro/SS-A and anti-La/SS-B activity of human serum monoclonal immunoglobulins (monoclonal gammopathies) Hum Antibod Hybridoma 3:75-80, 1992.
1409. 1992 The putative role of cytokines in the induction of primary anti-phospholipid syndrome Clin Exp Immunol 90:266-270, 1992.
1410. 1992 Vitiligo as an autoimmune disease Harefuah 123:339-341, 1992.
1411. 1992 The beta-2 glycoprotein I and antiphospholipid antibodies Clin Exp Rheumatol 10:205-209, 1992.
1412. 1991 Clinical aspects of antiphospholipid antibody syndrome. Harefuah 120:514-520, 1991.
1413. 1991 The erythrocyte sedimentation rate in modern medicine Harefuah 120:199-203, 1991.
1414. 1991 Neurologic complications in primary Sjogren’s syndrome. Harefuah 120:260-263, 1991.
1415. 1991 Determination of autoantibodies in patients with familial Mediterranean fever and their first degree relatives. J Rheumatol 18:606-608, 1991.
1416. 1991 Shifts in autoimmune diseases: the kaleidoscope of autoimmunity. Isr J Med Sci 27:216-217, 1991.
1417. 1991 Primary biliary cirrhosis is a multisystem disorder Ann Med Intern 142:283-287, 1991.
1418. 1991 Has schizophrenia an immunologic basis Harefuah 120:392-394, 1991.
1419. 1991 The idiotypic network in autoimmunity Giorn It Allergol Immunol Clin 1:3-15, 1991.
1420. 1991 Increased serum levels of vitamin D metabolites in black Bedouins with benign familial leukopenia. Eur J Int Medicine 2:55-61, 1991.
1421. 1991 Hypophosphatemia in sepsis Eur J Int Med 2:67-72, 1991.
1422. 1991 Parasites and autoimmunity. Harefuah 121:104-108, 1991.
1423. 1991 Bibliography - the Achiles heel of medical articles Harefuah 121:63-64, 1991.
1424. 1991 The significance of anti-neutrophil cytoplasmic antibody (ANCA). Harefuah 120-592-596, 1991.
1425. 1991 Raynaud’s phenomenon-can we predict a systemic disease? Harefuah 120:660-663, 1991.
1426. 1991 Parasitic infection and autoimmunity Autoimmunity 9:337-344, 1991.
1427. 1991 Idiotype specific T cell lines inducing experimental SLE in mice. Immunology 73:421-427, 1991.
1428. 1991 Anti-mitochondrial autoantibodies in primary biliary cirrhosis: breaking the code Giorn It Allergol Immunol Clin 1:583-592, 1991.
1429. 1991 Pancreatic carcinomas, sex hormones receptors and treatment with tamoxifen. Harefuah 120: 340-343, 1991.
1430. 1991 Stress reaction and the immune system. Harefuah 120:455-459, 1991.
1431. 1991 New aspects in the treatment of immunomediated diseases. Clin Exp Rheumatol 9:663-673, 1991.
1432. 1991 The possible role of prolactin in autoimmunity Amer J Reprod 26:118-123, 1991.
1433. 1991 Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anti-cardiolipin antibodies of patients with primary antiphospholipid syndrome. J Rheumatol 18:1537-1541, 1991.
1434. 1991 Effects of aging on the induction of SLE in mice. Mechanisms of Ageing and Development 58:233-244, 1991.
1435. 1991 Induction of SLE in naive mice with T cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculous antibody (TB/68) antibody (16/6 Id+). Clin Immunol Immunopathol 60:471-483, 1991.
1436. 1991 Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA antibody idiotype. Cell Immunol 137:474-486, 1991.
1437. 1991 Autoantibodies in male homosexuals and HIV infection Immunol Lett 30:31-36, 1991.
1438. 1991 Anti-pyruvate dehydrogenase in primary biliary cirrhosis J Clin Immunol 11:239-245, 1991.
1439. 1991 The effects of incubation temperature and coating procedure on the measurement of antibodies to cardiolipin J Immunol Methods 143:31-39, 1991.
1440. 1991 Autoantibodies in cancer patients. Are they tumor related or age related? Autoimmunity 1991
1441. 1991 Superior vena cava occlusion in a patient with antiphospholipid syndrome J Rheumatol 18:95-97, 1991.
1442. 1991 Antinuclear autoantibodies in healthy nonpregnant and pregnant women and their offspring Amer J Reproductive Immunol 26:28-31, 1991.
1443. 1991 Pathogenic anti-DNA idiotype (16/6 Id) in SLE. Rheumatology 11:91-96, 1991.
1444. 1991 The production of human monoclonal anti-MMTV antibodies by in vitro immunization with anti-idiotypic antibodies Immunol Lett 28:65-72, 1991.
1445. 1991 Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies. Proc Nat Acad Sci 88:3069-3073, 1991.
1446. 1991 Ageing, autoantigen specific Ts cells, involution of the thymus, autoimmunity and autoimmune diseases. Autoimmunity 8:251-252, 1991.
1447. 1991 Activity scores in systemic lupus erythematosus Harefuah 120:134-138, 1991.
1448. 1991 The human anti-DNA idiotype (16/6 idiotype) Monoclonal Antibodies, Cytokines and Arthritis. Editor: Kresina TF. Marcel Dekker, New-Yrok, 1991. pp. 435-464
1449. 1991 Ageing and autoimmunity: lesosns learnt from the presence of autoantibodies in patient with malignant conditions Immunotherapy with Intravenous Immunoglobulins. Editor: P. Imbach. Academic Press. 1991. pp. 307-318
1450. 1990 Antinuclear autoantibodies in sera of patients with IgA nephropathy. Nephron 55:33-36, 1990.
1451. 1990 Pathogenic idiotypes of antibodies and autoimmunity: A lesson from a new syndrome of experimental SLE. FASEB J 4:2646-2651, 1990.
1452. 1990 Sex hormone involvement in the induction of expeirmental SLE by a pathogenic anti-DNA idiotype in naive mice. J Rheumatol 17:311-317, 1990.
1453. 1990 Idiotypes and autoimmunity. Curr Opinion in Immunol 2:593-597, 1990.
1454. 1990 Autoantibodies in neoplasia: unresolved enigma. Cancer 65:2554-2558, 1990.
1455. 1990 Human anti-DNA idiotype (16/6 idiotype): pathogenic role in autoimmunity. Human Ab hybridomas 1:10-14, 1990.
1456. 1990 Characteristics of anti-neuronal antibodies in SLE patients with and without CNS involvement: The role of mycobacterial cross-reacting antigens Isr J Med Sci 26:367-373, 1990.
1457. 1990 Hyperviscosity syndrome and eye involvement. Harefuah 118:696-699, 1990.
1458. 1990 Future directions in anti-DNA antibody idiotype research. J Autoimmunity 3:389-393, 1990.
1459. 1990 Comparison of DNA antibody idiotypes in human sera: an international collaborative study of 19 idiotypes from 11 different laboratories. J Autoimmunity 3:393-415, 1990.
1460. 1990 Vitamin D and the immune system. Harefuah 119:390-392, 1990
1461. 1990 New autoimmune conditions Isr J Med Sci 26:663-666, 1990.
1462. 1990 High levels of bilirubin in hepatitis A infection of a patient with G6PD deficiency. Harefuah 119:126-130, 1990.
1463. 1990 Additional applications to captopril. Harefuah 119:280-284, 1990.
1464. 1990 Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases. Clin Rheumatol 9:346-355, 1990.
1465. 1990 Down regulation of autoantibody levels by cyclosporine and bromocriptine in patients with uveitis. Clin Immunol Immunopathol 54:87-94, 1990.
1466. 1990 Autoantibodies in cancer patients: are they tumor related or age related. Autoimmunity 5:232-233, 1990.
1467. 1990 Disease specificity of antibodies to poly (ADP-Ribose): Their relationship to anti-DNA antibodies and to disease activity in lupus Autoimmunity 5:169-177, 1990.
1468. 1990 Pyruvate dehydrogenase as an antigen to detect anti-mitochondrial antibodies. Isr J Med Sci 26:682-686, 1990.
1469. 1990 The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol 31:45-52, 1990.
1470. 1990 Recurrent abortions and the primary anti-phospholipid syndrome. Harefuah 118:158-161, 1990.
1471. 1990 Anti-DNA idiotype and anti-idiotype specific T cell responses in patients with SLE and their first degree relatives Clin Exp Immunol 82:504-508, 1990.
1472. 1990 Immunoregulation of autoimmune diseases. Isr J Med Sci 26:688-691, 1990.
1473. 1990 Renal crisis with normal blood pressure in a patient with scleroderma Harefuah 118:319-320, 1990.
1474. 1990 The effect of the immuno modulator agent AS-101 on interleukin-2 production in SLE induced in mice by a pathogenic anti-DNA antibody. Clin Exp Immunol 79:443-447, 1990.
1475. 1990 Immunological abnormalities in autoimmune liver diseases. Harefuah 118:264-268, 1990.
1476. 1990 The genetic regulation of the induction of experimental SLE Immunology 69:228-236, 1990.
1477. 1989 Why are autoimmune diseases so diversified? Pathogenic idiotypes-an additional etiological factor. Isr J Med Sci 25:667-669, 1989.
1478. 1989 Induction of experimental SLE in mice by immunization with a monoclonal anti-La autoantibody Int Immunol 2:225-230, 1989.
1479. 1989 Primary biliary cirrhosis: lymphocyte subsets and function in a time frame. Hepatology 10:526-527, 1989.
1480. 1989 Common anti-DNA idiotype and anti-phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmunity 2:803-812, 1989.
1481. 1989 Binding of monoclonal anti-DNA and anti-TB glycolipid to brain tissue. Autoimmunity 4:277-287, 1989.
1482. 1989 The significance of T-suppressor cells in the development of autoimmunity J Autoimmunity 2:739-758, 1989.
1483. 1989 Autoantibodies against a nuclear 56Kd protein: a marker for inflammatory muscle disease J Autoimmunity 2:877-888, 1989.
1484. 1989 Familial studies on the occurrence of natural autoantibodies Nat Immun Growth Regul 8:325-330, 1989.
1485. 1989 Antinuclear autoantibodies in chronic liver diseases. Hepatogastroenterol 36:341-345, 1989.
1486. 1989 The role of idiotype network in the induction of experimental SLE. J Cell Biochem 40:173-181, 1989.
1487. 1989 New experimental autoimmune models Isr J Med Sci 25:692-695, 1989.
1488. 1989 Is SLE an autoimmune disease? The role of pathogenic idiotypes. Harefuah 117:333-337, 1989.
1489. 1989 The genetic of autoimmunity: The familial tendency of SLE Isr J Med Sci 25:678-682, 1989.
1490. 1989 Experimental and induced animal models of SLE and Sjogren’s syndrome. Current Opinion in Rheumatology 1: 360-368, 1989.
1491. 1989 Gm allotype system and autoimmune diseases. Immunol Res 8:282-291, 1989.
1492. 1989 Natural Killer cells and autoimmunity Immunol Res 8:292-304, 1989.
1493. 1989 Detection of anti-mitochondrial antibodies characterization by ELISA and immunobloting. Autoimmunity 4:289-293, 1989.
1494. 1989 Full skin thickners burns caused by contact with the pavement in a heat stroke victim Burns 15:115-116, 1989.
1495. 1989 Chorea: A rare expression of neuropsychiatric manifestation of SLE. Isr J Med Sci 25:549-551, 1989.
1496. 1989 Antinuclear autoantibodies in uveitis. Clin Exp Rheumatol 7:237-241, 1989.
1497. 1989 Anti-histone antibodies in SLE and other autoimmune diseases. Clin Exp Rheumatol 7:265-271, 1989.
1498. 1989 AIDS and autoimmunity. Autoimmunity 3:201-212, 1989.
1499. 1989 The role of the human anti-DNA idiotype 16/6 in autoimmunity Clin Immunol Immunopathol 51:313-325, 1989.
1500. 1989 Another encounter with an old foe: autobreak of poliomyelitis in Israel-1988. Viral Immunol 2:57-60, 1989.
1501. 1989 Serum monoclonal antibodies derived from patients with multiple myeloma react with mycobacterial phosphoinositides and nuclear antigens. Clin Exp Immunol 76:378-383, 1989.
1502. 1989 The role of anti-idiotypic antibodies in the induction of experimental SLE in mice. Eur J Immunol 19:729-734, 1989.
1503. 1989 Autoantibody production by patients with Leishmania. Clin Exp Immunol 76:190-197, 1989.
1504. 1989 Subgroups of patients with SLE. Harefuah 117: 470-475, 1989.
1505. 1989 Anti-DNA antibody idiotypes: their pathogenic role and prognostic significance in SLE. Diagnostic and Clinical Testing 27:52-55, 1989.
1506. 1989 The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies. Clin Exp Immunol 76:349-353, 1989.
1507. 1989 Natural autoantibodies in the serum of healthy woman-a five year follow-up. Clin Exp Immunol 75:402-406, 1989.
1508. 1989 Tuberculosis in a general hospital; is the incidence increasing? Harefuah 117:351-354, 1989.
1509. 1989 Autoantibodies to histones and their subfractions in chronic liver diseases. Clin Immunol Immunopathol 51:77-82, 1989.
1510. 1989 Antinuclear and related autoantibodies in sera of healthy subjects with IgA deficiency J Autoimmunity 2:51-60, 1989.
1511. 1989 Harmful effects of smoking. Harefuah 116:283-287, 1989.
1512. 1989 The mosaic of autoimmunity. Immunology Today 10:123-126, 1989.
1513. 1989 Recurrent ischemic necrosis of the bones in young male with SLE. Harefuah 116:197-199, 1989.
1514. 1989 Hypertension Yediot Aharonoth Pub. pp. 339.
1515. 1989 The Mosaic of Autoimmunity Elsevier, Holland 1989, pp. 523.
1516. 1988 Fulminant hepatic failure due to hepatitis A Harefuah 116:95-96, 1989.
1517. 1988 Autoantibodies in malignant states. Harefuah 114:615-619, 1988.
1518. 1988 IgA deficiency and autoimmunity Harefuah 114:560-564, 1988.
1519. 1988 T cell-helper factors in autoimmunity. Isr J Med Sci 24:355-358, 1988.
1520. 1988 Autoimmune diseases: multiple factors involved in the etiology. Isr J Med Sci 24:351-352, 1988.
1521. 1988 In vitro immuinization of PBL with HuMTV, and the production of human MAbs reacting with MMTV and HuMTV In vitro Immunization in Hybridomas. Science Pub. Amsterdam, 1988
1522. 1988 Autoimmune syndrome in malignant diseases. Harefuah 114:239-242, 1988.
1523. 1988 The clinical significance of anti-histone antibodies. Harefuah 117:117-119, 1989.
1524. 1988 Vaccination with anti-idiotypic antibodies. Harefuah 114:19-22, 1988.
1525. 1988 Advances in therapy of autoimmune diseases. Semin Arthritis Rheum 17:206-220, 1988.
1526. 1988 The clinical significance of anti-Sm and anti-RNP autoantibodies. Harefuah 114:140-144, 1988.
1527. 1988 An analysis of autoimmunity through studies of DNA antibody idiotypes. Autoimmunity 1:67-75, 1988.
1528. 1988 Arthralgia associated with hypercarotenemia J Rheumatol 15:151-152, 1988
1529. 1988 A comparison of autoantibodies and common DNA antibody idiotypes in SLE patients and their spouses. Brit J Rheumatol 27:431-435, 1988.
1530. 1988 Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies Eur J Immunol 18:1713-1718, 1988
1531. 1988 Cancer in autoimmune disease Sem Arthritis Rheum 18:77-85, 1988.
1532. 1988 Radioimmunodetection of tumors with monoclonal antiplacental ferritin antibody: Preliminary results. Oncology 46:35-39, 1988.
1533. 1988 The significance of HLA studies in human-human hybridomas Tissue Antigens 32:209-213, 1988.
1534. 1988 1988 Nobel Prize for Medicine and Physiology. Harefuah 115:404, 1988.
1535. 1988 . Achievements and progress in medicine - 1987. Harefuah 115:394-397, 1988.
1536. 1988 Antinuclear antibodies in pregnancy. Harefuah 115:360-363, 1988.
1537. 1988 Anti-Ro and anti-La autoantibodies in autoimmune condition. Harefuah 114:88-92, 1988.
1538. 1988 Autoimmune conditions in the eye. Harefuah 114:352-355, 1988.
1539. 1988 Elisa measurments of antibody titer to purified protein derivative and mycobacteria-derived phosphoglycolipids: tool for diagnosing active pulmonary tuberculosis. Isr J Med Sci 23:1121-1124, 1988.
1540. 1988 Induction of SLE-like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying 16/6 Id J Autoimmunity 1:683-691, 1988.
1541. 1988 Induction of experimental SLE in mice Isr J Med Sci 24:741-744, 1988.
1542. 1988 Identification of anti-Sm and anti-RNP autoantibodies by immunoblotting and immunoassay. Isr J Med Sci 24:751-754, 1988.
1543. 1988 The use of ELISA for the measurment of autoantibodies to nuclear antigens: comparison with other methodologies. Isr J Med Sci 24:747-750, 1988.
1544. 1988 Complement deficiencies and autoimmune diseases. Harefuah 115:129-135, 1988.
1545. 1988 The significance of natural autoantibodies Immunol Invest 17:389-424, 1988.
1546. 1988 Bengin familial leukopenia and neutropenia in different ethnic groups. Eur J Hematol 41:273-277, 1988.
1547. 1988 More about benign familial neutropenia. Harefuah 114:192-194, 1988.
1548. 1988 Ageing and autoantibodies Autoimmunity 1:141-149, 1988.
1549. 1988 Serological markers in diagnosis of CNS involvement in SLE. Harefuah 114:387-390, 1988.
1550. 1988 Mycobacteria and autoimmunity Immunology Today 9:178-181, 1988.
1551. 1988 In vitro T cell function specific to anti-DNA idiotype and serological markers in patients with SLE J Clin Immunol 8:178-198, 1988.
1552. 1988 Immunoglobulin secretion of mononuclear cells induced by various mitogens. Int J Immunopharmacol 10:352-367, 1988.
1553. 1988 A human monoclonal anti-DNA antibody derived from a patient with polymyositis having the common lupus 16/6 idiotype. Immunol Lett 19:77-84, 1988.
1554. 1988 Autoantibodies and common idiotypes in men and women with sperm antibodies. Amer J Obstet Gynecol 158:596-603, 1988.
1555. 1988 Expression of an interspecies idiotype in sera of SLE patients and their first degree relatives. Clin Exp Immunol 71:445-450, 1988.
1556. 1988 Autoimmune diseases other than lupus share common anti-DNA idiotypes. Immunol Lett 17:285-290, 1988.
1557. 1988 Induction of a SLE-like disease in mice by a common anti-DNA idiotype. Proc Nat Acad Sci (USA) 85:2260-2264, 1988.
1558. 1988 Antinuclear autoantibodies in sera of healthy pregnant women and their offspirng. Amer J Rep Immunol 18:116-119, 1988.
1559. 1988 Naturally occuring tumor-reactive autoantibodies: a monoclonal antibody from normal mice reacts with tumor cells and with DNA Immunol Lett 18:43-50, 1988.
1560. 1988 Human monoclonal antibodies directed against viral antigens. Breast Cancer: Scientific and Clinical Progress. Editors: Rice MA, Hagen JL, Lopez DN. Kluwes Academic Pub. N.Y. USA. 1988, pp. 174-184
1561. 1987 Anti-platelet and anti-DNA IgM in Waldenstrom's macroglobulinemia and ITP. Amer J Hematol 24:351-355, 1987.
1562. 1987 Human monoclonal antibodies directed against MuMTV antigens from human breast cancer cells. In: New Experimental Modalities in the Control of Neoplasia. New Experimental Modalities in the Control of Neoplasia. Editor: P. Chandara. Plenum Press, 1987
1563. 1987 Treatment of autoimmune diseases: New modalities Prospective on Autoimmunity. Editor: IR Cohen. CRC Press, USA, 1987
1564. 1987 Analyses of anti-DNA idiotypes. Perspective on Autoimmunity. Editor: IR Cohen. Academic Press, 1987
1565. 1987 Infection and autoimmunity The Antigens, Editor: M. Sela. Academic Press, 1987. pp. 307-325.
1566. 1987 The importance of the study of monoclonal antibodies in SLE. SLE. Editor: Smolen JS & Zielinski CC. Springer-Verlag, Berlin, 1987
1567. 1987 Anti-RNP antibodies in chronic liver diseases Clin Exp Rheumatol 5:359-361, 1987.
1568. 1987 Human monoclonal antibodies derived from pleural effusion lymphocytes of a patient with breast carcinoma react with human breast cancer associated antigens (HMTV) and MMTV polypeptides. Exp Cell Biol 55:237-249, 1987.
1569. 1987 Vaccines against AIDS - difficulties and solutions. Harefuah 113:354-358, 1987.
1570. 1987 The origin and significance of anti-DNA antibodies. Immunol Today 8:279-281, 1987.
1571. 1987 ELISA measurement of antibodies titer to PPD and mycobacteria derived phosphoglycolipids as an aiding tool to the diagnosis of active pulmonary tuberculosis Isr J Med Sci 23:1121-1124, 1987.
1572. 1987 Common anti-DNA idiotypes (32/15 and 16/6) in sera of patietns with drug-induced lupus. J Clin Immunol 7:410-417, 1987.
1573. 1987 Treatment of autoimmune diseases. Harefuah 112:608-612, 1987.
1574. 1987 Placental type isoferritins in chronic liver diseases J Hepato-Gastroenterol 34:65-67, 1987.
1575. 1987 Quantitation of antinuclear autoantibodies by ELISA: Specificity correlation with other methods and clinical significance. Quart Med Rev 1:6-10, 1987.
1576. 1987 Myocardial infarction in Yemenite Jews and benign familial leukopenia neutropenia. Harefuah 112:484-450, 1987.
1577. 1987 A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with SLE. Clin Exp Immunol 68:528-534, 1987.
1578. 1987 Ibuprofen induced asthmatic attacks. Harefuah 112:345-346, 1987.
1579. 1987 A study of anti-polynucleotide antibodies, anti-Klebsiella (K30) antibodies and anti-DNA antibody idiotypes in ankylosing spondylitis. Brit J Rheumatol 26:168-171, 1987.
1580. 1987 HLA system and autoimmunity Harefuah 112:398-402, 1987.
1581. 1987 Immunoglobulin levels in Klebsiella and TB infection. Immunol Lett 15:117-220, 1987.
1582. 1987 Low serum anti-TB glycolipid antibodies titer in the sera of patients with SLE as an indicator of CNS involvement. J Rheumatol 14:507, 1987.
1583. 1987 Common anti-DNA idiotypes in chronic liver diseases. Clin Immunol Immunopathol 43:265-270, 1987.
1584. 1987 The lupus band test: its diagnostic value. Harefuah 112:554-556, 1987.
1585. 1987 Infecting agents and autoimmune diseases. Harefuah 112:285-288, 1987.
1586. 1987 Profile of autoantibodies in the sera of patients with tuberculosis, Klebsiella and other gram-negative infections. Clin Exp Immunol 67: 516-523, 1987.
1587. 1987 Anti-histones antibodies in the serum of lupus patients and their relatives. Arthritis Rheum 30:169-175, 1987.
1588. 1987 Does duodenal ulcer lead to an early diagnosis of gastric cancer? J Clinical Gastroenterol 9:37-39, 1987.
1589. 1987 The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6 Id) and anti-polynucleotide activity. Clin Exp Immunol 67:507-515, 1987.
1590. 1987 DNA antibody idiotypes: a review of their genetic, clinical and immunopathologic features. Semin Arthritis Rheum 16:245-252, 1987.
1591. 1987 Detection of anti-histone activity in sera of patients with monoclonal gammopathies. Clin Immunol Immunopathol 42:250-258, 1987.
1592. 1987 Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis. J Immunol 138:2463-2468, 1987.
1593. 1987 Sex hormones and autoimmune diseases. Harefuah 112:192-195, 1987.
1594. 1987 A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 30:50-55, 1987.
1595. 1987 Publishing articles in Harefuah. Harefuah 112: 36-37, 1987.
1596. 1986 Scabies associated angioimmunoblastic lymphadenopathy. Acta Hematol 76:166-168, 1986.
1597. 1986 Leukocytosis in non-hematological malignancies - A possible tumor-associated marker J Cancer Res Clinical Oncol 111:54-58, 1986.
1598. 1986 The analysis of common idiotypes of human monoclonal anti-DNA autoantibodies in SLE and related conditions. Clin Immunol Newsletter 7:70-72, 1986.
1599. 1986 Q fever endocarditis. Harefuah 110:47, 1986.
1600. 1986 Preferential secretion of common anti-DNA idiotype (16/6 Id) and anti-polynucleotide antibodies by mononuclear cells, following stimulation with Klebsiella pneumonia. Immunol Lett 12:313-319, 1986.
1601. 1986 Comments on the article by Crains et al Arthritis Rheum 29:1438-1439, 1986.
1602. 1986 Scientific Editor - Encyclopedia - The Human Body The Human Body. (Illustrated) 20 volumes (Hbrew Edition). Yediot Aharonoth, 1986.
1603. 1986 Anti-DNA Antibodies in: Systemic Lupus Erythematosus. Editor: M. Lahita. Academic Press, N.Y. 1986
1604. 1986 A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members. Ann Rheum Disease 45:502-507, 1986.
1605. 1986 High levels of a common anti-DNA idiotype (16/6 Id), a genetic marker for SLE. Acta Hematol 76:107-109, 1986.
1606. 1986 The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies J Clin Immunol 6:194-204, 1986.
1607. 1986 Promotion in medical school: a suggestion. Harefuah 110:579-580, 1986.
1608. 1986 Eaton-Lambert's syndrome - a new autoimmune condition Harefuah 110:536-538, 1986.
1609. 1986 Hybridomas from unimmunized individuals. Immunol Today 7:350-351, 1986.
1610. 1986 Lupus anticoagulant and anticardiolipin antibodies in SLE. Acta Hematol 76:86-89, 1986.
1611. 1986 Human monoclonal antibodies derived from lymph nodes of a female patient with breast carcinoma react with MuMTV polypeptides. Cancer 59:43-50, 1986.
1612. 1986 How to determine the academic rank of physicians Harefuah, 11: 579, 1986
1613. 1986 Effects of salt loading during exercise in a hot dry climate. Biomedicine 40:296-300, 1986.
1614. 1986 The crisis in internal medicine. Can research solve the problem? Harefuah 111:100-101, 1986.
1615. 1986 Autoimmune disease in pregnancy Harefuah 111:85-92, 1986.
1616. 1986 Infection and autoimmunity: Monoclonal anti-tuberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies bind to mycobacterial derived glycolipids. Clin Exp Immunol 66:255-261, 1986.
1617. 1985 Ibuprofen causes meningitis in (NZB/W)F1 mice. Arthritis Rheum 28:104-107, 1985.
1618. 1985 The production of monoclonal atnibodies by human-human hybridomas: Their application to studies of autoimmune diseases Human Hybridomas and Monoclonal Antibodies. Editors: E.G. Engelman et al. Plenum Press N.Y. 1985. pp. 247-260
1619. 1985 Zinc, the immune system, and autoimmunity. Harefuah 109:406-408, 1985.
1620. 1985 The MuMTV and its relation to human and breast carcinoma. Harefuah 109:338-342, 1985.
1621. 1985 Detection of cross-reactive anti-DNA antibody idiotype in the serum of lupus patients and their relatives. Arthritis Rheum 28:999-1007, 1985.
1622. 1985 Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies Eur J Immunol 15:1024-1028, 1985.
1623. 1985 Human human monoclonal autoantibodies bind to Raji cells Immunol Lett 11:121-126, 1985.
1624. 1985 Autoimmunity and pregnancy. Amer J Rep Immunol Microbiol 9:25-32. 1985.
1625. 1985 A combination of IgG and IgM autoantibodies in chronic cold agglutinin disease. Immunologic studies and response to splenectomy Vox Sang 48:105-109, 1985.
1626. 1985 Oncogenes in medicine. Harefuah 109:31-35, 1985.
1627. 1985 The T-cell receptor. Harefuah 108:46-48, 1985.
1628. 1984 Sensitization to ampicilin in infectious mononucleosis. Harefuah 97:174-176, 1984.
1629. 1984 Monoclonal gammopathy in patients with chronic and acute myeloid leukemia. Cancer 54:280-283, 1984.
1630. 1984 Measurement of anti-DNA antibody idiotypes to monitor the course of SLE. Lancet 2:418-422, 1984.
1631. 1984 The use of hybridomas to analyze autoimmunity. Brit Med Bull 40:262-266, 1984.
1632. 1984 Casual blood pressure: Its relationship to several cardiovascular risk factors in middle-aged men. Pub Health (London), 98:209-215, 1984.
1633. 1984 Genetic and immunologic factors in autoimmune diseases. New Eng J Med 311:1019-1029, 1984.
1634. 1984 Anti-DNA antibody idiotypes in SLE Lancet 2:821, 1984.
1635. 1984 Binding of cytoskeletal proteins by monoclonal anti-DNA lupus antibodies. Clin Immunol Immunopathol 31:261-271, 1984.
1636. 1984 Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B cell proliferation? Cancer 54:312-314, 1984.
1637. 1984 Polymyalgia rheumatica and temporal arteritis in a married couple. Am J Med Sci 287:48-49, 1984.
1638. 1984 Antibody activity of monoclonal immunoglobulin components in plasma cell dyscrasia. Harefuah 97:420-422, 1984.
1639. 1984 Influence of fusion cell ratio and cell plating density on the production of human-human hybridomas secreting anti-DNA autoantibodies from patients with SLE. Hybridoma 3::215-222, 1984.
1640. 1984 Antibodies to cytoskeleton proteins in autoimmune diseases. Harefuah 107:291-193, 1984.
1641. 1984 The thymic hormones: their function and therapeutic potential. Harefuah 97:244-247, 1984.
1642. 1984 The outcome of bacterial infection in subjects with benign familial leukopenia. Biomedicine 38:23-26, 1984.
1643. 1983 Hamatologic manifestations of SLE The Clinical Management of Systemic Lupus Erythematosus. Editor: Peter H. Schur, Grune & Stratton, N.Y. 1983. pp. 123-137.
1644. 1983 Internal Medicine Zerikover Inc. Tel-Aviv, (Hebrew) 1983. pp. 287.
1645. 1983 Drug induced lupus. Harefuah 105:75-77, 1983.
1646. 1983 Multiple serological reactions and their relationship to clinical activity in systemic lupus erythematosus. A study of 56 patients. Arthritis Rheum 27:132-138, 1984.
1647. 1983 Transient monoclonal gammopathy in hydralazine induced lupus erythematosus Brit Med J 1:224, 1983
1648. 1983 Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. New Eng J med 308:414-420, 1983.
1649. 1983 Fatal peripheral neurolymphomatosis following remission of histiocytic lymphoma. Neurology 33:243-245, 1983.
1650. 1983 The rheumatologic complication of hematologic disorders. Semin Arthritis Rheum 12:348-358, 1983.
1651. 1983 Idiotypic cross reactions of monoclonal human lupus autoantibodies. J Exp Med 158:718-730, 1983.
1652. 1983 SLE and lymphoma: A family study. Scand J Rheumatol 12:310-314, 1983.
1653. 1983 Leukocytosis in pregnancy and labour. Harefuah 104:69-70, 1983.
1654. 1982 Homogeneous populations of macrophages from histiocytic lymphoma patients as a source for macrophage subpopulations which differ in immunoregulatory properties. Cancer 50:69-77, 1982.
1655. 1982 Morphological platelet anomalies in thrombotic thrombocytopenic purpura Acta Haematol 67:119-123, 1982.
1656. 1982 Primary pulmonary hypertension: A fact of a diffuse angiopathic process. Respiration 43:76-79, 1982.
1657. 1982 Hybridomas: A potent new biotechnology: The production and the use of monoclonal antibodies. Harefuah 102:479-481, 1982.
1658. 1982 . Gaucher's disease: A disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106:388-391, 1982.
1659. 1982 Carbamazepine (Tegretol)-induced thrombocytopenia. Acta Haematol 68:74, 1982.
1660. 1982 Errors in blood pressure recording. Harefuah 102:76-78, 1982.
1661. 1982 Production of monoclonal autoantibodies by human-human hybridomas. J Clin Invest 70:205-208, 1982.
1662. 1982 Central nervous system involvement in patients with lymphoma. Harefuah 102:124-125, 1982.
1663. 1982 Absence of predictive parameters for CNS involvement in adult non-lymphocytic leukemia at time of diagnosis. Scand J Haematol 28:335-340, 1982.
1664. 1982 The production of human-hybridomas and their contribution to the research of autoimmune diseases. Harefuah 107:134-135, 1982.
1665. 1982 Arthritis Yediot Aharonoth Pub. Tel-Aviv, 1982. pp. 271.
1666. 1982 Neutropenia induced by hypercarotenemia. Lancet 1:1259, 1982
1667. 1982 Leukopenia: Idiopathic or drug induced - how to differentiate New Eng J Med 307:251, 1982
1668. 1982 Aggressive plasma cell myeloma Acta Haematol 68:160-161, 1982
1669. 1982 Hypophosphatemia as a diagnostic aid in sepsis. NY St J Med 82:163-165, 1982.
1670. 1982 The mechanism of benign hereditary neutropenia. Arch Int Med 142:797-799, 1982.
1671. 1981 The Israeli Fitness Strategy Morrow Pub. New-York (English) 1981. pp. 260.
1672. 1981 Pulmonary hypertension in a patient with Marfan's syndrome. Respiration 41:214-215, 1981.
1673. 1981 Surgery in patients with hepatitis. Medicine Int 19: 211-215, 1981.
1674. 1981 Idiopathic mixed cryoglobulinemia in two sisters. Acta Haematol. 65:219-220, 1981
1675. 1981 Warfarim treatment during pregnancy in patients with prosthetic valves. Acta Haematol 66:65-66, 1981
1676. 1981 Surgery in patients with circulating anticoagulant. Int Surg 66:157-159, 1981.
1677. 1981 Passive smoking. Harefuah 100:345-347, 1981.
1678. 1981 Autoimmune disease in mice. Harefuah 100:529-530, 1981.
1679. 1981 The relationship between body temperature and intraocular pressure. Ann Ophthalmol 28:159-161, 1981.
1680. 1981 Conservative treatment of Budd-Chiari syndrome in polycythemia vera. Hematologia 66:220-222, 1981.
1681. 1981 Plasma cell dyscrasia. part I: Fluorescein angiography findings in plasma cell dyscrasia. Metab Pediat Ophthal 5:171-175, 1981.
1682. 1981 Chronic benign neutropenia. Harefuah 100:198-199, 1981.
1683. 1981 Cholinergic urticaria: A seasonal disease Arch Int Med 141:1029-1030, 1981.
1684. 1981 Spontaneous remission of erythroleukemia following interestitial pneumonia NY St J Med 41:772-773, 1981.
1685. 1981 Effect of physical effort on the white blood cells in benign familial leukopenia. Acta Haematol 65:108-113, 1981.
1686. 1981 The leukomogenic action of cytotoxic drugs. Harefuah 100:44-45, 1981.
1687. 1981 The effect of hypophosphatemia on peripheral blood cells. Harefuah 101:126-127, 1981.
1688. 1981 Age, weight, and heart rate at rest as predictors of aerobic fitness. J Sport Med 21:377-382, 1981.
1689. 1981 Leiomyosarcoma of the pulmonary artery. Respiration 41:208-213, 1981.
1690. 1981 Prednisone-induced leukocytosis: The influence of dosage, method and duration of administration on the degree of leukocytosis. Amer J Med 71:773-778, 1981.
1691. 1980 Sensitization to ibuprofen in SLE. JAMA 244:547-548, 1980.
1692. 1980 Cancer: Vital Information for all Yediot Aharonoth Pub. Tel-Aviv, 1980. pp. 240.
1693. 1980 Life threatening hypophosphatemia in a patient with acute myeloid leukemia. Acta Haematol 64:117-119, 1980.
1694. 1980 Inappropriate ADH secretion secondary to fibrothorax. Respiration 29:283-285, 1980.
1695. 1980 Cryoglobulinemia in chronic liver diseases. Amer J Gastroenterol 74:439-440, 1980.
1696. 1980 Splenectomy in myeloproliferative diseases. Harefuah 98:274-275, 1980.
1697. 1980 Hypertension and obesity. Harefuah 93:427-428, 1980.
1698. 1980 Mixed connective tissue disease. Harefuah 98:475-477, 1980.
1699. 1980 Hypercalcemia in Hodgkin's disease. Hematologia 65:459-463, 1980.
1700. 1980 Acclimatization to heat. Harefuah 98:3-33, 1980.
1701. 1980 Salazopyrine induced tachycardia. Biomedicine 33:1-2, 1980.
1702. 1980 Salazopyrin induced eosinophilic pneumonia. Respiration 39:119-120, 1980.
1703. 1980 Transient mixed cryoglobulinemia associated with typhoid hepatitis. New Instanbul Contro Cli Res 13:55-57, 1980.
1704. 1980 Age related distribution of serum immunoglobulin concentrations in 1003 healthy children and adults. Biomedicine 33:8-12, 1980.
1705. 1980 Thromboembolic phenomeon in patients with "lupus type circulating anticoagulant". Rheumatologica 51:417-424, 1980.
1706. 1980 Gaucher's disease and dysproteinemia. Acta Haematol 64:241-243, 1980.
1707. 1980 Circulating anticoagulant and serological tests for syphilis. Acta Dermatovener 60:365-367, 1980.
1708. 1980 Aortic stenosis associated with gastrointestinal bleeding: A survey of 612 patients. Amer Heart J 137:179-182, 1980.
1709. 1980 Walking - a quick method for improving physical fitness. JAMA 243:2062-2063, 1980.
1710. 1980 Epidermal ridge disarrangement and Hamman-Rich syndrome Dermatology 160:21-24, 1980.
1711. 1980 Leukopenia and incidence of myocardial infarctions New Eng J Med 304:1606, 1981
1712. 1980 Central vein thrombosis in a patient with primary pulmonary hypertension Amer Heart J 100:134, 1980
1713. 1980 Thrombocytopenia from acetaminophen New Eng J Med 383:47, 1980
1714. 1980 Oculomotor nerve paresis-presenting sign of acute myeloid leukemia. Hamatologia 65:769-771, 1980.
1715. 1979 Biological, Biochemical and Health Aspects in Physical Education Ministry of Education, The Hebrew University, Jerusalem, 1979. pp. 128
1716. 1979 Textbook of Physical Fitness Wingate Institute,. Ministry of Education, Natanya, 1979. pp. 17
1717. 1979 Living Well Yediot Aharonoth Pub. Tel-Aviv, 1979. pp. 167
1718. 1979 Heat intolerance in former heatstroke patients. Ann Int Med 90:913-916, 1979.
1719. 1979 Testicular lymphoma: Presentation of 6 patients. Harefuah 96:573-574, 1979.
1720. 1979 Anthropological and physiological characteristics of the different Jeweish ethnic groups in Israel. S Afric J Phys Sports Phys Educ Rec 2:5-8, 1979.
1721. 1979 Clinical Immunology: Diseases with Defects in the Humoral System Akademon, The Hebrew University, Jerusalem, 1979. pp 400
1722. 1979 The use of the reference list. Harefuah 97:141-142, 1979.
1723. 1979 Allergic purpura following intravenous administration of interferon. Acta Hematol 62:178, 1979.
1724. 1979 The effect of exposure to heat on intraocular pressure. Grafe Archiv Ophthalmologie 210:183-185, 1979.
1725. 1979 Depressed PHA transformation and acute leukemia in macrolobulinemia. Cancer 44:1741-1744, 1979.
1726. 1979 Pulmonary alveolar proteinosis associated with Fanconi's anemia. Respiration 38:177-180, 1979.
1727. 1979 The interferon: Mode of action and therapeutic action. Harefuah 96:299-300, 1979.
1728. 1979 Hypercalcemia-induced psychopathology in malignant disease. Brit J Psychiat 135:363-366, 1979.
1729. 1979 HLA antigens in genetic neutropenia of Yemenite Jews. Vox Sang 36:105-108, 1979.
1730. 1979 Plasma cell dyscrasia: Analysis of 423 patients. JAMA 241:2275-2278, 1979.
1731. 1979 Clinico-pathological conferences: CPC, progressive dyspnea, dry cough, syncope, hemoptysis, loss of weight, death. Harefuah 97:313-317, 1979.
1732. 1979 Bone pains in chronic myelomonocytic leukemia treated by cytosine arabinoside. S Afr Med J 55:318, 1979.
1733. 1979 The anaerobic capacity. Harefuah 96:557-558, 1979.
1734. 1979 Bone pains in chronic myelomonocytic leukemia treated by cytosine arabinoside. Ann Rheum Dis 37:298-299, 1978
1735. 1979 Hyperviscosity syndrome in plasma cell dyscrasia Harefuah 96:161-163, 1979.
1736. 1978 Infiltration lymphocytaire lecemique et ulcere chronique simulant und cancer de l'estomac Gastroenterol Clin Biol 2:71-76, 1978.
1737. 1978 Simultaneous appearance of testicular and nasopharyngeal lymphoma. S Afr Med J 54:469, 1978
1738. 1978 Age and sex differences in short exposure to extreme heat. J Appl Physiol 44:1-4, 1978
1739. 1978 Tumors of the urinary bladder and the immunological system. Harefuah 94:193-195, 1978.
1740. 1978 Crohn's disease and the immunological system Harefua 94:240-241, 1978.
1741. 1978 Orthostatic hypotension in amputees and subjects with spinal cord injuries Arch Phys Med Rehab 59:138-141, 1978.
1742. 1978 Pleural effusion as a presenting sign in multiple myeloma. Respiration 36:160-164, 1978.
1743. 1978 Squamos cell carcinoma associated with sarcoidosis in the lung Oncology 35:112-113, 1978.
1744. 1978 Optimal backpack load for short distances. Arch Phys Med rehab 59:281-285, 1978.
1745. 1978 CPC - Sezary syndrome and bacterial endocarditis. Harefuah 95:95-100, 1978.
1746. 1978 Systemic lupus erythematosus associated with mixed cryoglobulinemia and circulating anticoagulant. South Afr J Med 54:1056-1058, 1978.
1747. 1978 Familial leukopenia among Yemenite Jews. Isr J Med Sci 14:1271-1274, 1978.
1748. 1978 The work capacity in high school students in the "kibbutz" in Israel. J Sport Med 18:385-390, 1978.
1749. 1978 Survey of 26 patients. Rheumatologica 36:137-143, 1978.
1750. 1978 Macroglobulinemia - a survey of 33 patients. Harefuah 94:253-263, 1978.
1751. 1978 Chronic eosinophilic pneumonia. Harefuah 96:66-69, 1978.
1752. 1978 Eosinophilic gastroenteritis. Harefuah 95:108, 1978.
1753. 1978 Description and forecast of summer climate in physiologically significant terms Int J Biometerol 22:75-81, 1978.
1754. 1978 Diagnostic parameters in SBE. Harefuah 95:271-272, 1978.
1755. 1978 The effect of standardized submaximal work load on intraocular pressure. Brit J Ophtahlmol 62:679-681, 1978.
1756. 1978 Cold induced profuse sweating on back and chest. Lancet 2:1073-1075, 1978
1757. 1978 Prevalence of pterygium in Israel. Harefuah 95:161-162, 1978.
1758. 1978 Recurrent gastrointestinal bleeding associated with aortic stenosis Harefuah 95:395-396, 1978.
1759. 1978 Transient mixed cryoglobulinemia associated with chronic myelocitic leukemia. Biomedicine 29:259, 1978.
1760. 1978 An assessment of exercise and heat orthostatism Physical Fitness Assessment: Principles, Practices and Application. Editors: Shepard RJ and Lavallee A. Charles C Thomas, Spirngfield, I11. 1978. pp. 102-110.
1761. 1977 Coffee drinking and myocardial infarction Harefuah 93:44-45, 1977
1762. 1977 TheF and its influence on the human body. Harefuah 92:512-514, 1977
1763. 1977 Cimetidine - an unexpected ally. Isr J Med Sci 33: 363-365, 1997.
1764. 1977 Tumor metastases – new experimental anti-metastatic therapies.    Harefuah 133: 636-642, 1997
1765. 1977 Continuous infusion versus intermittent adminitration of furosemide in pediatric and adult pateints with severe congestive heart failure. Paddiatr. Grenzgeb. 36: 181-184, 1997.
1766. 1977 Schizophrenia – an autoimmune disease? Harefuah 133: 629-632, 1997.
1767. 1977 Immunological aspects of endocarditis. Harefuah 132: 288-290, 1997.
1768. 1977 Primary subclavian vein thrombosis after physical exertion.    Harefuah 133: 610-613, 1997.
1769. 1977 Hepatitis C virus, autoimmunity and rheumatic disease    Lupus 6: 685-690, 1997.
1770. 1977 Primary biliary cirrhosis – association or overlap with other autoimmune diseases.    Isr J Med Sci 33: 823-825, 1997.
1771. 1977 Antiperinuclear factor – clinical , serological and genetic correlates in Israeli patients with rheumatoid arthritis.   Rheumatol Int 17: 141-143.
1772. 1977 Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 6:723-729, 1997.
1773. 1977 Tumor metastases: mechanisms and dissemination pathways.    Harefuah 133:564-570,1997.
1774. 1977 Physical Activity and Health. (Hebrew). Akademon, The Hebrew University, Jerusalem, 1977. pp. 380
1775. 1977 Aerobic work capacity in 1200, 18-60 year old men and 400 athletes. Isr J Med Sci 13:240-244, 1977.
1776. 1977 Anti-endothelial cell antibodies-clinical significance   Harefuah 133: 458-462, 1997.
1777. 1977 Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents.    Clin Rheumatol 16:606-608,1997.
1778. 1977 Hereditary ovalocytosis Harefuah 92:358-359, 1977.
1779. 1977 Aspirin for prevention of myocardial infarction, a double edge- sword   Ann Med Interne 6: 148: 430-433, 1997.
1780. 1977 Physical activity, physical fitness and health Harefuah 91:125-128, 1977.
1781. 1977 Why did the entity of effort syndrome disappear ? Harefuah 132: 266, 1997.
1782. 1977 T cell help and antiphospholipid antibody immunogenesis (letter). Arthritis Rheumat 40: 196-197, 1997.
1783. 1977 Tests for syphilis in patients with SLE New Eng J Med 296:451, 1977
1784. 1977 Heparin-induced thrombocytopenia as an autoimmune disease - idiotypic evidence for the role of anti-heparin/PF4 autoantibodies Israel Journal of Medical Sciences 33: 4; 243-245, April 1997.
1785. 1977 The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 6: 559-560, 1997
1786. 1977 Smoking and immunity. An additional player in the mosaic of autoimmunity. Scand J Immunol 45: 1-6, 1997.
1787. 1977 Hemorrhagic diathesis    Harefuah, 133: 98-99,1997
1788. 1977 Colchicine as therapy for recurrent pericarditis Harefuah, 133: 100-102, 1997.
1789. 1977 Is familial mediterranean fever an autoimmune disease or an immune mediated condition? Familial Mediterranean Fever. Sohar E. Gafni J, Pras M. (Eds.) Freund Publlishing House Ltd. London, 267-278,1997.
1790. 1977 Intracellular fluorescence polarization measurements by the cellscan system:detection of cellular activity in autoimmune disorders.    Isr J Med Sci 33: 4; 273-279, April 1997.
1791. 1977 Thymectomy and autoimmune diseases - The dual connection.      Sem Clin Immunol 1: 5-11, 1997.
1792. 1977 Autoantibodies - diagnostic, pathogenic and prognostic relevance.    Clin Exp Rheumatol 15: 457-465, 1997.
1793. 1977 Exercise and heat orthostatism and the effect on heat acclimatization and physical fitness Avi Space Environ Med 48:836, 1977.
1794. 1977 Cardiovascular and pathophysiological effects of the sauna Internal Medicine: Topics. Editors: Louhija A and Valtonen V. Karger S. New-York, 1977. pp. 322-330.
1795. 1977 The climate, condition and way of life in the Jordan Valley Judea and Samaria Editors: Shmueli A, Grossman D and Zeevi R. Onaan, Jerusalem.
1796. 1977 Adjustment to the climatic conditions in the cold dessert pp. 128-133. II. Cold injuries in the dessert. The Dessert-Past, Present and Future. Editor: Sohar E, Reshafim, Tel-Aviv (Hebrew), 1977
1797. 1977 Serum glucose and lactic concentrations during prolonged strenuous exercise in man Amer J Phy Med 56:249-256, 1977.
1798. 1977 Q fever endocarditis and bicuspid aortic valve.    Harefuah 133: 281-283, 1997.
1799. 1977 Blunt trauma causing emboli from friable atherosclerosis plaques.    Harefuah 133: 355-357, 1977.
1800. 1977 Autoantibody dominance pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies    Pathobiology 65: 204-209, 1997.
1801. 1977 Magnesium fortification of water a possible step forward in preventive medicine? Ann Med Interne 6:440-444, 1997.
1802. 1977 A family with hereditary ovalocytosis Harefuah 92:351-352, 1977
1803. 1977 Orthostatism in healthy people and spinal cord injury Harefuah 92:219-222, 1977
1804. 1977 Aerobic work capacity in male and female high school students Isr J Med Sci 13:245-252, 1977
1805. 1977 Diagnostic significance of CEA concentration - A study of 61 patients with malignancies. Amer J Protocol 28:37-43, 1977
1806. 1977 Asymptomatic (benign) monoclonal gammopathy - a study of 100 patients Ann Clin Lab Sci 7:335-343, 1977
1807. 1977 Cytomegalovirus mononucleosis Harefuah 92:466-467, 1977
1808. 1977 Agammaglobulinemia, plasma cell dyscrasia and amyloidosis in a 12 year old child Amer J Dis Child 131:682-686, 1977
1809. 1977 Rehabilitation of patients with NCA (neurocirculatory asthenia) through a short term training program. Amer J Phys Med 56:1-5, 1977
1810. 1977 Maximal backpack load for long distance hiking J Sport Med 17:147-153, 1977.
1811. 1977 Hereditary benign leukopenia harefuah 93:203-204, 1977
1812. 1977 Animal models for antiphospholipid syndrome in pregnancy. Rheum Dis Clin of North America 23: 99-117, 1997.
1813. 1977 Physicians and the battle against road accidents. Harefuah 132: 183-184, 1997.
1814. 1977 Our experience with the carcinoembryonic antigens (CEA and AFP). Harefuah 93:177-181, 1977
1815. 1977 Generalized pruritus in metastatic adenocarcinoma of the stomach Dermatologia 155:122-124, 1977
1816. 1976 Congenital ectodermal dysplasia: presentation of 7 cases Harefuah 91:227-229, 1976
1817. 1976 ECG changes in top athletes Cardiology 61:267-278, 1976
1818. 1976 Effects of exposure to Finnish sauna Isr J Med Sci 12:1275-1282, 1976.
1819. 1976 Comparison of the climatic data in the west and east inclinations of the Judean mountains. Meteorology 1:34-37, 1976
1820. 1976 Athlete's heart syndrome Harefuah 91:90-95, 1976
1821. 1976 Hypothermia secondary to endocrine dysfunction. Harefuah 90:419-421, 1976
1822. 1976 Disturbances in immunological mechanisms and development of malignancy Harefuah 90:373-379, 1976
1823. 1976 Acidental hypothermia Harefuah 90:175-180, 1976.
1824. 1976 Accidental hypothermia in healthy adults Harefua 90:164-167, 1976
1825. 1976 Physiologic pigmentation of the gingiva Harefuah 90:12-13, 1976
1826. 1976 Sweat studies in hyperhidrosis palmaris and plantaris Dermatologica 152:257-263, 1976
1827. 1976 Medicine and medical forces Israel Army and Defence (Hebrew). Editors: Schiff Z, Haber E and Bitan Z. Modan 1976
1828. 1976 Alpha-feto-protein in a 3 year old child with hepatoma Tumori 62:43-50, 1976
1829. 1976 B lymphocyte activation Harefuah 90:578-581, 1976.
1830. 1976 Phenomena associated with sympathectomy following hyperhidrosis Harefuah 90:309-311, 1976
1831. 1976 Heat stress: Comparison of short exposure to wet and dry saunas Arch Phys Med Rehab 57:126-131, 1976
1832. 1976 Superficial cold lesions Harefuah 90:229-231, 1976
1833. 1976 Physiology and pathophysiology of exposure to cold. Harefuah 90:124-128, 1976.
1834. 1976 The Skin and the Body (Hebrew) Akademon, The Hebrew University, Jerusalem, 1976. pp 400
1835. 1975 AFP in testicular carcinoma Urol Int 30:162-171, 1975
1836. 1975 The effectiveness of melphalan in multiple myeloma. Modern Medicine 5:117, 1975
1837. 1975 Sweat studies in patients with plantar hyperhidrosis Selected Topics in Environmental Biology. Editors: Bhatia B, China GS, Singh B, 1975. pp. 453-454.
1838. 1975 Hyperhidrosis palmaris and plantaris Harefuah 88:184-185, 1975
1839. 1975 Neurocirculatory asthenia Harefuah 89:414-416, 1975.
1840. 1975 Lymphocyte, plasma cell and the immune response Harefuah 88:466-474, 1975.
1841. 1975 Sweating in the "adhidrotic type" of congenital ectodermal dysplasia. Dermatology 180:277-282, 1975
1842. 1975 Osteogenesis imperfecta: Review of the literature and presentation of 29 cases Amer J Dis Child 129:679-694, 1975
1843. 1975 AFP assay, signficance and clinical application Ny St J Med 27:1403, 1975
1844. 1975 Malignant hyperthermia Harefuah 89:120-131, 1975
1845. 1975 Methods in investigating physical fitness Harefuah 88:578-579, 1975.
1846. 1974 Adjustment to climatic conditions of the Sinai desert Harefuah 87:452-454, 1974.
1847. 1974 Treatment of multiple myeloma Harefuah 86:558-560, 1974
1848. 1974 IgA-heavy chain (alpha chain) disease Harefuah 87:77-79, 1974.
1849. 1974 Multiple myeloma: A study of 40 patients Isr J Med Sci 10:1371-1378, 1974.
1850. 1974 Patterns of T wave changes in ECG in urticaria Brit J Drm 90:283-288, 1974
1851. 1974 Non-secretory multiple myelloma Harefuah 86:540-543, 1974
1852. 1973 Hypophyseal insufficiency due to metastases of breast carcinoma in males. Harefuah 84:301-302, 1973
1853. 1973 Heart diseases and physical fitness in Yemenite Jews Harefuah 94:349, 1973
1854. 1973 T wave changes in urticaria Harefuah 85:359-362, 1973
1855. 1973 AFP in embryonal cell carcinoma of the testis Harefuah 85:163-165, 1973.
1856. 1972 Osteogenesis imperfecta Harefuah 83:319-322, 1972
1857. 1972 Immunoglobulin changes in SLE Ann Allergy 39:99-102, 1972


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.